data_2kqd_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kqd _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 98.4 t . . . . . 0 N--CA 1.493 1.714 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 14.3 mttm -78.66 90.82 4.59 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 121.162 -0.961 . . . . 0.0 109.431 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 43.2 mtm-85 -61.51 154.39 24.77 Favored 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.389 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 4.7 t -79.25 138.49 37.81 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 10.8 p -53.39 151.17 5.73 Favored 'General case' 0 N--CA 1.515 2.798 0 O-C-N 120.882 -1.136 . . . . 0.0 108.52 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 23.4 t -79.82 156.12 27.54 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 120.887 -1.133 . . . . 0.0 111.618 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 65.7 mtm -48.32 -30.94 5.37 Favored 'General case' 0 N--CA 1.519 2.985 0 O-C-N 121.288 -0.882 . . . . 0.0 111.067 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -140.61 37.37 1.84 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.199 -0.938 . . . . 0.0 109.081 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -38.4 -46.07 1.95 Allowed Glycine 0 N--CA 1.506 3.334 0 O-C-N 121.206 -0.933 . . . . 0.0 113.112 -178.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -58.59 -28.69 65.81 Favored 'General case' 0 N--CA 1.51 2.529 0 CA-C-N 118.808 1.304 . . . . 0.0 110.687 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . 0.415 ' O ' ' N ' ' A' ' 386' ' ' TYR . 4.8 m-80 -135.11 28.77 3.44 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.028 -1.045 . . . . 0.0 110.977 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 19.2 t -53.02 88.74 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.807 0 O-C-N 121.091 -1.006 . . . . 0.0 110.957 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 386' ' ' TYR . . . . . 0.415 ' N ' ' O ' ' A' ' 384' ' ' ASN . 20.1 p90 -62.73 -35.94 81.41 Favored 'General case' 0 N--CA 1.507 2.418 0 O-C-N 120.988 -1.07 . . . . 0.0 111.138 -178.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.402 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 5.6 ptm85 -75.99 163.22 27.38 Favored 'General case' 0 N--CA 1.505 2.284 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.538 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -161.04 111.98 1.78 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.328 -0.857 . . . . 0.0 110.967 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -118.93 169.76 7.56 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.103 -0.998 . . . . 0.0 109.691 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -74.56 -29.35 9.13 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 O-C-N 123.463 1.244 . . . . 0.0 110.629 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 60.9 t -100.37 -21.52 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 121.084 -1.01 . . . . 0.0 111.718 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 37.2 t60 -61.95 -38.15 87.41 Favored 'General case' 0 N--CA 1.506 2.374 0 O-C-N 120.625 -1.297 . . . . 0.0 110.056 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -58.95 -31.86 69.09 Favored 'General case' 0 N--CA 1.506 2.365 0 C-N-CA 119.231 -0.987 . . . . 0.0 109.346 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -75.33 -31.56 60.64 Favored 'General case' 0 N--CA 1.508 2.469 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.744 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 16.8 m170 -82.84 -33.83 27.03 Favored 'General case' 0 N--CA 1.507 2.407 0 O-C-N 120.962 -1.086 . . . . 0.0 111.475 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 396' ' ' PHE . . . . . 0.421 ' N ' ' CD1' ' A' ' 396' ' ' PHE . 68.7 m-85 -124.05 141.95 51.61 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.934 -1.104 . . . . 0.0 110.838 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.54 170.81 9.87 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 109.089 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -144.62 153.76 55.24 Favored Pre-proline 0 N--CA 1.485 1.285 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.042 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -60.23 138.81 83.65 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 N-CA-C 108.713 -1.303 . . . . 0.0 108.713 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 102.06 -1.12 51.19 Favored Glycine 0 CA--C 1.554 2.477 0 C-N-CA 119.794 -1.193 . . . . 0.0 110.788 -177.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -114.38 165.3 12.86 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 119.788 1.794 . . . . 0.0 108.656 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 8.9 t -70.22 -25.27 63.32 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.186 -0.946 . . . . 0.0 111.39 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -98.38 5.62 48.01 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.696 -1.253 . . . . 0.0 112.908 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 32.6 t80 . . . . . 0 N--CA 1.507 2.413 0 O-C-N 120.434 -1.416 . . . . 0.0 109.188 179.496 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 90.2 t . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 17.8 mttp -87.73 95.82 10.22 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.335 -0.853 . . . . 0.0 109.187 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.69 162.62 6.38 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 120.211 -0.596 . . . . 0.0 109.898 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 4.4 t -89.83 137.91 31.94 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.42 150.84 4.5 Favored 'General case' 0 N--CA 1.517 2.907 0 O-C-N 120.995 -1.066 . . . . 0.0 109.337 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 47.8 t -80.62 150.59 29.41 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 120.95 -1.094 . . . . 0.0 111.442 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 46.7 mtm -48.21 -30.32 4.58 Favored 'General case' 0 N--CA 1.519 2.983 0 O-C-N 121.283 -0.886 . . . . 0.0 111.709 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -140.54 36.15 1.84 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.183 -0.948 . . . . 0.0 109.369 178.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -37.62 -42.64 1.03 Allowed Glycine 0 N--CA 1.507 3.374 0 O-C-N 121.196 -0.94 . . . . 0.0 113.333 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -60.04 -30.24 69.05 Favored 'General case' 0 N--CA 1.508 2.448 0 O-C-N 121.03 -1.277 . . . . 0.0 110.538 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -134.63 26.06 3.71 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.063 -1.023 . . . . 0.0 111.075 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 35.8 t -49.11 92.2 0.01 OUTLIER 'General case' 0 N--CA 1.519 2.981 0 O-C-N 120.788 -1.195 . . . . 0.0 111.692 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -68.75 -39.04 80.52 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 121.074 -1.016 . . . . 0.0 110.176 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.86 148.43 51.8 Favored 'General case' 0 N--CA 1.508 2.466 0 O-C-N 121.21 -0.931 . . . . 0.0 109.511 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.74 90.81 1.73 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.175 -0.953 . . . . 0.0 110.935 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -100.29 168.54 9.24 Favored Pre-proline 0 N--CA 1.499 2.019 0 O-C-N 120.666 -1.271 . . . . 0.0 110.263 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -75.99 -26.34 9.49 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 O-C-N 123.538 1.283 . . . . 0.0 110.894 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 76.5 t -101.75 -19.57 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 O-C-N 121.074 -1.016 . . . . 0.0 111.779 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 41.5 t60 -63.05 -40.29 97.28 Favored 'General case' 0 N--CA 1.51 2.526 0 O-C-N 120.53 -1.356 . . . . 0.0 110.217 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -56.68 -34.26 67.22 Favored 'General case' 0 N--CA 1.51 2.568 0 O-C-N 121.134 -0.979 . . . . 0.0 109.113 178.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -72.82 -31.32 64.71 Favored 'General case' 0 N--CA 1.507 2.4 0 C-N-CA 119.109 -1.036 . . . . 0.0 111.15 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 20.9 m170 -87.38 -31.94 19.85 Favored 'General case' 0 N--CA 1.508 2.439 0 O-C-N 121.019 -1.051 . . . . 0.0 111.748 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -121.38 144.03 48.89 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.847 -1.158 . . . . 0.0 111.255 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.54 173.02 8.9 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.386 -0.821 . . . . 0.0 109.39 178.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -144.88 155.86 55.64 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.419 -0.801 . . . . 0.0 109.771 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -60.72 136.64 67.91 Favored 'Trans proline' 0 C--N 1.318 -1.07 0 N-CA-C 109.126 -1.144 . . . . 0.0 109.126 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 104.08 -2.46 44.21 Favored Glycine 0 CA--C 1.553 2.455 0 C-N-CA 119.962 -1.113 . . . . 0.0 110.715 -178.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -116.6 150.92 37.27 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 119.62 1.71 . . . . 0.0 108.884 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 2.1 p -58.16 -28.07 64.4 Favored 'General case' 0 N--CA 1.503 2.186 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.318 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -88.18 -0.71 57.42 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 120.727 -1.233 . . . . 0.0 113.349 -178.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 16.5 t80 . . . . . 0 N--CA 1.522 3.156 0 CA-C-N 120.379 1.445 . . . . 0.0 111.756 -178.441 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 10.8 p . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.797 0.332 . . . . 0.0 110.55 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? -89.47 99.05 12.13 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.285 -0.884 . . . . 0.0 108.646 178.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 376' ' ' ARG . . . . . 0.433 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 0.0 OUTLIER -68.66 168.17 13.7 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.63 -0.669 . . . . 0.0 110.22 -179.747 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 5.1 t -85.77 139.9 30.93 Favored 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 119.651 -0.819 . . . . 0.0 110.395 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 378' ' ' SER . . . . . 0.461 ' OG ' ' CE1' ' A' ' 404' ' ' TYR . 9.8 t -59.74 123.21 16.23 Favored 'General case' 0 N--CA 1.512 2.659 0 O-C-N 121.254 -0.904 . . . . 0.0 111.007 -178.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 16.9 t -44.12 144.04 1.04 Allowed 'General case' 0 N--CA 1.508 2.471 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -178.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 57.4 mtm -42.51 -35.86 1.18 Allowed 'General case' 0 N--CA 1.518 2.931 0 O-C-N 122.129 -0.357 . . . . 0.0 110.984 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -133.88 37.35 3.25 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 121.389 -0.82 . . . . 0.0 109.407 178.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -36.94 -47.35 1.29 Allowed Glycine 0 N--CA 1.51 3.625 0 O-C-N 120.902 -1.124 . . . . 0.0 113.346 -178.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -59.2 -24.75 63.38 Favored 'General case' 0 N--CA 1.514 2.761 0 CA-C-N 118.924 1.362 . . . . 0.0 111.159 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -136.07 25.37 3.29 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.92 -1.113 . . . . 0.0 111.105 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 46.9 t -51.92 90.76 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.894 0 O-C-N 120.814 -1.178 . . . . 0.0 111.168 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 386' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 20.0 p90 -66.01 -36.58 83.65 Favored 'General case' 0 N--CA 1.506 2.364 0 O-C-N 121.074 -1.016 . . . . 0.0 111.052 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.436 ' HD3' ' CE1' ' A' ' 392' ' ' HIS . 14.1 ptm180 -64.92 161.96 17.38 Favored 'General case' 0 N--CA 1.511 2.583 0 O-C-N 120.918 -1.114 . . . . 0.0 110.356 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.59 84.86 1.18 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.133 -0.98 . . . . 0.0 111.505 -178.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -103.18 164.73 14.91 Favored Pre-proline 0 N--CA 1.502 2.174 0 O-C-N 120.543 -1.348 . . . . 0.0 110.356 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -76.83 -29.96 5.05 Favored 'Trans proline' 0 N--CA 1.489 1.223 0 O-C-N 123.47 1.247 . . . . 0.0 111.046 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 58.8 t -97.71 -24.63 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 O-C-N 120.985 -1.072 . . . . 0.0 111.51 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 392' ' ' HIS . . . . . 0.436 ' CE1' ' HD3' ' A' ' 387' ' ' ARG . 40.3 t60 -57.53 -37.51 73.17 Favored 'General case' 0 N--CA 1.509 2.51 0 O-C-N 120.794 -1.191 . . . . 0.0 110.05 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -58.73 -33.57 70.38 Favored 'General case' 0 N--CA 1.505 2.291 0 C-N-CA 119.253 -0.979 . . . . 0.0 108.84 178.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -75.08 -35.12 61.82 Favored 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 119.097 -1.041 . . . . 0.0 110.421 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 8.4 m170 -74.56 -29.73 61.46 Favored 'General case' 0 N--CA 1.511 2.621 0 O-C-N 120.996 -1.065 . . . . 0.0 111.903 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -132.97 143.12 49.24 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.705 -1.247 . . . . 0.0 110.739 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 397' ' ' SER . . . . . 0.433 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 74.9 m -83.14 170.78 14.39 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -144.18 157.56 56.69 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.051 -1.031 . . . . 0.0 109.468 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.58 139.37 69.65 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 N-CA-C 108.648 -1.328 . . . . 0.0 108.648 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 96.74 -1.34 61.52 Favored Glycine 0 N--CA 1.494 2.536 0 C-N-CA 119.493 -1.337 . . . . 0.0 111.176 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -115.4 173.14 6.67 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 119.577 1.689 . . . . 0.0 108.271 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 74.8 p -75.03 -31.78 61.43 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 118.869 -1.133 . . . . 0.0 110.284 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -80.37 -6.05 57.4 Favored 'General case' 0 N--CA 1.508 2.442 0 O-C-N 120.777 -1.202 . . . . 0.0 114.087 -176.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . 0.461 ' CE1' ' OG ' ' A' ' 378' ' ' SER . 5.8 t80 . . . . . 0 N--CA 1.528 3.463 0 CA-C-N 120.679 1.581 . . . . 0.0 111.076 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 72.1 t . . . . . 0 N--CA 1.494 1.744 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -82.95 83.22 7.89 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.223 -0.923 . . . . 0.0 109.165 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 376' ' ' ARG . . . . . 0.433 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 1.3 mmt180 -62.16 151.81 34.86 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.831 -0.748 . . . . 0.0 109.977 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 1.9 m -70.48 139.31 51.65 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 14.6 t -55.43 168.94 0.33 Allowed 'General case' 0 N--CA 1.512 2.655 0 O-C-N 120.866 -1.146 . . . . 0.0 109.101 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 50.1 t -86.54 155.09 20.62 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 120.93 -1.106 . . . . 0.0 109.377 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -50.57 -35.61 30.74 Favored 'General case' 0 N--CA 1.515 2.81 0 O-C-N 121.126 -0.984 . . . . 0.0 111.293 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -131.38 36.59 3.77 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.34 -0.85 . . . . 0.0 109.62 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -37.35 -46.59 1.43 Allowed Glycine 0 N--CA 1.509 3.501 0 O-C-N 121.143 -0.973 . . . . 0.0 113.518 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -58.52 -26.74 63.82 Favored 'General case' 0 N--CA 1.512 2.667 0 CA-C-N 118.964 1.382 . . . . 0.0 110.923 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . 0.446 ' O ' ' N ' ' A' ' 386' ' ' TYR . 5.5 m-80 -136.53 24.95 3.17 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.939 -1.101 . . . . 0.0 111.182 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 36.2 t -50.18 87.93 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.052 0 O-C-N 120.9 -1.125 . . . . 0.0 111.356 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 386' ' ' TYR . . . . . 0.46 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 21.9 p90 -60.73 -38.28 84.6 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.041 -1.037 . . . . 0.0 111.16 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.46 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 14.1 ptm180 -59.23 149.59 28.04 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 121.176 -0.953 . . . . 0.0 110.225 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.98 76.09 1.61 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.323 -0.861 . . . . 0.0 110.933 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -114.3 152.74 46.26 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.071 -1.018 . . . . 0.0 109.29 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -71.59 -76.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.316 -1.183 0 O-C-N 123.408 1.215 . . . . 0.0 110.193 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 11.2 p -38.68 -33.16 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.524 3.258 0 O-C-N 120.888 -1.133 . . . . 0.0 112.639 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 392' ' ' HIS . . . . . 0.424 ' CE1' ' HD3' ' A' ' 387' ' ' ARG . 37.3 t60 -65.22 -37.87 88.64 Favored 'General case' 0 N--CA 1.511 2.598 0 O-C-N 121.092 -1.005 . . . . 0.0 109.552 178.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -59.06 -34.21 71.68 Favored 'General case' 0 N--CA 1.508 2.464 0 O-C-N 121.082 -1.011 . . . . 0.0 108.887 177.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -77.43 -30.94 53.66 Favored 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.242 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 14.9 m170 -78.12 -25.63 47.56 Favored 'General case' 0 N--CA 1.511 2.598 0 O-C-N 121.075 -1.016 . . . . 0.0 111.95 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -135.89 147.07 48.01 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.686 -1.259 . . . . 0.0 110.556 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 397' ' ' SER . . . . . 0.433 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 54.6 m -89.21 160.78 16.78 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.365 -0.834 . . . . 0.0 109.772 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -136.55 156.38 76.38 Favored Pre-proline 0 N--CA 1.485 1.279 0 C-N-CA 119.786 -0.766 . . . . 0.0 110.051 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . 0.414 ' HD3' ' CE1' ' A' ' 404' ' ' TYR . 37.2 Cg_endo -62.57 137.97 67.41 Favored 'Trans proline' 0 C--N 1.319 -1.023 0 N-CA-C 108.303 -1.46 . . . . 0.0 108.303 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 98.51 0.11 58.09 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.471 -1.347 . . . . 0.0 110.64 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -111.57 177.54 4.62 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 119.561 1.68 . . . . 0.0 108.597 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -81.06 -25.41 37.12 Favored 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 119.081 -1.047 . . . . 0.0 110.93 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -97.13 4.75 51.09 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 120.621 -1.299 . . . . 0.0 114.469 -177.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . 0.414 ' CE1' ' HD3' ' A' ' 399' ' ' PRO . 4.3 t80 . . . . . 0 N--CA 1.53 3.57 0 CA-C-N 120.676 1.58 . . . . 0.0 110.965 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 89.1 t . . . . . 0 N--CA 1.493 1.714 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.67 83.1 7.76 Favored 'General case' 0 N--CA 1.504 2.238 0 C-N-CA 119.311 -0.956 . . . . 0.0 108.444 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 376' ' ' ARG . . . . . 0.437 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 2.3 mmt180 -60.56 154.34 21.25 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 119.949 -0.7 . . . . 0.0 110.103 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 1.8 m -71.32 140.67 50.35 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 29.2 t -52.48 166.5 0.18 Allowed 'General case' 0 N--CA 1.511 2.613 0 C-N-CA 119.239 -0.984 . . . . 0.0 109.349 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 50.9 t -90.17 154.86 19.44 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 120.837 -1.164 . . . . 0.0 109.613 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 56.0 mtm -49.65 -32.07 12.3 Favored 'General case' 0 N--CA 1.519 2.995 0 O-C-N 121.279 -0.888 . . . . 0.0 111.726 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -138.5 38.31 2.25 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.229 -0.919 . . . . 0.0 109.552 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -37.65 -49.65 1.86 Allowed Glycine 0 N--CA 1.508 3.473 0 O-C-N 121.231 -0.918 . . . . 0.0 113.032 -178.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -55.24 -27.21 44.69 Favored 'General case' 0 N--CA 1.51 2.53 0 O-C-N 120.997 -1.296 . . . . 0.0 111.231 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . 0.436 ' O ' ' N ' ' A' ' 386' ' ' TYR . 4.9 m-80 -138.1 29.31 2.52 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.95 -1.094 . . . . 0.0 110.936 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 37.8 t -53.54 85.89 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.988 0 O-C-N 120.98 -1.075 . . . . 0.0 111.516 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 386' ' ' TYR . . . . . 0.436 ' N ' ' O ' ' A' ' 384' ' ' ASN . 17.3 p90 -61.24 -31.17 70.96 Favored 'General case' 0 N--CA 1.51 2.565 0 O-C-N 121.005 -1.059 . . . . 0.0 111.64 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 3.6 ptm85 -79.79 160.63 26.09 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 120.977 -1.077 . . . . 0.0 110.943 -179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.74 112.75 2.97 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.329 -0.857 . . . . 0.0 110.909 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -121.42 169.54 8.97 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.847 -1.158 . . . . 0.0 109.785 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.9 -30.66 8.98 Favored 'Trans proline' 0 C--N 1.314 -1.27 0 O-C-N 123.473 1.249 . . . . 0.0 110.609 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 73.9 t -100.38 -22.65 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.094 -1.004 . . . . 0.0 111.772 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 41.2 t60 -61.5 -39.38 90.76 Favored 'General case' 0 N--CA 1.51 2.525 0 O-C-N 120.528 -1.358 . . . . 0.0 109.829 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -55.73 -33.15 63.98 Favored 'General case' 0 N--CA 1.507 2.416 0 C-N-CA 119.294 -0.962 . . . . 0.0 108.916 178.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.406 ' O ' ' NE ' ' A' ' 376' ' ' ARG . 1.0 OUTLIER -78.43 -32.09 48.4 Favored 'General case' 0 N--CA 1.504 2.237 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.556 179.791 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -79.93 -17.83 52.03 Favored 'General case' 0 N--CA 1.513 2.699 0 O-C-N 120.927 -1.108 . . . . 0.0 112.976 -178.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -145.09 142.61 29.83 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.442 -1.411 . . . . 0.0 110.725 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 397' ' ' SER . . . . . 0.437 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 19.9 m -85.05 170.54 12.87 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.255 -0.903 . . . . 0.0 110.506 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -143.7 151.5 53.69 Favored Pre-proline 0 N--CA 1.482 1.153 0 C-N-CA 119.831 -0.748 . . . . 0.0 109.645 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -60.73 139.51 85.91 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 N-CA-C 107.767 -1.667 . . . . 0.0 107.767 178.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.18 2.43 55.83 Favored Glycine 0 CA--C 1.548 2.131 0 C-N-CA 119.331 -1.414 . . . . 0.0 110.44 -177.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.52 158.92 26.25 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 119.77 1.785 . . . . 0.0 108.681 177.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 39.8 t -62.93 -30.77 71.82 Favored 'General case' 0 N--CA 1.501 2.091 0 C-N-CA 118.995 -1.082 . . . . 0.0 110.819 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -89.42 -2.73 58.5 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 120.64 -1.287 . . . . 0.0 113.732 -177.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 34.8 t80 . . . . . 0 N--CA 1.516 2.859 0 CA-C-N 120.492 1.496 . . . . 0.0 110.491 -179.522 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 120.627 0.251 . . . . 0.0 110.43 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.7 84.73 6.19 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.283 -0.886 . . . . 0.0 109.411 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 376' ' ' ARG . . . . . 0.453 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 1.2 mmt180 -60.83 148.92 37.62 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.664 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 5.5 t -67.77 140.93 56.69 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 1.3 p -54.16 158.93 2.04 Favored 'General case' 0 N--CA 1.507 2.379 0 C-N-CA 119.311 -0.956 . . . . 0.0 109.374 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 53.6 t -84.08 154.73 23.03 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 120.996 -1.065 . . . . 0.0 110.139 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 51.5 mtm -51.74 -30.82 24.04 Favored 'General case' 0 N--CA 1.515 2.821 0 O-C-N 121.306 -0.872 . . . . 0.0 111.82 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . 0.422 ' O ' ' N ' ' A' ' 385' ' ' CYS . 22.3 m-85 -137.11 36.73 2.55 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.063 -1.023 . . . . 0.0 109.3 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -40.31 -46.84 3.53 Favored Glycine 0 N--CA 1.506 3.3 0 O-C-N 121.34 -0.85 . . . . 0.0 112.901 -178.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -59.22 -28.26 66.5 Favored 'General case' 0 N--CA 1.509 2.486 0 CA-C-N 118.789 1.295 . . . . 0.0 110.957 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -136.92 28.82 2.87 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.818 -1.176 . . . . 0.0 111.039 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . 0.422 ' N ' ' O ' ' A' ' 381' ' ' TYR . 9.9 t -47.44 140.24 5.94 Favored 'General case' 0 N--CA 1.518 2.967 0 O-C-N 120.961 -1.087 . . . . 0.0 111.722 -178.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 386' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 4.1 p90 -113.05 -39.78 4.12 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.192 -0.942 . . . . 0.0 110.654 178.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.438 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 13.6 ptm180 -69.53 155.46 40.45 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 120.9 -1.125 . . . . 0.0 109.626 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.33 97.21 2.51 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.153 -0.967 . . . . 0.0 110.871 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -113.76 169.25 6.7 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 120.752 -1.217 . . . . 0.0 110.502 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -75.44 -25.76 10.89 Favored 'Trans proline' 0 CA--C 1.549 1.226 0 O-C-N 123.54 1.284 . . . . 0.0 110.466 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.8 t -100.87 -23.04 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 O-C-N 121.115 -0.99 . . . . 0.0 112.14 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 392' ' ' HIS . . . . . 0.41 ' CE1' ' HD3' ' A' ' 387' ' ' ARG . 40.9 t60 -62.85 -38.3 90.28 Favored 'General case' 0 N--CA 1.515 2.782 0 O-C-N 120.529 -1.357 . . . . 0.0 110.013 -178.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -56.31 -32.16 64.36 Favored 'General case' 0 N--CA 1.508 2.43 0 C-N-CA 119.175 -1.01 . . . . 0.0 108.927 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.42 ' O ' ' NE ' ' A' ' 376' ' ' ARG . 1.0 OUTLIER -80.73 -32.69 35.65 Favored 'General case' 0 N--CA 1.505 2.314 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.149 179.461 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 395' ' ' HIS . . . . . 0.403 ' HB3' ' CE2' ' A' ' 396' ' ' PHE . 16.5 m170 -72.92 -30.76 64.16 Favored 'General case' 0 N--CA 1.509 2.519 0 O-C-N 121.069 -1.019 . . . . 0.0 111.01 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 396' ' ' PHE . . . . . 0.403 ' CE2' ' HB3' ' A' ' 395' ' ' HIS . 47.6 m-85 -138.01 148.04 44.76 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.83 -1.169 . . . . 0.0 110.53 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 397' ' ' SER . . . . . 0.453 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 3.0 m -90.05 172.24 8.98 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.481 -0.762 . . . . 0.0 110.409 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -142.46 151.03 56.66 Favored Pre-proline 0 N--CA 1.487 1.38 0 C-N-CA 119.656 -0.818 . . . . 0.0 110.816 -178.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -61.96 139.44 79.32 Favored 'Trans proline' 0 C--N 1.321 -0.902 0 N-CA-C 107.489 -1.774 . . . . 0.0 107.489 178.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 98.54 0.57 57.93 Favored Glycine 0 CA--C 1.552 2.382 0 C-N-CA 119.37 -1.395 . . . . 0.0 110.203 -177.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -114.85 165.23 13.06 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 119.529 1.664 . . . . 0.0 107.933 177.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.85 -25.35 62.78 Favored 'General case' 0 N--CA 1.506 2.361 0 C-N-CA 119.086 -1.046 . . . . 0.0 111.615 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -99.51 8.57 44.39 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 120.576 -1.328 . . . . 0.0 113.133 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 21.2 t80 . . . . . 0 N--CA 1.516 2.847 0 CA-C-N 120.279 1.399 . . . . 0.0 110.652 -179.421 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 90.6 t . . . . . 0 N--CA 1.495 1.788 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 26.6 tttm -83.77 84.87 7.4 Favored 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 119.223 -0.991 . . . . 0.0 109.202 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 376' ' ' ARG . . . . . 0.474 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 1.9 mmt180 -69.07 152.78 44.78 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.277 -0.969 . . . . 0.0 108.925 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 6.5 t -70.62 144.37 51.17 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 119.486 -0.886 . . . . 0.0 108.903 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.34 158.66 4.07 Favored 'General case' 0 N--CA 1.509 2.487 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 44.1 t -78.91 157.58 28.22 Favored 'General case' 0 N--CA 1.508 2.445 0 O-C-N 120.712 -1.243 . . . . 0.0 110.384 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 55.0 mtm -48.67 -29.5 4.45 Favored 'General case' 0 N--CA 1.513 2.721 0 O-C-N 121.211 -0.93 . . . . 0.0 112.242 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -121.83 17.83 11.03 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.967 -1.083 . . . . 0.0 112.447 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 46.42 -114.41 1.44 Allowed Glycine 0 N--CA 1.499 2.834 0 O-C-N 120.782 -1.199 . . . . 0.0 112.487 177.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -76.83 -18.31 58.46 Favored 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.488 -1.007 . . . . 0.0 112.585 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . 0.443 ' O ' ' N ' ' A' ' 386' ' ' TYR . 33.6 m-80 -84.9 0.69 50.24 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 120.546 -1.346 . . . . 0.0 111.871 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 49.2 t -49.67 87.5 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.935 0 O-C-N 120.775 -1.203 . . . . 0.0 111.585 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 386' ' ' TYR . . . . . 0.443 ' N ' ' O ' ' A' ' 384' ' ' ASN . 31.8 p90 -66.14 -36.41 83.07 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 120.848 -1.157 . . . . 0.0 110.865 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -71.19 160.99 31.85 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.193 -0.942 . . . . 0.0 110.072 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 36.4 pttt -159.5 110.97 2.04 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.336 -0.853 . . . . 0.0 110.534 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -117.73 170.83 5.67 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 120.949 -1.095 . . . . 0.0 110.355 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -74.28 -27.93 11.01 Favored 'Trans proline' 0 N--CA 1.489 1.238 0 O-C-N 123.486 1.256 . . . . 0.0 110.875 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 58.3 t -103.12 -18.86 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 120.987 -1.071 . . . . 0.0 111.933 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 34.3 t60 -65.12 -39.42 93.06 Favored 'General case' 0 N--CA 1.508 2.471 0 O-C-N 120.559 -1.338 . . . . 0.0 109.961 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -55.15 -37.18 66.65 Favored 'General case' 0 N--CA 1.51 2.568 0 C-N-CA 119.215 -0.994 . . . . 0.0 108.467 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.42 ' O ' ' NE ' ' A' ' 376' ' ' ARG . 1.2 mp0 -74.84 -31.01 61.55 Favored 'General case' 0 N--CA 1.502 2.16 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.076 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 23.2 m170 -75.72 -27.09 58.05 Favored 'General case' 0 N--CA 1.509 2.522 0 O-C-N 120.975 -1.078 . . . . 0.0 111.61 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -140.19 150.72 44.53 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.821 -1.174 . . . . 0.0 110.612 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 397' ' ' SER . . . . . 0.474 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 3.1 m -89.46 171.74 9.5 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.467 -0.771 . . . . 0.0 109.836 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -144.56 153.03 54.56 Favored Pre-proline 0 N--CA 1.487 1.415 0 O-C-N 121.437 -0.79 . . . . 0.0 108.903 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -60.72 137.75 75.1 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 N-CA-C 109.0 -1.192 . . . . 0.0 109.0 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 104.07 -1.2 44.23 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.619 -1.277 . . . . 0.0 111.566 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -112.87 176.2 5.11 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 119.987 1.894 . . . . 0.0 109.3 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 2.7 t -79.15 -25.57 42.86 Favored 'General case' 0 N--CA 1.506 2.332 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.864 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -98.1 1.48 47.63 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.66 -1.275 . . . . 0.0 112.498 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 31.5 t80 . . . . . 0 N--CA 1.515 2.817 0 CA-C-N 120.096 1.316 . . . . 0.0 110.738 -179.923 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 57.7 t . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 375' ' ' LYS . 0.0 OUTLIER -89.05 100.11 12.96 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 122.089 0.947 . . . . 0.0 109.078 179.093 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.46 -177.22 0.06 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.484 -0.76 . . . . 0.0 111.109 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 3.3 m -108.24 130.84 55.14 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 378' ' ' SER . . . . . 0.46 ' OG ' ' CE1' ' A' ' 404' ' ' TYR . 30.7 t -48.91 118.44 2.6 Favored 'General case' 0 N--CA 1.515 2.802 0 O-C-N 121.656 -0.653 . . . . 0.0 110.724 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . 0.415 ' HB2' ' CD2' ' A' ' 398' ' ' HIS . 9.3 t -38.56 151.35 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.731 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -178.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 53.9 mtm -46.27 -34.6 4.57 Favored 'General case' 0 N--CA 1.509 2.513 0 O-C-N 121.838 -0.539 . . . . 0.0 111.117 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -114.52 9.33 16.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.123 -0.985 . . . . 0.0 113.163 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 57.82 -120.44 21.55 Favored Glycine 0 N--CA 1.491 2.361 0 O-C-N 120.175 -1.578 . . . . 0.0 112.159 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -75.6 -13.38 60.34 Favored 'General case' 0 N--CA 1.51 2.531 0 O-C-N 121.485 -1.009 . . . . 0.0 112.655 -178.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . 0.402 ' O ' ' N ' ' A' ' 386' ' ' TYR . 58.1 m-20 -86.01 -2.35 58.22 Favored 'General case' 0 N--CA 1.507 2.407 0 O-C-N 120.575 -1.328 . . . . 0.0 111.12 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 52.7 t -47.02 89.54 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.998 0 O-C-N 120.825 -1.172 . . . . 0.0 111.872 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 386' ' ' TYR . . . . . 0.402 ' N ' ' O ' ' A' ' 384' ' ' ASN . 31.3 p90 -70.34 -38.19 74.8 Favored 'General case' 0 N--CA 1.508 2.428 0 O-C-N 120.892 -1.13 . . . . 0.0 110.956 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.433 ' HD3' ' CE1' ' A' ' 392' ' ' HIS . 14.1 ptm180 -57.79 152.26 16.08 Favored 'General case' 0 N--CA 1.51 2.532 0 O-C-N 121.028 -1.045 . . . . 0.0 110.262 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -142.16 79.16 1.66 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.244 -0.91 . . . . 0.0 111.058 -179.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -97.26 160.64 28.45 Favored Pre-proline 0 N--CA 1.502 2.137 0 O-C-N 120.977 -1.077 . . . . 0.0 110.534 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -75.96 -29.2 6.98 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 O-C-N 123.547 1.288 . . . . 0.0 111.214 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 57.3 t -99.15 -22.38 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 O-C-N 121.236 -0.915 . . . . 0.0 111.594 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 392' ' ' HIS . . . . . 0.433 ' CE1' ' HD3' ' A' ' 387' ' ' ARG . 38.4 t60 -59.19 -37.76 78.2 Favored 'General case' 0 N--CA 1.51 2.542 0 O-C-N 120.611 -1.305 . . . . 0.0 110.152 -179.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -59.39 -33.72 71.55 Favored 'General case' 0 N--CA 1.505 2.295 0 C-N-CA 119.112 -1.035 . . . . 0.0 108.805 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -72.19 -33.34 67.59 Favored 'General case' 0 N--CA 1.503 2.19 0 C-N-CA 119.206 -0.997 . . . . 0.0 110.828 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 27.2 m170 -79.64 -34.81 40.2 Favored 'General case' 0 N--CA 1.509 2.485 0 O-C-N 120.983 -1.073 . . . . 0.0 111.224 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -121.92 158.51 28.87 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.029 -1.044 . . . . 0.0 110.304 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.45 173.77 6.16 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 178.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . 0.415 ' CD2' ' HB2' ' A' ' 379' ' ' CYS . 76.6 m80 -145.74 157.35 51.47 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 120.891 -1.131 . . . . 0.0 108.871 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . 0.41 ' HD3' ' CE1' ' A' ' 404' ' ' TYR . 36.6 Cg_endo -62.69 140.57 81.49 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 N-CA-C 108.892 -1.234 . . . . 0.0 108.892 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.88 -3.63 55.9 Favored Glycine 0 N--CA 1.496 2.689 0 C-N-CA 119.684 -1.246 . . . . 0.0 111.299 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -112.14 177.17 4.73 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 119.544 1.672 . . . . 0.0 108.689 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 1.4 p -79.36 -28.34 41.97 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.099 -1.04 . . . . 0.0 110.556 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -88.29 -4.45 58.69 Favored 'General case' 0 N--CA 1.509 2.501 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -176.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . 0.46 ' CE1' ' OG ' ' A' ' 378' ' ' SER . 7.9 t80 . . . . . 0 N--CA 1.533 3.679 0 CA-C-N 120.742 1.61 . . . . 0.0 111.869 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 120.598 0.237 . . . . 0.0 110.595 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.23 97.62 10.03 Favored 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 119.337 -0.945 . . . . 0.0 108.533 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.64 148.14 50.88 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.641 -0.824 . . . . 0.0 109.919 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 5.8 t -69.08 142.59 54.44 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 19.0 p -55.65 156.49 4.79 Favored 'General case' 0 N--CA 1.508 2.427 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 48.5 t -80.31 154.08 28.03 Favored 'General case' 0 N--CA 1.507 2.419 0 O-C-N 120.763 -1.211 . . . . 0.0 111.039 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 60.4 mtm -49.34 -33.26 13.03 Favored 'General case' 0 N--CA 1.516 2.844 0 O-C-N 121.303 -0.873 . . . . 0.0 111.288 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -136.36 39.13 2.69 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.208 -0.932 . . . . 0.0 108.831 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -39.02 -43.07 1.72 Allowed Glycine 0 N--CA 1.509 3.504 0 O-C-N 121.521 -0.737 . . . . 0.0 113.064 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -62.01 -29.53 70.34 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.015 -1.285 . . . . 0.0 110.745 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . 0.4 ' O ' ' N ' ' A' ' 386' ' ' TYR . 7.2 m-80 -133.66 25.14 4.05 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.955 -1.091 . . . . 0.0 111.803 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 17.1 t -47.81 90.12 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.022 0 O-C-N 120.788 -1.195 . . . . 0.0 112.269 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 386' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 24.8 p90 -62.92 -41.92 99.63 Favored 'General case' 0 N--CA 1.51 2.569 0 O-C-N 120.832 -1.168 . . . . 0.0 110.289 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.451 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.2 OUTLIER -63.98 157.07 26.02 Favored 'General case' 0 N--CA 1.509 2.499 0 O-C-N 121.134 -0.979 . . . . 0.0 110.231 -179.531 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.38 92.23 1.58 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.314 -0.866 . . . . 0.0 110.805 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -106.84 162.68 18.9 Favored Pre-proline 0 N--CA 1.5 2.059 0 O-C-N 121.138 -0.976 . . . . 0.0 110.44 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -74.17 -26.53 12.6 Favored 'Trans proline' 0 CA--C 1.545 1.072 0 O-C-N 123.56 1.295 . . . . 0.0 111.264 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 60.8 t -99.86 -24.8 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 O-C-N 121.141 -0.974 . . . . 0.0 111.492 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 392' ' ' HIS . . . . . 0.433 ' CE1' ' NH1' ' A' ' 387' ' ' ARG . 44.8 t60 -61.36 -36.93 81.56 Favored 'General case' 0 N--CA 1.511 2.588 0 O-C-N 120.633 -1.292 . . . . 0.0 110.19 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -56.49 -34.27 66.8 Favored 'General case' 0 N--CA 1.507 2.4 0 C-N-CA 119.117 -1.033 . . . . 0.0 108.492 177.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.72 -32.85 58.1 Favored 'General case' 0 N--CA 1.506 2.36 0 C-N-CA 119.454 -0.899 . . . . 0.0 111.087 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -75.74 -34.41 60.29 Favored 'General case' 0 N--CA 1.509 2.524 0 O-C-N 121.133 -0.979 . . . . 0.0 110.938 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -128.56 151.27 49.65 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.985 -1.072 . . . . 0.0 110.528 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.33 168.83 11.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.577 -0.702 . . . . 0.0 109.322 178.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -140.94 152.93 66.7 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.357 -0.839 . . . . 0.0 109.728 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . 0.468 ' HA ' ' CD2' ' A' ' 404' ' ' TYR . 36.3 Cg_endo -59.43 136.87 74.55 Favored 'Trans proline' 0 C--N 1.316 -1.153 0 N-CA-C 108.839 -1.254 . . . . 0.0 108.839 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 102.41 0.04 50.16 Favored Glycine 0 CA--C 1.55 2.244 0 C-N-CA 119.635 -1.269 . . . . 0.0 111.419 -179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -111.28 171.91 7.2 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 119.954 1.877 . . . . 0.0 109.451 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 50.5 m -75.5 -24.48 56.88 Favored 'General case' 0 N--CA 1.505 2.323 0 C-N-CA 119.246 -0.982 . . . . 0.0 111.103 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -102.14 5.89 40.57 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 120.644 -1.285 . . . . 0.0 112.728 -178.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . 0.468 ' CD2' ' HA ' ' A' ' 399' ' ' PRO . 14.0 t80 . . . . . 0 N--CA 1.515 2.815 0 O-C-N 120.688 -1.258 . . . . 0.0 112.483 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 60.0 t . . . . . 0 N--CA 1.493 1.693 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 31.6 mtpt -88.71 94.32 9.87 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 119.618 -0.833 . . . . 0.0 109.732 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 376' ' ' ARG . . . . . 0.412 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 42.1 mtm-85 -55.81 146.01 22.83 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.706 -0.621 . . . . 0.0 110.573 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 2.3 m -69.28 137.48 53.08 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 87.4 p -52.84 157.3 1.7 Allowed 'General case' 0 N--CA 1.512 2.656 0 O-C-N 121.054 -1.029 . . . . 0.0 109.749 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 12.7 t -80.74 158.52 25.49 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 120.854 -1.154 . . . . 0.0 109.107 179.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -55.59 -39.12 70.3 Favored 'General case' 0 N--CA 1.513 2.688 0 O-C-N 121.149 -0.97 . . . . 0.0 109.946 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . 0.404 ' CD1' ' N ' ' A' ' 381' ' ' TYR . 8.5 m-85 -128.29 38.29 4.01 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -38.04 -44.87 1.58 Allowed Glycine 0 N--CA 1.507 3.373 0 O-C-N 121.321 -0.862 . . . . 0.0 113.13 -177.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -59.35 -27.86 66.32 Favored 'General case' 0 N--CA 1.507 2.422 0 CA-C-N 118.653 1.226 . . . . 0.0 110.703 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . 0.419 ' O ' ' N ' ' A' ' 386' ' ' TYR . 7.4 m-80 -133.14 19.82 4.06 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.843 -1.161 . . . . 0.0 112.109 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 33.7 t -43.75 88.78 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.367 0 CA-C-N 119.787 1.176 . . . . 0.0 112.775 -178.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 386' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 20.4 p90 -63.17 -40.59 97.96 Favored 'General case' 0 N--CA 1.509 2.504 0 O-C-N 120.95 -1.094 . . . . 0.0 111.537 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.455 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 15.1 ptm180 -56.02 151.15 12.41 Favored 'General case' 0 N--CA 1.513 2.708 0 O-C-N 120.821 -1.175 . . . . 0.0 110.376 -179.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -133.34 72.68 1.49 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.142 -0.974 . . . . 0.0 110.725 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -106.71 149.27 38.22 Favored Pre-proline 0 N--CA 1.498 1.972 0 O-C-N 121.094 -1.004 . . . . 0.0 109.547 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -69.73 -83.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.316 -1.173 0 O-C-N 123.498 1.262 . . . . 0.0 108.94 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 88.2 t -38.64 -26.48 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.526 3.358 0 O-C-N 120.833 -1.167 . . . . 0.0 113.288 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 392' ' ' HIS . . . . . 0.433 ' CE1' ' HD3' ' A' ' 387' ' ' ARG . 25.9 t60 -64.15 -39.36 93.84 Favored 'General case' 0 N--CA 1.512 2.626 0 O-C-N 120.312 -1.493 . . . . 0.0 108.504 177.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -59.87 -37.42 79.26 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.291 -0.881 . . . . 0.0 109.228 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -70.01 -26.55 64.12 Favored 'General case' 0 N--CA 1.507 2.393 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.215 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 19.2 m170 -90.99 -34.6 15.08 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.757 -1.214 . . . . 0.0 110.605 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -117.33 144.45 44.88 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.048 -1.033 . . . . 0.0 110.355 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 397' ' ' SER . . . . . 0.412 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 0.1 OUTLIER -98.0 167.03 11.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 110.528 179.611 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -140.07 153.57 69.43 Favored Pre-proline 0 N--CA 1.488 1.431 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.894 -178.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . 0.426 ' HA ' ' CD2' ' A' ' 404' ' ' TYR . 37.9 Cg_endo -62.28 137.9 68.53 Favored 'Trans proline' 0 N--CA 1.484 0.954 0 N-CA-C 108.038 -1.562 . . . . 0.0 108.038 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.37 -2.35 56.22 Favored Glycine 0 CA--C 1.551 2.343 0 C-N-CA 119.695 -1.24 . . . . 0.0 110.384 -177.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -115.47 140.07 49.48 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 119.649 1.725 . . . . 0.0 108.499 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 5.8 m -49.43 -25.61 2.69 Favored 'General case' 0 N--CA 1.509 2.512 0 O-C-N 121.11 -0.994 . . . . 0.0 113.201 -178.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -99.32 11.1 40.04 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 120.28 -1.513 . . . . 0.0 113.551 -177.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . 0.426 ' CD2' ' HA ' ' A' ' 399' ' ' PRO . 6.1 t80 . . . . . 0 N--CA 1.515 2.816 0 O-C-N 120.365 -1.46 . . . . 0.0 109.487 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.73 148.53 46.85 Favored 'Trans proline' 0 C--N 1.317 -1.108 0 O-C-N 123.378 1.199 . . . . 0.0 110.411 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 1.1 tp -142.96 -172.91 3.76 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.202 -0.936 . . . . 0.0 110.147 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 112.08 56.67 0.46 Allowed Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 38.7 p -142.82 57.31 1.42 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.214 -1.168 . . . . 0.0 110.208 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -117.97 104.36 1.13 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 1.4 t -143.07 108.65 5.09 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.217 -1.167 . . . . 0.0 110.292 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -114.87 110.77 20.18 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.19 -0.944 . . . . 0.0 110.068 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -69.08 -78.71 0.32 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -153.72 37.16 0.46 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.198 -1.178 . . . . 0.0 110.687 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -158.29 40.49 0.26 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.151 -0.968 . . . . 0.0 110.835 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 98.4 t -149.0 161.04 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.428 -0.795 . . . . 0.0 109.617 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 14.3 mttm -78.66 90.82 4.59 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 121.162 -0.961 . . . . 0.0 109.431 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 43.2 mtm-85 -61.51 154.39 24.77 Favored 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.389 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 4.7 t -79.25 138.49 37.81 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 10.8 p -53.39 151.17 5.73 Favored 'General case' 0 N--CA 1.515 2.798 0 O-C-N 120.882 -1.136 . . . . 0.0 108.52 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 23.4 t -79.82 156.12 27.54 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 120.887 -1.133 . . . . 0.0 111.618 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 65.7 mtm -48.32 -30.94 5.37 Favored 'General case' 0 N--CA 1.519 2.985 0 O-C-N 121.288 -0.882 . . . . 0.0 111.067 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . 0.444 ' CD1' ' N3 ' ' A' 1002 ' ' ADN . 14.7 m-85 -140.61 37.37 1.84 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.199 -0.938 . . . . 0.0 109.081 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -38.4 -46.07 1.95 Allowed Glycine 0 N--CA 1.506 3.334 0 O-C-N 121.206 -0.933 . . . . 0.0 113.112 -178.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -58.59 -28.69 65.81 Favored 'General case' 0 N--CA 1.51 2.529 0 CA-C-N 118.808 1.304 . . . . 0.0 110.687 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . 0.454 ' HB2' HN61 ' A' 1002 ' ' ADN . 4.8 m-80 -135.11 28.77 3.44 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.028 -1.045 . . . . 0.0 110.977 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 19.2 t -53.02 88.74 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.807 0 O-C-N 121.091 -1.006 . . . . 0.0 110.957 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' TYR . . . . . 0.7 ' OH ' " H1'" ' A' 1003 ' ' RIB . 20.1 p90 -62.73 -35.94 81.41 Favored 'General case' 0 N--CA 1.507 2.418 0 O-C-N 120.988 -1.07 . . . . 0.0 111.138 -178.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.484 ' HD2' " H3'" ' A' 1003 ' ' RIB . 5.6 ptm85 -75.99 163.22 27.38 Favored 'General case' 0 N--CA 1.505 2.284 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.538 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -161.04 111.98 1.78 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.328 -0.857 . . . . 0.0 110.967 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -118.93 169.76 7.56 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.103 -0.998 . . . . 0.0 109.691 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -74.56 -29.35 9.13 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 O-C-N 123.463 1.244 . . . . 0.0 110.629 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 60.9 t -100.37 -21.52 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 121.084 -1.01 . . . . 0.0 111.718 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 37.2 t60 -61.95 -38.15 87.41 Favored 'General case' 0 N--CA 1.506 2.374 0 O-C-N 120.625 -1.297 . . . . 0.0 110.056 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -58.95 -31.86 69.09 Favored 'General case' 0 N--CA 1.506 2.365 0 C-N-CA 119.231 -0.987 . . . . 0.0 109.346 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -75.33 -31.56 60.64 Favored 'General case' 0 N--CA 1.508 2.469 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.744 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 16.8 m170 -82.84 -33.83 27.03 Favored 'General case' 0 N--CA 1.507 2.407 0 O-C-N 120.962 -1.086 . . . . 0.0 111.475 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' PHE . . . . . 0.421 ' N ' ' CD1' ' A' ' 396' ' ' PHE . 68.7 m-85 -124.05 141.95 51.61 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.934 -1.104 . . . . 0.0 110.838 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.54 170.81 9.87 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 109.089 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -144.62 153.76 55.24 Favored Pre-proline 0 N--CA 1.485 1.285 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.042 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -60.23 138.81 83.65 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 N-CA-C 108.713 -1.303 . . . . 0.0 108.713 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 102.06 -1.12 51.19 Favored Glycine 0 CA--C 1.554 2.477 0 C-N-CA 119.794 -1.193 . . . . 0.0 110.788 -177.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -114.38 165.3 12.86 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 119.788 1.794 . . . . 0.0 108.656 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 8.9 t -70.22 -25.27 63.32 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.186 -0.946 . . . . 0.0 111.39 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -98.38 5.62 48.01 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.696 -1.253 . . . . 0.0 112.908 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -55.98 143.4 32.32 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 120.434 -1.416 . . . . 0.0 109.188 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -158.23 41.85 0.51 Allowed Glycine 0 N--CA 1.496 2.668 0 C-N-CA 119.547 -1.311 . . . . 0.0 110.045 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' GLY . . . . . 0.403 ' HA3' ' NE2' ' A' ' 408' ' ' GLN . . . -99.99 -54.01 1.07 Allowed Glycine 0 N--CA 1.482 1.749 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 86.5 t 44.4 66.23 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.739 -0.86 . . . . 0.0 111.631 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 0.403 ' NE2' ' HA3' ' A' ' 406' ' ' GLY . 2.2 mp0 -105.32 71.87 0.96 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.29 -0.881 . . . . 0.0 110.08 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 46.7 mm 50.81 71.96 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 120.978 -1.076 . . . . 0.0 110.956 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 63.5 t -113.75 80.22 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.335 -0.853 . . . . 0.0 108.781 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 79.08 58.72 2.9 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 108.345 -1.902 . . . . 0.0 108.345 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -49.4 -66.41 0.4 Allowed 'General case' 0 N--CA 1.511 2.616 0 O-C-N 121.335 -1.097 . . . . 0.0 110.948 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -159.27 39.46 0.21 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.179 -0.951 . . . . 0.0 110.836 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -115.01 40.52 2.62 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.135 -0.978 . . . . 0.0 110.239 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.32 65.28 0.94 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.238 -0.914 . . . . 0.0 109.935 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -118.2 41.72 2.86 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.3 -0.875 . . . . 0.0 110.207 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.494 1.754 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.211 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A 1002 ' ' ADN . . . . . 0.454 HN61 ' HB2' ' A' ' 384' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1003 ' ' RIB . . . . . 0.7 " H1'" ' OH ' ' A' ' 386' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.68 -171.23 0.71 Allowed 'Trans proline' 0 C--N 1.316 -1.154 0 O-C-N 123.44 1.232 . . . . 0.0 110.339 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 42.6 mt -115.32 105.13 12.51 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.173 -0.954 . . . . 0.0 110.183 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 120.18 103.84 1.99 Allowed Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 4.2 t -117.03 117.04 28.56 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.131 -1.217 . . . . 0.0 110.256 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -137.63 168.48 24.45 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 1.7 m -123.85 120.58 32.99 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.147 -1.208 . . . . 0.0 110.157 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -138.5 85.61 2.1 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.185 -0.947 . . . . 0.0 110.269 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -139.52 42.29 1.25 Allowed Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -145.29 -65.9 0.32 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.183 -1.186 . . . . 0.0 110.252 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 2.3 tptp -142.2 65.14 1.37 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.223 -0.923 . . . . 0.0 110.08 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 90.2 t -145.82 161.0 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -0.908 . . . . 0.0 109.985 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 17.8 mttp -87.73 95.82 10.22 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.335 -0.853 . . . . 0.0 109.187 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.69 162.62 6.38 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 120.211 -0.596 . . . . 0.0 109.898 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 4.4 t -89.83 137.91 31.94 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.42 150.84 4.5 Favored 'General case' 0 N--CA 1.517 2.907 0 O-C-N 120.995 -1.066 . . . . 0.0 109.337 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 47.8 t -80.62 150.59 29.41 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 120.95 -1.094 . . . . 0.0 111.442 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 46.7 mtm -48.21 -30.32 4.58 Favored 'General case' 0 N--CA 1.519 2.983 0 O-C-N 121.283 -0.886 . . . . 0.0 111.709 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . 0.43 ' CD1' ' N3 ' ' A' 1002 ' ' ADN . 20.6 m-85 -140.54 36.15 1.84 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.183 -0.948 . . . . 0.0 109.369 178.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -37.62 -42.64 1.03 Allowed Glycine 0 N--CA 1.507 3.374 0 O-C-N 121.196 -0.94 . . . . 0.0 113.333 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -60.04 -30.24 69.05 Favored 'General case' 0 N--CA 1.508 2.448 0 O-C-N 121.03 -1.277 . . . . 0.0 110.538 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . 0.45 ' HB2' HN61 ' A' 1002 ' ' ADN . 4.8 m-80 -134.63 26.06 3.71 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.063 -1.023 . . . . 0.0 111.075 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 35.8 t -49.11 92.2 0.01 OUTLIER 'General case' 0 N--CA 1.519 2.981 0 O-C-N 120.788 -1.195 . . . . 0.0 111.692 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' TYR . . . . . 0.711 ' OH ' " H1'" ' A' 1003 ' ' RIB . 20.6 p90 -68.75 -39.04 80.52 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 121.074 -1.016 . . . . 0.0 110.176 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.44 ' CZ ' HO3' ' A' 1003 ' ' RIB . 0.0 OUTLIER -65.86 148.43 51.8 Favored 'General case' 0 N--CA 1.508 2.466 0 O-C-N 121.21 -0.931 . . . . 0.0 109.511 179.757 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.74 90.81 1.73 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.175 -0.953 . . . . 0.0 110.935 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -100.29 168.54 9.24 Favored Pre-proline 0 N--CA 1.499 2.019 0 O-C-N 120.666 -1.271 . . . . 0.0 110.263 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -75.99 -26.34 9.49 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 O-C-N 123.538 1.283 . . . . 0.0 110.894 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 76.5 t -101.75 -19.57 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 O-C-N 121.074 -1.016 . . . . 0.0 111.779 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 41.5 t60 -63.05 -40.29 97.28 Favored 'General case' 0 N--CA 1.51 2.526 0 O-C-N 120.53 -1.356 . . . . 0.0 110.217 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -56.68 -34.26 67.22 Favored 'General case' 0 N--CA 1.51 2.568 0 O-C-N 121.134 -0.979 . . . . 0.0 109.113 178.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -72.82 -31.32 64.71 Favored 'General case' 0 N--CA 1.507 2.4 0 C-N-CA 119.109 -1.036 . . . . 0.0 111.15 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 20.9 m170 -87.38 -31.94 19.85 Favored 'General case' 0 N--CA 1.508 2.439 0 O-C-N 121.019 -1.051 . . . . 0.0 111.748 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -121.38 144.03 48.89 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.847 -1.158 . . . . 0.0 111.255 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.54 173.02 8.9 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.386 -0.821 . . . . 0.0 109.39 178.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -144.88 155.86 55.64 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.419 -0.801 . . . . 0.0 109.771 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -60.72 136.64 67.91 Favored 'Trans proline' 0 C--N 1.318 -1.07 0 N-CA-C 109.126 -1.144 . . . . 0.0 109.126 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 104.08 -2.46 44.21 Favored Glycine 0 CA--C 1.553 2.455 0 C-N-CA 119.962 -1.113 . . . . 0.0 110.715 -178.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -116.6 150.92 37.27 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 119.62 1.71 . . . . 0.0 108.884 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 2.1 p -58.16 -28.07 64.4 Favored 'General case' 0 N--CA 1.503 2.186 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.318 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -88.18 -0.71 57.42 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 120.727 -1.233 . . . . 0.0 113.349 -178.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -43.6 120.3 1.93 Allowed 'General case' 0 N--CA 1.522 3.156 0 CA-C-N 120.379 1.445 . . . . 0.0 111.756 -178.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -54.33 -48.17 65.47 Favored Glycine 0 N--CA 1.497 2.719 0 O-C-N 121.305 -0.872 . . . . 0.0 111.251 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 141.89 -143.71 13.33 Favored Glycine 0 N--CA 1.477 1.369 0 N-CA-C 107.571 -2.212 . . . . 0.0 107.571 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 73.5 t -111.53 92.82 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.297 -1.12 . . . . 0.0 110.614 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -108.81 84.01 1.86 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.34 -0.85 . . . . 0.0 110.062 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 4.6 mp 51.59 67.78 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.04 -1.038 . . . . 0.0 110.549 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 62.7 t -121.63 65.75 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 93.94 51.81 2.04 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 108.109 -1.996 . . . . 0.0 108.109 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -46.98 -60.66 2.3 Favored 'General case' 0 N--CA 1.512 2.666 0 O-C-N 121.478 -1.013 . . . . 0.0 111.333 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -144.55 42.67 1.37 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.263 -0.898 . . . . 0.0 110.424 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -124.29 39.65 3.92 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.151 -0.968 . . . . 0.0 110.261 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.58 60.72 1.68 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.261 -0.899 . . . . 0.0 109.796 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -137.05 40.14 2.51 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.167 -0.958 . . . . 0.0 110.348 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.366 179.967 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A 1002 ' ' ADN . . . . . 0.594 " O5'" ' H8 ' ' A' 1002 ' ' ADN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1003 ' ' RIB . . . . . 0.711 " H1'" ' OH ' ' A' ' 386' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.91 105.97 2.05 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 O-C-N 123.315 1.166 . . . . 0.0 110.35 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -136.28 48.43 2.15 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.212 -0.93 . . . . 0.0 110.229 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 118.26 -82.19 0.33 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 54.2 p -120.9 71.7 0.95 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.222 -1.164 . . . . 0.0 110.197 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -140.96 107.87 0.53 Allowed Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 66.4 m -117.31 56.48 0.82 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.291 -1.123 . . . . 0.0 110.135 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -143.13 -172.0 3.59 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.188 -0.945 . . . . 0.0 110.198 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -81.44 -98.11 0.41 Allowed Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -132.05 71.95 1.48 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.217 -1.167 . . . . 0.0 110.101 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 52.51 61.25 3.29 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 120.959 -1.088 . . . . 0.0 110.469 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 10.8 p -142.92 162.73 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.216 -0.927 . . . . 0.0 110.55 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? -89.47 99.05 12.13 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.285 -0.884 . . . . 0.0 108.646 178.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' ARG . . . . . 0.433 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 0.0 OUTLIER -68.66 168.17 13.7 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.63 -0.669 . . . . 0.0 110.22 -179.747 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 5.1 t -85.77 139.9 30.93 Favored 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 119.651 -0.819 . . . . 0.0 110.395 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' SER . . . . . 0.461 ' OG ' ' CE1' ' A' ' 404' ' ' TYR . 9.8 t -59.74 123.21 16.23 Favored 'General case' 0 N--CA 1.512 2.659 0 O-C-N 121.254 -0.904 . . . . 0.0 111.007 -178.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 16.9 t -44.12 144.04 1.04 Allowed 'General case' 0 N--CA 1.508 2.471 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -178.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 57.4 mtm -42.51 -35.86 1.18 Allowed 'General case' 0 N--CA 1.518 2.931 0 O-C-N 122.129 -0.357 . . . . 0.0 110.984 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . 0.426 ' CD1' ' N3 ' ' A' 1002 ' ' ADN . 13.9 m-85 -133.88 37.35 3.25 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 121.389 -0.82 . . . . 0.0 109.407 178.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -36.94 -47.35 1.29 Allowed Glycine 0 N--CA 1.51 3.625 0 O-C-N 120.902 -1.124 . . . . 0.0 113.346 -178.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -59.2 -24.75 63.38 Favored 'General case' 0 N--CA 1.514 2.761 0 CA-C-N 118.924 1.362 . . . . 0.0 111.159 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . 0.454 ' CB ' HN61 ' A' 1002 ' ' ADN . 7.1 m-80 -136.07 25.37 3.29 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.92 -1.113 . . . . 0.0 111.105 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 46.9 t -51.92 90.76 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.894 0 O-C-N 120.814 -1.178 . . . . 0.0 111.168 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' TYR . . . . . 0.711 ' OH ' " H1'" ' A' 1003 ' ' RIB . 20.0 p90 -66.01 -36.58 83.65 Favored 'General case' 0 N--CA 1.506 2.364 0 O-C-N 121.074 -1.016 . . . . 0.0 111.052 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.436 ' HD3' ' CE1' ' A' ' 392' ' ' HIS . 14.1 ptm180 -64.92 161.96 17.38 Favored 'General case' 0 N--CA 1.511 2.583 0 O-C-N 120.918 -1.114 . . . . 0.0 110.356 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.59 84.86 1.18 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.133 -0.98 . . . . 0.0 111.505 -178.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -103.18 164.73 14.91 Favored Pre-proline 0 N--CA 1.502 2.174 0 O-C-N 120.543 -1.348 . . . . 0.0 110.356 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -76.83 -29.96 5.05 Favored 'Trans proline' 0 N--CA 1.489 1.223 0 O-C-N 123.47 1.247 . . . . 0.0 111.046 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 58.8 t -97.71 -24.63 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 O-C-N 120.985 -1.072 . . . . 0.0 111.51 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . 0.436 ' CE1' ' HD3' ' A' ' 387' ' ' ARG . 40.3 t60 -57.53 -37.51 73.17 Favored 'General case' 0 N--CA 1.509 2.51 0 O-C-N 120.794 -1.191 . . . . 0.0 110.05 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -58.73 -33.57 70.38 Favored 'General case' 0 N--CA 1.505 2.291 0 C-N-CA 119.253 -0.979 . . . . 0.0 108.84 178.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -75.08 -35.12 61.82 Favored 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 119.097 -1.041 . . . . 0.0 110.421 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 8.4 m170 -74.56 -29.73 61.46 Favored 'General case' 0 N--CA 1.511 2.621 0 O-C-N 120.996 -1.065 . . . . 0.0 111.903 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -132.97 143.12 49.24 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.705 -1.247 . . . . 0.0 110.739 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' SER . . . . . 0.433 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 74.9 m -83.14 170.78 14.39 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -144.18 157.56 56.69 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.051 -1.031 . . . . 0.0 109.468 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.58 139.37 69.65 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 N-CA-C 108.648 -1.328 . . . . 0.0 108.648 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 96.74 -1.34 61.52 Favored Glycine 0 N--CA 1.494 2.536 0 C-N-CA 119.493 -1.337 . . . . 0.0 111.176 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -115.4 173.14 6.67 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 119.577 1.689 . . . . 0.0 108.271 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 74.8 p -75.03 -31.78 61.43 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 118.869 -1.133 . . . . 0.0 110.284 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -80.37 -6.05 57.4 Favored 'General case' 0 N--CA 1.508 2.442 0 O-C-N 120.777 -1.202 . . . . 0.0 114.087 -176.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . 0.461 ' CE1' ' OG ' ' A' ' 378' ' ' SER . 5.8 t80 -40.85 119.96 1.22 Allowed 'General case' 0 N--CA 1.528 3.463 0 CA-C-N 120.679 1.581 . . . . 0.0 111.076 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -174.02 76.04 0.08 OUTLIER Glycine 0 N--CA 1.502 3.05 0 C-N-CA 119.531 -1.318 . . . . 0.0 110.823 -178.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' GLY . . . . . 0.404 ' N ' ' HB2' ' A' ' 378' ' ' SER . . . -146.2 -55.13 0.02 OUTLIER Glycine 0 N--CA 1.5 2.944 0 C-N-CA 119.882 -1.151 . . . . 0.0 111.391 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.58 64.89 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.136 -1.214 . . . . 0.0 110.698 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 0.428 ' NE2' ' CE2' ' A' ' 404' ' ' TYR . 14.4 mt-30 -136.08 91.86 2.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.896 . . . . 0.0 109.982 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 51.2 mm -103.71 65.57 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.325 -0.86 . . . . 0.0 109.566 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 64.0 t -112.67 77.99 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 83.74 57.95 2.34 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 108.089 -2.004 . . . . 0.0 108.089 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' GLN . . . . . 0.413 ' NE2' ' HA ' ' A' ' 412' ' ' GLN . 12.2 mm-40 -56.1 -39.69 72.56 Favored 'General case' 0 N--CA 1.509 2.488 0 O-C-N 121.316 -1.109 . . . . 0.0 110.291 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -114.62 34.74 4.59 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.171 -0.956 . . . . 0.0 110.274 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 50.75 52.09 15.62 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.888 -1.132 . . . . 0.0 110.976 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -113.55 66.38 0.66 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.216 -0.928 . . . . 0.0 110.187 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -118.24 81.16 1.63 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.364 -0.835 . . . . 0.0 110.122 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.214 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A 1002 ' ' ADN . . . . . 0.454 HN61 ' CB ' ' A' ' 384' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1003 ' ' RIB . . . . . 0.711 " H1'" ' OH ' ' A' ' 386' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.7 133.05 19.64 Favored 'Trans proline' 0 C--N 1.316 -1.135 0 O-C-N 123.49 1.258 . . . . 0.0 110.434 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -116.43 -65.26 1.21 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.205 -0.935 . . . . 0.0 110.159 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -134.06 136.52 8.67 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.53 89.39 2.21 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.214 -1.168 . . . . 0.0 110.209 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -132.67 63.73 0.62 Allowed Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 58.5 m -144.84 125.65 14.31 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.237 -1.155 . . . . 0.0 110.318 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -140.74 -164.39 1.72 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.129 -0.982 . . . . 0.0 109.998 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 84.46 41.51 7.82 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -138.53 -63.83 0.54 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.221 -1.164 . . . . 0.0 110.363 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.71 54.93 1.67 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.066 -1.021 . . . . 0.0 110.246 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 72.1 t -148.01 158.38 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.212 -0.93 . . . . 0.0 110.279 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -82.95 83.22 7.89 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.223 -0.923 . . . . 0.0 109.165 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' ARG . . . . . 0.433 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 1.3 mmt180 -62.16 151.81 34.86 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.831 -0.748 . . . . 0.0 109.977 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 1.9 m -70.48 139.31 51.65 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' SER . . . . . 0.408 ' HB2' ' N ' ' A' ' 406' ' ' GLY . 14.6 t -55.43 168.94 0.33 Allowed 'General case' 0 N--CA 1.512 2.655 0 O-C-N 120.866 -1.146 . . . . 0.0 109.101 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 50.1 t -86.54 155.09 20.62 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 120.93 -1.106 . . . . 0.0 109.377 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -50.57 -35.61 30.74 Favored 'General case' 0 N--CA 1.515 2.81 0 O-C-N 121.126 -0.984 . . . . 0.0 111.293 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . 0.434 ' CD1' ' N3 ' ' A' 1002 ' ' ADN . 22.8 m-85 -131.38 36.59 3.77 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.34 -0.85 . . . . 0.0 109.62 178.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -37.35 -46.59 1.43 Allowed Glycine 0 N--CA 1.509 3.501 0 O-C-N 121.143 -0.973 . . . . 0.0 113.518 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -58.52 -26.74 63.82 Favored 'General case' 0 N--CA 1.512 2.667 0 CA-C-N 118.964 1.382 . . . . 0.0 110.923 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . 0.446 ' O ' ' N ' ' A' ' 386' ' ' TYR . 5.5 m-80 -136.53 24.95 3.17 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.939 -1.101 . . . . 0.0 111.182 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 36.2 t -50.18 87.93 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.052 0 O-C-N 120.9 -1.125 . . . . 0.0 111.356 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' TYR . . . . . 0.708 ' OH ' " H1'" ' A' 1003 ' ' RIB . 21.9 p90 -60.73 -38.28 84.6 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.041 -1.037 . . . . 0.0 111.16 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.46 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 14.1 ptm180 -59.23 149.59 28.04 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 121.176 -0.953 . . . . 0.0 110.225 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.98 76.09 1.61 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.323 -0.861 . . . . 0.0 110.933 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -114.3 152.74 46.26 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.071 -1.018 . . . . 0.0 109.29 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -71.59 -76.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.316 -1.183 0 O-C-N 123.408 1.215 . . . . 0.0 110.193 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 11.2 p -38.68 -33.16 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.524 3.258 0 O-C-N 120.888 -1.133 . . . . 0.0 112.639 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . 0.424 ' CE1' ' HD3' ' A' ' 387' ' ' ARG . 37.3 t60 -65.22 -37.87 88.64 Favored 'General case' 0 N--CA 1.511 2.598 0 O-C-N 121.092 -1.005 . . . . 0.0 109.552 178.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -59.06 -34.21 71.68 Favored 'General case' 0 N--CA 1.508 2.464 0 O-C-N 121.082 -1.011 . . . . 0.0 108.887 177.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -77.43 -30.94 53.66 Favored 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.242 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 14.9 m170 -78.12 -25.63 47.56 Favored 'General case' 0 N--CA 1.511 2.598 0 O-C-N 121.075 -1.016 . . . . 0.0 111.95 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -135.89 147.07 48.01 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.686 -1.259 . . . . 0.0 110.556 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' SER . . . . . 0.433 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 54.6 m -89.21 160.78 16.78 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.365 -0.834 . . . . 0.0 109.772 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -136.55 156.38 76.38 Favored Pre-proline 0 N--CA 1.485 1.279 0 C-N-CA 119.786 -0.766 . . . . 0.0 110.051 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . 0.414 ' HD3' ' CE1' ' A' ' 404' ' ' TYR . 37.2 Cg_endo -62.57 137.97 67.41 Favored 'Trans proline' 0 C--N 1.319 -1.023 0 N-CA-C 108.303 -1.46 . . . . 0.0 108.303 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 98.51 0.11 58.09 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.471 -1.347 . . . . 0.0 110.64 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -111.57 177.54 4.62 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 119.561 1.68 . . . . 0.0 108.597 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -81.06 -25.41 37.12 Favored 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 119.081 -1.047 . . . . 0.0 110.93 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -97.13 4.75 51.09 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 120.621 -1.299 . . . . 0.0 114.469 -177.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . 0.477 ' CE2' ' HB3' ' A' ' 408' ' ' GLN . 4.3 t80 -40.2 121.29 1.33 Allowed 'General case' 0 N--CA 1.53 3.57 0 CA-C-N 120.676 1.58 . . . . 0.0 110.965 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -168.61 80.15 0.1 Allowed Glycine 0 N--CA 1.495 2.602 0 C-N-CA 119.37 -1.395 . . . . 0.0 111.033 -178.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' GLY . . . . . 0.408 ' N ' ' HB2' ' A' ' 378' ' ' SER . . . -171.64 -55.22 0.04 OUTLIER Glycine 0 N--CA 1.499 2.858 0 C-N-CA 119.274 -1.441 . . . . 0.0 112.571 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.1 p -138.96 92.2 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-N 118.943 1.371 . . . . 0.0 111.048 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 0.477 ' HB3' ' CE2' ' A' ' 404' ' ' TYR . 1.0 OUTLIER -152.6 83.03 1.23 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.17 -0.957 . . . . 0.0 110.663 179.131 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 28.7 mt -110.26 76.32 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.427 -0.796 . . . . 0.0 109.792 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 9.8 p -115.79 69.35 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.369 -0.832 . . . . 0.0 109.197 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 93.78 56.31 1.43 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.116 -1.994 . . . . 0.0 108.116 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -48.85 -66.42 0.4 Allowed 'General case' 0 N--CA 1.511 2.62 0 O-C-N 121.45 -1.029 . . . . 0.0 110.891 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -169.15 44.26 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.188 -0.945 . . . . 0.0 110.763 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -124.42 63.34 1.1 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.178 -0.951 . . . . 0.0 110.306 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 6.0 t -132.64 62.16 1.66 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.143 -0.973 . . . . 0.0 110.196 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -103.48 38.83 1.7 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.164 -0.96 . . . . 0.0 109.871 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 1.4 t70 . . . . . 0 N--CA 1.494 1.774 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.356 179.974 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A 1002 ' ' ADN . . . . . 0.445 HN61 ' HB2' ' A' ' 384' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1003 ' ' RIB . . . . . 0.708 " H1'" ' OH ' ' A' ' 386' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.63 144.36 39.67 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 O-C-N 123.473 1.249 . . . . 0.0 110.455 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 1.6 mp -123.66 104.77 9.21 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.256 -0.902 . . . . 0.0 110.178 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -128.34 179.6 16.47 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 69.8 p -122.23 45.0 2.45 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.139 -1.212 . . . . 0.0 110.228 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -105.9 170.76 17.26 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 1.8 m -140.2 39.81 1.93 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.165 -1.197 . . . . 0.0 110.354 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -157.85 159.23 36.45 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.279 -0.888 . . . . 0.0 110.687 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -87.61 -56.48 2.11 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -145.91 65.18 1.22 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.144 -1.209 . . . . 0.0 110.411 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? 52.63 75.67 0.22 Allowed 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.954 -1.091 . . . . 0.0 110.674 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 89.1 t -148.39 158.98 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.217 -0.927 . . . . 0.0 110.229 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.67 83.1 7.76 Favored 'General case' 0 N--CA 1.504 2.238 0 C-N-CA 119.311 -0.956 . . . . 0.0 108.444 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' ARG . . . . . 0.437 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 2.3 mmt180 -60.56 154.34 21.25 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 119.949 -0.7 . . . . 0.0 110.103 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 1.8 m -71.32 140.67 50.35 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' SER . . . . . 0.441 ' CB ' ' HA3' ' A' ' 406' ' ' GLY . 29.2 t -52.48 166.5 0.18 Allowed 'General case' 0 N--CA 1.511 2.613 0 C-N-CA 119.239 -0.984 . . . . 0.0 109.349 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 50.9 t -90.17 154.86 19.44 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 120.837 -1.164 . . . . 0.0 109.613 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 56.0 mtm -49.65 -32.07 12.3 Favored 'General case' 0 N--CA 1.519 2.995 0 O-C-N 121.279 -0.888 . . . . 0.0 111.726 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . 0.438 ' CD1' ' N3 ' ' A' 1002 ' ' ADN . 24.3 m-85 -138.5 38.31 2.25 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.229 -0.919 . . . . 0.0 109.552 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -37.65 -49.65 1.86 Allowed Glycine 0 N--CA 1.508 3.473 0 O-C-N 121.231 -0.918 . . . . 0.0 113.032 -178.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -55.24 -27.21 44.69 Favored 'General case' 0 N--CA 1.51 2.53 0 O-C-N 120.997 -1.296 . . . . 0.0 111.231 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . 0.501 ' HB2' HN61 ' A' 1002 ' ' ADN . 4.9 m-80 -138.1 29.31 2.52 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.95 -1.094 . . . . 0.0 110.936 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 37.8 t -53.54 85.89 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.988 0 O-C-N 120.98 -1.075 . . . . 0.0 111.516 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' TYR . . . . . 0.666 ' OH ' " H1'" ' A' 1003 ' ' RIB . 17.3 p90 -61.24 -31.17 70.96 Favored 'General case' 0 N--CA 1.51 2.565 0 O-C-N 121.005 -1.059 . . . . 0.0 111.64 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.416 ' HD2' " H3'" ' A' 1003 ' ' RIB . 3.6 ptm85 -79.79 160.63 26.09 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 120.977 -1.077 . . . . 0.0 110.943 -179.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.74 112.75 2.97 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.329 -0.857 . . . . 0.0 110.909 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -121.42 169.54 8.97 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.847 -1.158 . . . . 0.0 109.785 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.9 -30.66 8.98 Favored 'Trans proline' 0 C--N 1.314 -1.27 0 O-C-N 123.473 1.249 . . . . 0.0 110.609 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 73.9 t -100.38 -22.65 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.094 -1.004 . . . . 0.0 111.772 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 41.2 t60 -61.5 -39.38 90.76 Favored 'General case' 0 N--CA 1.51 2.525 0 O-C-N 120.528 -1.358 . . . . 0.0 109.829 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -55.73 -33.15 63.98 Favored 'General case' 0 N--CA 1.507 2.416 0 C-N-CA 119.294 -0.962 . . . . 0.0 108.916 178.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.406 ' O ' ' NE ' ' A' ' 376' ' ' ARG . 1.0 OUTLIER -78.43 -32.09 48.4 Favored 'General case' 0 N--CA 1.504 2.237 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.556 179.791 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -79.93 -17.83 52.03 Favored 'General case' 0 N--CA 1.513 2.699 0 O-C-N 120.927 -1.108 . . . . 0.0 112.976 -178.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -145.09 142.61 29.83 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.442 -1.411 . . . . 0.0 110.725 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' SER . . . . . 0.437 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 19.9 m -85.05 170.54 12.87 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.255 -0.903 . . . . 0.0 110.506 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -143.7 151.5 53.69 Favored Pre-proline 0 N--CA 1.482 1.153 0 C-N-CA 119.831 -0.748 . . . . 0.0 109.645 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -60.73 139.51 85.91 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 N-CA-C 107.767 -1.667 . . . . 0.0 107.767 178.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.18 2.43 55.83 Favored Glycine 0 CA--C 1.548 2.131 0 C-N-CA 119.331 -1.414 . . . . 0.0 110.44 -177.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.52 158.92 26.25 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 119.77 1.785 . . . . 0.0 108.681 177.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 39.8 t -62.93 -30.77 71.82 Favored 'General case' 0 N--CA 1.501 2.091 0 C-N-CA 118.995 -1.082 . . . . 0.0 110.819 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -89.42 -2.73 58.5 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 120.64 -1.287 . . . . 0.0 113.732 -177.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -48.82 138.61 10.96 Favored 'General case' 0 N--CA 1.516 2.859 0 CA-C-N 120.492 1.496 . . . . 0.0 110.491 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -167.57 58.42 0.22 Allowed Glycine 0 N--CA 1.501 2.992 0 C-N-CA 119.536 -1.316 . . . . 0.0 110.43 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' GLY . . . . . 0.441 ' HA3' ' CB ' ' A' ' 378' ' ' SER . . . -110.61 -60.12 0.49 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 91.1 t 34.52 63.95 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 122.414 -0.463 . . . . 0.0 111.983 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 11.6 mp0 -103.05 92.75 4.68 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.361 -0.837 . . . . 0.0 110.526 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 84.1 mt -111.31 67.24 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.25 -0.906 . . . . 0.0 109.685 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 61.7 t -115.18 73.5 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 83.5 55.31 2.89 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.168 -1.973 . . . . 0.0 108.168 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -47.83 -63.31 1.1 Allowed 'General case' 0 N--CA 1.513 2.724 0 O-C-N 121.477 -1.013 . . . . 0.0 110.932 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -138.37 37.59 2.28 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.307 -0.871 . . . . 0.0 110.429 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -141.93 69.84 1.33 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.177 -0.952 . . . . 0.0 110.133 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 7.5 t -133.69 49.2 2.3 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.126 -0.984 . . . . 0.0 110.189 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 3.2 t70 51.05 34.25 10.52 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.101 -0.999 . . . . 0.0 111.108 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 17.8 t0 . . . . . 0 N--CA 1.494 1.734 0 O-C-N 121.032 -1.042 . . . . 0.0 110.171 179.981 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A 1002 ' ' ADN . . . . . 0.501 HN61 ' HB2' ' A' ' 384' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1003 ' ' RIB . . . . . 0.666 " H1'" ' OH ' ' A' ' 386' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -72.97 147.81 44.21 Favored 'Trans proline' 0 C--N 1.317 -1.114 0 O-C-N 123.428 1.225 . . . . 0.0 110.456 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.62 -59.79 0.44 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.186 -0.946 . . . . 0.0 110.277 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -142.35 121.31 1.76 Allowed Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 33.5 m -143.26 87.71 1.98 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.268 -1.137 . . . . 0.0 110.241 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -79.55 81.08 1.49 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.39 56.44 1.45 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.117 -1.225 . . . . 0.0 110.183 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -159.57 178.43 9.87 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.17 -0.956 . . . . 0.0 110.946 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -76.29 -89.56 0.26 Allowed Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -136.75 67.65 1.44 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.169 -1.194 . . . . 0.0 110.111 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 52.4 65.77 1.41 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.007 -1.058 . . . . 0.0 110.61 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 11.1 p -143.38 162.3 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.319 -0.863 . . . . 0.0 110.43 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.7 84.73 6.19 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.283 -0.886 . . . . 0.0 109.411 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' ARG . . . . . 0.453 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 1.2 mmt180 -60.83 148.92 37.62 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.664 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 5.5 t -67.77 140.93 56.69 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 1.3 p -54.16 158.93 2.04 Favored 'General case' 0 N--CA 1.507 2.379 0 C-N-CA 119.311 -0.956 . . . . 0.0 109.374 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 53.6 t -84.08 154.73 23.03 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 120.996 -1.065 . . . . 0.0 110.139 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 51.5 mtm -51.74 -30.82 24.04 Favored 'General case' 0 N--CA 1.515 2.821 0 O-C-N 121.306 -0.872 . . . . 0.0 111.82 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . 0.422 ' O ' ' N ' ' A' ' 385' ' ' CYS . 22.3 m-85 -137.11 36.73 2.55 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.063 -1.023 . . . . 0.0 109.3 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -40.31 -46.84 3.53 Favored Glycine 0 N--CA 1.506 3.3 0 O-C-N 121.34 -0.85 . . . . 0.0 112.901 -178.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -59.22 -28.26 66.5 Favored 'General case' 0 N--CA 1.509 2.486 0 CA-C-N 118.789 1.295 . . . . 0.0 110.957 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -136.92 28.82 2.87 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.818 -1.176 . . . . 0.0 111.039 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . 0.422 ' N ' ' O ' ' A' ' 381' ' ' TYR . 9.9 t -47.44 140.24 5.94 Favored 'General case' 0 N--CA 1.518 2.967 0 O-C-N 120.961 -1.087 . . . . 0.0 111.722 -178.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' TYR . . . . . 0.687 ' OH ' " H1'" ' A' 1003 ' ' RIB . 4.1 p90 -113.05 -39.78 4.12 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.192 -0.942 . . . . 0.0 110.654 178.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.438 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 13.6 ptm180 -69.53 155.46 40.45 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 120.9 -1.125 . . . . 0.0 109.626 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.33 97.21 2.51 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.153 -0.967 . . . . 0.0 110.871 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -113.76 169.25 6.7 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 120.752 -1.217 . . . . 0.0 110.502 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -75.44 -25.76 10.89 Favored 'Trans proline' 0 CA--C 1.549 1.226 0 O-C-N 123.54 1.284 . . . . 0.0 110.466 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.8 t -100.87 -23.04 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 O-C-N 121.115 -0.99 . . . . 0.0 112.14 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . 0.41 ' CE1' ' HD3' ' A' ' 387' ' ' ARG . 40.9 t60 -62.85 -38.3 90.28 Favored 'General case' 0 N--CA 1.515 2.782 0 O-C-N 120.529 -1.357 . . . . 0.0 110.013 -178.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -56.31 -32.16 64.36 Favored 'General case' 0 N--CA 1.508 2.43 0 C-N-CA 119.175 -1.01 . . . . 0.0 108.927 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.42 ' O ' ' NE ' ' A' ' 376' ' ' ARG . 1.0 OUTLIER -80.73 -32.69 35.65 Favored 'General case' 0 N--CA 1.505 2.314 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.149 179.461 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' HIS . . . . . 0.403 ' HB3' ' CE2' ' A' ' 396' ' ' PHE . 16.5 m170 -72.92 -30.76 64.16 Favored 'General case' 0 N--CA 1.509 2.519 0 O-C-N 121.069 -1.019 . . . . 0.0 111.01 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' PHE . . . . . 0.403 ' CE2' ' HB3' ' A' ' 395' ' ' HIS . 47.6 m-85 -138.01 148.04 44.76 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.83 -1.169 . . . . 0.0 110.53 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' SER . . . . . 0.453 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 3.0 m -90.05 172.24 8.98 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.481 -0.762 . . . . 0.0 110.409 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -142.46 151.03 56.66 Favored Pre-proline 0 N--CA 1.487 1.38 0 C-N-CA 119.656 -0.818 . . . . 0.0 110.816 -178.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -61.96 139.44 79.32 Favored 'Trans proline' 0 C--N 1.321 -0.902 0 N-CA-C 107.489 -1.774 . . . . 0.0 107.489 178.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 98.54 0.57 57.93 Favored Glycine 0 CA--C 1.552 2.382 0 C-N-CA 119.37 -1.395 . . . . 0.0 110.203 -177.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -114.85 165.23 13.06 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 119.529 1.664 . . . . 0.0 107.933 177.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.85 -25.35 62.78 Favored 'General case' 0 N--CA 1.506 2.361 0 C-N-CA 119.086 -1.046 . . . . 0.0 111.615 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -99.51 8.57 44.39 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 120.576 -1.328 . . . . 0.0 113.133 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -47.08 130.3 12.46 Favored 'General case' 0 N--CA 1.516 2.847 0 CA-C-N 120.279 1.399 . . . . 0.0 110.652 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -72.94 -34.39 58.93 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 115.18 -121.89 5.44 Favored Glycine 0 C--O 1.216 -0.997 0 N-CA-C 106.778 -2.529 . . . . 0.0 106.778 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 98.1 t -136.3 99.26 2.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 O-C-N 121.741 -0.858 . . . . 0.0 109.644 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -110.6 48.85 0.89 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.284 -0.885 . . . . 0.0 110.613 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 5.2 mp 46.4 66.01 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.38 -0.825 . . . . 0.0 111.142 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 8.3 p -119.39 68.37 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 104.44 56.63 0.72 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.17 -1.972 . . . . 0.0 108.17 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -54.26 -63.83 1.02 Allowed 'General case' 0 N--CA 1.509 2.479 0 O-C-N 121.386 -1.067 . . . . 0.0 110.313 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -160.08 40.25 0.18 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.15 -0.969 . . . . 0.0 110.629 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -114.26 62.26 0.66 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.241 -0.912 . . . . 0.0 110.066 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 415' ' ' THR . . . . . 0.568 ' CB ' HO5' ' A' 1002 ' ' ADN . 0.2 OUTLIER -113.09 65.21 0.64 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.217 -0.927 . . . . 0.0 110.005 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -140.57 40.44 1.87 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.246 -0.909 . . . . 0.0 110.267 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 118.099 -0.953 . . . . 0.0 110.206 -179.999 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A 1002 ' ' ADN . . . . . 0.568 HO5' ' CB ' ' A' ' 415' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1003 ' ' RIB . . . . . 0.687 " H1'" ' OH ' ' A' ' 386' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -72.84 167.58 26.89 Favored 'Trans proline' 0 C--N 1.317 -1.09 0 O-C-N 123.427 1.224 . . . . 0.0 110.381 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 53.14 78.42 0.14 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.045 -1.034 . . . . 0.0 110.782 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 102.21 119.51 4.57 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 8.0 t 54.55 99.59 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.145 -1.209 . . . . 0.0 110.806 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 151.94 -121.54 1.21 Allowed Glycine 0 N--CA 1.497 2.709 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 5.8 t -116.2 96.53 5.59 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.227 -1.161 . . . . 0.0 110.417 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -142.48 67.36 1.32 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.241 -0.912 . . . . 0.0 109.992 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -139.48 41.66 1.31 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.14 -58.75 0.27 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.259 -1.142 . . . . 0.0 110.358 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.68 56.08 1.74 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.167 -0.958 . . . . 0.0 110.473 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 90.6 t -149.65 160.9 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.182 -0.949 . . . . 0.0 110.168 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 26.6 tttm -83.77 84.87 7.4 Favored 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 119.223 -0.991 . . . . 0.0 109.202 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' ARG . . . . . 0.474 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 1.9 mmt180 -69.07 152.78 44.78 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.277 -0.969 . . . . 0.0 108.925 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 6.5 t -70.62 144.37 51.17 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 119.486 -0.886 . . . . 0.0 108.903 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.34 158.66 4.07 Favored 'General case' 0 N--CA 1.509 2.487 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 44.1 t -78.91 157.58 28.22 Favored 'General case' 0 N--CA 1.508 2.445 0 O-C-N 120.712 -1.243 . . . . 0.0 110.384 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 55.0 mtm -48.67 -29.5 4.45 Favored 'General case' 0 N--CA 1.513 2.721 0 O-C-N 121.211 -0.93 . . . . 0.0 112.242 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -121.83 17.83 11.03 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.967 -1.083 . . . . 0.0 112.447 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 46.42 -114.41 1.44 Allowed Glycine 0 N--CA 1.499 2.834 0 O-C-N 120.782 -1.199 . . . . 0.0 112.487 177.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -76.83 -18.31 58.46 Favored 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.488 -1.007 . . . . 0.0 112.585 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . 0.574 ' CB ' HN61 ' A' 1002 ' ' ADN . 33.6 m-80 -84.9 0.69 50.24 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 120.546 -1.346 . . . . 0.0 111.871 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 49.2 t -49.67 87.5 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.935 0 O-C-N 120.775 -1.203 . . . . 0.0 111.585 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' TYR . . . . . 0.688 ' OH ' " H1'" ' A' 1003 ' ' RIB . 31.8 p90 -66.14 -36.41 83.07 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 120.848 -1.157 . . . . 0.0 110.865 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.578 ' HD2' " H3'" ' A' 1003 ' ' RIB . 10.6 ptm180 -71.19 160.99 31.85 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.193 -0.942 . . . . 0.0 110.072 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 36.4 pttt -159.5 110.97 2.04 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.336 -0.853 . . . . 0.0 110.534 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -117.73 170.83 5.67 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 120.949 -1.095 . . . . 0.0 110.355 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -74.28 -27.93 11.01 Favored 'Trans proline' 0 N--CA 1.489 1.238 0 O-C-N 123.486 1.256 . . . . 0.0 110.875 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 58.3 t -103.12 -18.86 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 120.987 -1.071 . . . . 0.0 111.933 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 34.3 t60 -65.12 -39.42 93.06 Favored 'General case' 0 N--CA 1.508 2.471 0 O-C-N 120.559 -1.338 . . . . 0.0 109.961 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -55.15 -37.18 66.65 Favored 'General case' 0 N--CA 1.51 2.568 0 C-N-CA 119.215 -0.994 . . . . 0.0 108.467 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.42 ' O ' ' NE ' ' A' ' 376' ' ' ARG . 1.2 mp0 -74.84 -31.01 61.55 Favored 'General case' 0 N--CA 1.502 2.16 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.076 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 23.2 m170 -75.72 -27.09 58.05 Favored 'General case' 0 N--CA 1.509 2.522 0 O-C-N 120.975 -1.078 . . . . 0.0 111.61 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -140.19 150.72 44.53 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.821 -1.174 . . . . 0.0 110.612 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' SER . . . . . 0.474 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 3.1 m -89.46 171.74 9.5 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.467 -0.771 . . . . 0.0 109.836 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -144.56 153.03 54.56 Favored Pre-proline 0 N--CA 1.487 1.415 0 O-C-N 121.437 -0.79 . . . . 0.0 108.903 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -60.72 137.75 75.1 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 N-CA-C 109.0 -1.192 . . . . 0.0 109.0 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 104.07 -1.2 44.23 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.619 -1.277 . . . . 0.0 111.566 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -112.87 176.2 5.11 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 119.987 1.894 . . . . 0.0 109.3 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 2.7 t -79.15 -25.57 42.86 Favored 'General case' 0 N--CA 1.506 2.332 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.864 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -98.1 1.48 47.63 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.66 -1.275 . . . . 0.0 112.498 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -46.16 137.62 5.94 Favored 'General case' 0 N--CA 1.515 2.817 0 CA-C-N 120.096 1.316 . . . . 0.0 110.738 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -139.56 20.85 2.92 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.461 -1.352 . . . . 0.0 112.196 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . -56.23 -26.16 49.52 Favored Glycine 0 N--CA 1.492 2.379 0 CA-C-N 119.959 1.879 . . . . 0.0 111.185 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 84.9 t -102.83 70.79 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.342 -1.093 . . . . 0.0 110.256 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -77.48 81.67 3.94 Favored 'General case' 0 N--CA 1.513 2.694 0 O-C-N 120.978 -1.076 . . . . 0.0 110.074 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 88.3 mt -114.12 69.61 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.994 -1.066 . . . . 0.0 110.118 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 10.6 p -118.87 63.93 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.427 -0.796 . . . . 0.0 108.863 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 93.78 52.27 1.99 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 107.931 -2.068 . . . . 0.0 107.931 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -47.83 -68.11 0.22 Allowed 'General case' 0 N--CA 1.512 2.652 0 O-C-N 121.46 -1.024 . . . . 0.0 111.265 -178.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -172.25 46.31 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.037 -1.039 . . . . 0.0 110.917 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -116.1 49.8 1.09 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.145 -0.972 . . . . 0.0 110.443 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.35 66.38 0.71 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.291 -0.881 . . . . 0.0 109.884 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -137.92 41.39 2.31 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.258 -0.901 . . . . 0.0 110.225 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.195 179.981 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A 1002 ' ' ADN . . . . . 0.574 HN61 ' CB ' ' A' ' 384' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1003 ' ' RIB . . . . . 0.688 " H1'" ' OH ' ' A' ' 386' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -72.62 169.15 22.58 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 O-C-N 123.45 1.237 . . . . 0.0 110.429 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.13 -176.37 3.33 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.289 -0.882 . . . . 0.0 110.143 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 83.31 -176.69 52.86 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 1.3 p -116.43 -57.87 2.15 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.205 -1.174 . . . . 0.0 110.239 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -138.37 53.2 0.72 Allowed Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 3.1 t -131.02 94.23 3.55 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.134 -1.215 . . . . 0.0 110.316 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -119.06 106.35 12.32 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.174 -0.954 . . . . 0.0 109.979 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -143.04 41.37 1.17 Allowed Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -146.57 -66.12 0.28 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.202 -1.175 . . . . 0.0 110.587 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.06 73.28 0.67 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.174 -0.954 . . . . 0.0 110.86 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 57.7 t -146.83 159.75 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.122 -0.986 . . . . 0.0 110.158 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 375' ' ' LYS . 0.0 OUTLIER -89.05 100.11 12.96 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 122.089 0.947 . . . . 0.0 109.078 179.093 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.46 -177.22 0.06 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.484 -0.76 . . . . 0.0 111.109 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 3.3 m -108.24 130.84 55.14 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' SER . . . . . 0.46 ' OG ' ' CE1' ' A' ' 404' ' ' TYR . 30.7 t -48.91 118.44 2.6 Favored 'General case' 0 N--CA 1.515 2.802 0 O-C-N 121.656 -0.653 . . . . 0.0 110.724 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . 0.415 ' HB2' ' CD2' ' A' ' 398' ' ' HIS . 9.3 t -38.56 151.35 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.731 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -178.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 53.9 mtm -46.27 -34.6 4.57 Favored 'General case' 0 N--CA 1.509 2.513 0 O-C-N 121.838 -0.539 . . . . 0.0 111.117 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -114.52 9.33 16.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.123 -0.985 . . . . 0.0 113.163 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 57.82 -120.44 21.55 Favored Glycine 0 N--CA 1.491 2.361 0 O-C-N 120.175 -1.578 . . . . 0.0 112.159 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -75.6 -13.38 60.34 Favored 'General case' 0 N--CA 1.51 2.531 0 O-C-N 121.485 -1.009 . . . . 0.0 112.655 -178.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . 0.583 ' CB ' HN61 ' A' 1002 ' ' ADN . 58.1 m-20 -86.01 -2.35 58.22 Favored 'General case' 0 N--CA 1.507 2.407 0 O-C-N 120.575 -1.328 . . . . 0.0 111.12 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 52.7 t -47.02 89.54 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.998 0 O-C-N 120.825 -1.172 . . . . 0.0 111.872 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' TYR . . . . . 0.658 ' OH ' " H1'" ' A' 1003 ' ' RIB . 31.3 p90 -70.34 -38.19 74.8 Favored 'General case' 0 N--CA 1.508 2.428 0 O-C-N 120.892 -1.13 . . . . 0.0 110.956 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.433 ' HD3' ' CE1' ' A' ' 392' ' ' HIS . 14.1 ptm180 -57.79 152.26 16.08 Favored 'General case' 0 N--CA 1.51 2.532 0 O-C-N 121.028 -1.045 . . . . 0.0 110.262 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -142.16 79.16 1.66 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.244 -0.91 . . . . 0.0 111.058 -179.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -97.26 160.64 28.45 Favored Pre-proline 0 N--CA 1.502 2.137 0 O-C-N 120.977 -1.077 . . . . 0.0 110.534 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -75.96 -29.2 6.98 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 O-C-N 123.547 1.288 . . . . 0.0 111.214 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 57.3 t -99.15 -22.38 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 O-C-N 121.236 -0.915 . . . . 0.0 111.594 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . 0.433 ' CE1' ' HD3' ' A' ' 387' ' ' ARG . 38.4 t60 -59.19 -37.76 78.2 Favored 'General case' 0 N--CA 1.51 2.542 0 O-C-N 120.611 -1.305 . . . . 0.0 110.152 -179.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -59.39 -33.72 71.55 Favored 'General case' 0 N--CA 1.505 2.295 0 C-N-CA 119.112 -1.035 . . . . 0.0 108.805 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -72.19 -33.34 67.59 Favored 'General case' 0 N--CA 1.503 2.19 0 C-N-CA 119.206 -0.997 . . . . 0.0 110.828 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 27.2 m170 -79.64 -34.81 40.2 Favored 'General case' 0 N--CA 1.509 2.485 0 O-C-N 120.983 -1.073 . . . . 0.0 111.224 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -121.92 158.51 28.87 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.029 -1.044 . . . . 0.0 110.304 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.45 173.77 6.16 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 178.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . 0.415 ' CD2' ' HB2' ' A' ' 379' ' ' CYS . 76.6 m80 -145.74 157.35 51.47 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 120.891 -1.131 . . . . 0.0 108.871 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . 0.41 ' HD3' ' CE1' ' A' ' 404' ' ' TYR . 36.6 Cg_endo -62.69 140.57 81.49 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 N-CA-C 108.892 -1.234 . . . . 0.0 108.892 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.88 -3.63 55.9 Favored Glycine 0 N--CA 1.496 2.689 0 C-N-CA 119.684 -1.246 . . . . 0.0 111.299 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -112.14 177.17 4.73 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 119.544 1.672 . . . . 0.0 108.689 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 1.4 p -79.36 -28.34 41.97 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.099 -1.04 . . . . 0.0 110.556 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -88.29 -4.45 58.69 Favored 'General case' 0 N--CA 1.509 2.501 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -176.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . 0.46 ' CE1' ' OG ' ' A' ' 378' ' ' SER . 7.9 t80 -39.06 125.07 1.52 Allowed 'General case' 0 N--CA 1.533 3.679 0 CA-C-N 120.742 1.61 . . . . 0.0 111.869 -178.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -177.05 75.83 0.07 OUTLIER Glycine 0 N--CA 1.501 2.986 0 C-N-CA 119.308 -1.425 . . . . 0.0 111.327 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' GLY . . . . . 0.458 ' HA3' ' HB3' ' A' ' 378' ' ' SER . . . -144.62 -55.66 0.02 OUTLIER Glycine 0 N--CA 1.505 3.263 0 C-N-CA 119.501 -1.333 . . . . 0.0 111.933 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 11.5 p -105.72 61.3 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-N 118.713 1.256 . . . . 0.0 110.312 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -134.0 92.89 3.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.396 -0.815 . . . . 0.0 109.601 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 77.8 mt -99.59 68.84 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.245 -0.909 . . . . 0.0 109.559 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 57.8 t -119.86 70.96 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 97.59 53.83 1.29 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 108.379 -1.889 . . . . 0.0 108.379 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -49.27 -62.73 1.38 Allowed 'General case' 0 N--CA 1.511 2.615 0 O-C-N 121.348 -1.089 . . . . 0.0 110.711 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -141.39 36.01 1.68 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.269 -0.894 . . . . 0.0 110.343 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -113.22 43.29 1.76 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.152 -0.967 . . . . 0.0 110.142 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -116.72 66.9 0.72 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.293 -0.88 . . . . 0.0 109.902 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 53.41 41.13 32.15 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.11 -0.994 . . . . 0.0 110.643 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 27.5 t0 . . . . . 0 N--CA 1.501 2.094 0 O-C-N 121.066 -1.021 . . . . 0.0 110.761 179.979 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A 1002 ' ' ADN . . . . . 0.583 HN61 ' CB ' ' A' ' 384' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1003 ' ' RIB . . . . . 0.658 " H1'" ' OH ' ' A' ' 386' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.317 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -72.78 -40.45 1.94 Allowed 'Trans proline' 0 C--N 1.317 -1.12 0 O-C-N 123.4 1.21 . . . . 0.0 110.4 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.75 -60.23 0.83 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.143 -0.973 . . . . 0.0 110.171 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 96.72 -82.79 0.76 Allowed Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 2.4 t -116.92 -57.23 2.19 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.224 -1.162 . . . . 0.0 110.141 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 135.88 148.61 5.61 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 17.4 m -116.16 44.08 2.03 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.217 -1.167 . . . . 0.0 109.916 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -114.42 -54.68 2.56 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.332 -0.855 . . . . 0.0 110.547 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 155.59 -78.65 0.19 Allowed Glycine 0 N--CA 1.497 2.722 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -143.17 60.56 1.41 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.183 -1.186 . . . . 0.0 110.348 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 52.01 65.03 1.62 Allowed 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.057 -1.027 . . . . 0.0 110.626 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 11.1 p -143.67 160.66 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.259 -0.901 . . . . 0.0 110.595 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.23 97.62 10.03 Favored 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 119.337 -0.945 . . . . 0.0 108.533 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.64 148.14 50.88 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.641 -0.824 . . . . 0.0 109.919 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 5.8 t -69.08 142.59 54.44 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 19.0 p -55.65 156.49 4.79 Favored 'General case' 0 N--CA 1.508 2.427 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 48.5 t -80.31 154.08 28.03 Favored 'General case' 0 N--CA 1.507 2.419 0 O-C-N 120.763 -1.211 . . . . 0.0 111.039 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 60.4 mtm -49.34 -33.26 13.03 Favored 'General case' 0 N--CA 1.516 2.844 0 O-C-N 121.303 -0.873 . . . . 0.0 111.288 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . 0.431 ' CD1' ' N3 ' ' A' 1002 ' ' ADN . 16.0 m-85 -136.36 39.13 2.69 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.208 -0.932 . . . . 0.0 108.831 178.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -39.02 -43.07 1.72 Allowed Glycine 0 N--CA 1.509 3.504 0 O-C-N 121.521 -0.737 . . . . 0.0 113.064 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -62.01 -29.53 70.34 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.015 -1.285 . . . . 0.0 110.745 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . 0.449 ' HB2' HN61 ' A' 1002 ' ' ADN . 7.2 m-80 -133.66 25.14 4.05 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.955 -1.091 . . . . 0.0 111.803 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 17.1 t -47.81 90.12 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.022 0 O-C-N 120.788 -1.195 . . . . 0.0 112.269 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' TYR . . . . . 0.457 ' OH ' " H1'" ' A' 1003 ' ' RIB . 24.8 p90 -62.92 -41.92 99.63 Favored 'General case' 0 N--CA 1.51 2.569 0 O-C-N 120.832 -1.168 . . . . 0.0 110.289 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.451 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.2 OUTLIER -63.98 157.07 26.02 Favored 'General case' 0 N--CA 1.509 2.499 0 O-C-N 121.134 -0.979 . . . . 0.0 110.231 -179.531 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.38 92.23 1.58 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.314 -0.866 . . . . 0.0 110.805 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -106.84 162.68 18.9 Favored Pre-proline 0 N--CA 1.5 2.059 0 O-C-N 121.138 -0.976 . . . . 0.0 110.44 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -74.17 -26.53 12.6 Favored 'Trans proline' 0 CA--C 1.545 1.072 0 O-C-N 123.56 1.295 . . . . 0.0 111.264 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 60.8 t -99.86 -24.8 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 O-C-N 121.141 -0.974 . . . . 0.0 111.492 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . 0.433 ' CE1' ' NH1' ' A' ' 387' ' ' ARG . 44.8 t60 -61.36 -36.93 81.56 Favored 'General case' 0 N--CA 1.511 2.588 0 O-C-N 120.633 -1.292 . . . . 0.0 110.19 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -56.49 -34.27 66.8 Favored 'General case' 0 N--CA 1.507 2.4 0 C-N-CA 119.117 -1.033 . . . . 0.0 108.492 177.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.72 -32.85 58.1 Favored 'General case' 0 N--CA 1.506 2.36 0 C-N-CA 119.454 -0.899 . . . . 0.0 111.087 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -75.74 -34.41 60.29 Favored 'General case' 0 N--CA 1.509 2.524 0 O-C-N 121.133 -0.979 . . . . 0.0 110.938 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -128.56 151.27 49.65 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.985 -1.072 . . . . 0.0 110.528 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.33 168.83 11.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.577 -0.702 . . . . 0.0 109.322 178.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -140.94 152.93 66.7 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.357 -0.839 . . . . 0.0 109.728 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . 0.468 ' HA ' ' CD2' ' A' ' 404' ' ' TYR . 36.3 Cg_endo -59.43 136.87 74.55 Favored 'Trans proline' 0 C--N 1.316 -1.153 0 N-CA-C 108.839 -1.254 . . . . 0.0 108.839 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 102.41 0.04 50.16 Favored Glycine 0 CA--C 1.55 2.244 0 C-N-CA 119.635 -1.269 . . . . 0.0 111.419 -179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -111.28 171.91 7.2 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 119.954 1.877 . . . . 0.0 109.451 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 50.5 m -75.5 -24.48 56.88 Favored 'General case' 0 N--CA 1.505 2.323 0 C-N-CA 119.246 -0.982 . . . . 0.0 111.103 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -102.14 5.89 40.57 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 120.644 -1.285 . . . . 0.0 112.728 -178.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . 0.468 ' CD2' ' HA ' ' A' ' 399' ' ' PRO . 14.0 t80 -44.65 133.46 5.91 Favored 'General case' 0 N--CA 1.515 2.815 0 O-C-N 120.688 -1.258 . . . . 0.0 112.483 -179.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -72.26 -34.13 61.28 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.209 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 109.13 94.6 2.33 Favored Glycine 0 N--CA 1.496 2.643 0 CA-C-N 119.236 1.518 . . . . 0.0 110.902 179.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 14.9 p -23.36 102.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.433 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -178.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -144.57 72.04 1.33 Allowed 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 176.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 70.2 mt -81.26 67.66 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 O-C-N 121.325 -0.859 . . . . 0.0 110.564 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 81.5 t -125.49 63.02 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 96.41 52.38 1.59 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 107.868 -2.093 . . . . 0.0 107.868 -177.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -49.51 -62.71 1.4 Allowed 'General case' 0 N--CA 1.512 2.67 0 O-C-N 121.385 -1.067 . . . . 0.0 110.733 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -129.41 41.16 3.5 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.21 -0.931 . . . . 0.0 109.758 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 53.0 39.39 29.36 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.133 -0.979 . . . . 0.0 110.615 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.44 64.86 0.94 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.288 -0.882 . . . . 0.0 110.044 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -119.49 43.07 2.72 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.256 -0.903 . . . . 0.0 110.172 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.142 -179.934 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A 1002 ' ' ADN . . . . . 0.449 HN61 ' HB2' ' A' ' 384' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1003 ' ' RIB . . . . . 0.457 " H1'" ' OH ' ' A' ' 386' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.347 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.74 109.29 2.75 Favored 'Trans proline' 0 C--N 1.318 -1.036 0 O-C-N 123.482 1.253 . . . . 0.0 110.442 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 4.0 tp -128.93 129.33 45.33 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.215 -0.928 . . . . 0.0 110.174 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 84.7 -109.47 3.26 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 1.9 t -134.23 78.94 1.78 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.21 -1.171 . . . . 0.0 110.168 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -132.72 84.58 0.29 Allowed Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 6.2 t -142.48 129.47 20.72 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.174 -1.191 . . . . 0.0 110.195 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -142.68 88.14 2.04 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.191 -0.943 . . . . 0.0 110.174 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -144.32 41.03 1.13 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -137.27 -65.0 0.55 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.23 -1.159 . . . . 0.0 110.029 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.49 62.34 1.42 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.194 -0.941 . . . . 0.0 110.227 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 60.0 t -144.61 160.51 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.202 -0.936 . . . . 0.0 109.917 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 31.6 mtpt -88.71 94.32 9.87 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 119.618 -0.833 . . . . 0.0 109.732 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' ARG . . . . . 0.412 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 42.1 mtm-85 -55.81 146.01 22.83 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.706 -0.621 . . . . 0.0 110.573 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 2.3 m -69.28 137.48 53.08 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 87.4 p -52.84 157.3 1.7 Allowed 'General case' 0 N--CA 1.512 2.656 0 O-C-N 121.054 -1.029 . . . . 0.0 109.749 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 12.7 t -80.74 158.52 25.49 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 120.854 -1.154 . . . . 0.0 109.107 179.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -55.59 -39.12 70.3 Favored 'General case' 0 N--CA 1.513 2.688 0 O-C-N 121.149 -0.97 . . . . 0.0 109.946 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . 0.406 ' HB2' ' N1 ' ' A' 1002 ' ' ADN . 8.5 m-85 -128.29 38.29 4.01 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -38.04 -44.87 1.58 Allowed Glycine 0 N--CA 1.507 3.373 0 O-C-N 121.321 -0.862 . . . . 0.0 113.13 -177.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -59.35 -27.86 66.32 Favored 'General case' 0 N--CA 1.507 2.422 0 CA-C-N 118.653 1.226 . . . . 0.0 110.703 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . 0.419 ' O ' ' N ' ' A' ' 386' ' ' TYR . 7.4 m-80 -133.14 19.82 4.06 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.843 -1.161 . . . . 0.0 112.109 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 33.7 t -43.75 88.78 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.367 0 CA-C-N 119.787 1.176 . . . . 0.0 112.775 -178.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' TYR . . . . . 0.717 ' OH ' " H1'" ' A' 1003 ' ' RIB . 20.4 p90 -63.17 -40.59 97.96 Favored 'General case' 0 N--CA 1.509 2.504 0 O-C-N 120.95 -1.094 . . . . 0.0 111.537 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.455 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 15.1 ptm180 -56.02 151.15 12.41 Favored 'General case' 0 N--CA 1.513 2.708 0 O-C-N 120.821 -1.175 . . . . 0.0 110.376 -179.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -133.34 72.68 1.49 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.142 -0.974 . . . . 0.0 110.725 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -106.71 149.27 38.22 Favored Pre-proline 0 N--CA 1.498 1.972 0 O-C-N 121.094 -1.004 . . . . 0.0 109.547 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -69.73 -83.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.316 -1.173 0 O-C-N 123.498 1.262 . . . . 0.0 108.94 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 88.2 t -38.64 -26.48 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.526 3.358 0 O-C-N 120.833 -1.167 . . . . 0.0 113.288 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . 0.433 ' CE1' ' HD3' ' A' ' 387' ' ' ARG . 25.9 t60 -64.15 -39.36 93.84 Favored 'General case' 0 N--CA 1.512 2.626 0 O-C-N 120.312 -1.493 . . . . 0.0 108.504 177.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -59.87 -37.42 79.26 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.291 -0.881 . . . . 0.0 109.228 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -70.01 -26.55 64.12 Favored 'General case' 0 N--CA 1.507 2.393 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.215 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 19.2 m170 -90.99 -34.6 15.08 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.757 -1.214 . . . . 0.0 110.605 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -117.33 144.45 44.88 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.048 -1.033 . . . . 0.0 110.355 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' SER . . . . . 0.412 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 0.1 OUTLIER -98.0 167.03 11.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 110.528 179.611 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -140.07 153.57 69.43 Favored Pre-proline 0 N--CA 1.488 1.431 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.894 -178.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . 0.426 ' HA ' ' CD2' ' A' ' 404' ' ' TYR . 37.9 Cg_endo -62.28 137.9 68.53 Favored 'Trans proline' 0 N--CA 1.484 0.954 0 N-CA-C 108.038 -1.562 . . . . 0.0 108.038 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.37 -2.35 56.22 Favored Glycine 0 CA--C 1.551 2.343 0 C-N-CA 119.695 -1.24 . . . . 0.0 110.384 -177.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -115.47 140.07 49.48 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 119.649 1.725 . . . . 0.0 108.499 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 5.8 m -49.43 -25.61 2.69 Favored 'General case' 0 N--CA 1.509 2.512 0 O-C-N 121.11 -0.994 . . . . 0.0 113.201 -178.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -99.32 11.1 40.04 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 120.28 -1.513 . . . . 0.0 113.551 -177.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . 0.476 ' CE2' ' O ' ' A' ' 406' ' ' GLY . 6.1 t80 -51.91 142.73 14.88 Favored 'General case' 0 N--CA 1.515 2.816 0 O-C-N 120.365 -1.46 . . . . 0.0 109.487 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -135.26 29.2 2.94 Favored Glycine 0 N--CA 1.499 2.895 0 C-N-CA 119.267 -1.444 . . . . 0.0 112.157 -178.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' GLY . . . . . 0.476 ' O ' ' CE2' ' A' ' 404' ' ' TYR . . . -141.71 142.54 12.03 Favored Glycine 0 C--O 1.209 -1.464 0 N-CA-C 107.544 -2.222 . . . . 0.0 107.544 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 95.4 t -129.02 72.82 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 O-C-N 121.264 -1.139 . . . . 0.0 108.558 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -79.87 88.92 5.26 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.928 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 61.8 mt -103.08 78.08 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.105 -0.997 . . . . 0.0 109.912 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 59.1 t -113.53 63.67 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.234 -0.916 . . . . 0.0 109.612 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 118.42 -46.34 1.15 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 65.85 -66.08 0.17 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.713 -0.875 . . . . 0.0 110.93 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -159.69 39.55 0.19 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.111 -0.993 . . . . 0.0 110.961 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 51.52 41.88 28.96 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.953 -1.092 . . . . 0.0 110.888 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 6.1 t -131.94 62.65 1.63 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.272 -0.893 . . . . 0.0 110.116 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -102.87 39.25 1.57 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.223 -0.923 . . . . 0.0 109.944 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 . . . . . 0 N--CA 1.495 1.824 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.342 179.933 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A 1002 ' ' ADN . . . . . 0.406 HN61 ' HB2' ' A' ' 384' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1003 ' ' RIB . . . . . 0.717 " H1'" ' OH ' ' A' ' 386' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 98.4 t . . . . . 0 N--CA 1.493 1.714 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 14.3 mttm -78.66 90.82 4.59 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 121.162 -0.961 . . . . 0.0 109.431 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 43.2 mtm-85 -61.51 154.39 24.77 Favored 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.389 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 4.7 t -79.25 138.49 37.81 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 10.8 p -53.39 151.17 5.73 Favored 'General case' 0 N--CA 1.515 2.798 0 O-C-N 120.882 -1.136 . . . . 0.0 108.52 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 23.4 t -79.82 156.12 27.54 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 120.887 -1.133 . . . . 0.0 111.618 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 65.7 mtm -48.32 -30.94 5.37 Favored 'General case' 0 N--CA 1.519 2.985 0 O-C-N 121.288 -0.882 . . . . 0.0 111.067 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -140.61 37.37 1.84 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.199 -0.938 . . . . 0.0 109.081 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -38.4 -46.07 1.95 Allowed Glycine 0 N--CA 1.506 3.334 0 O-C-N 121.206 -0.933 . . . . 0.0 113.112 -178.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -58.59 -28.69 65.81 Favored 'General case' 0 N--CA 1.51 2.529 0 CA-C-N 118.808 1.304 . . . . 0.0 110.687 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 384' ' ' ASN . . . . . 0.415 ' O ' ' N ' ' A' ' 386' ' ' TYR . 7.3 m120 -135.11 28.77 3.44 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.028 -1.045 . . . . 0.0 110.977 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 19.2 t -53.02 88.74 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.807 0 O-C-N 121.091 -1.006 . . . . 0.0 110.957 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 386' ' ' TYR . . . . . 0.415 ' N ' ' O ' ' A' ' 384' ' ' ASN . 20.1 p90 -62.73 -35.94 81.41 Favored 'General case' 0 N--CA 1.507 2.418 0 O-C-N 120.988 -1.07 . . . . 0.0 111.138 -178.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.404 ' HB2' ' NH1' ' A' ' 387' ' ' ARG . 5.6 ptm85 -75.99 163.22 27.38 Favored 'General case' 0 N--CA 1.505 2.284 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.538 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -161.04 111.98 1.78 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.328 -0.857 . . . . 0.0 110.967 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -118.93 169.76 7.56 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.103 -0.998 . . . . 0.0 109.691 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -74.56 -29.35 9.13 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 O-C-N 123.463 1.244 . . . . 0.0 110.629 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 60.9 t -100.37 -21.52 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 121.084 -1.01 . . . . 0.0 111.718 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 37.2 t60 -61.95 -38.15 87.41 Favored 'General case' 0 N--CA 1.506 2.374 0 O-C-N 120.625 -1.297 . . . . 0.0 110.056 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -58.95 -31.86 69.09 Favored 'General case' 0 N--CA 1.506 2.365 0 C-N-CA 119.231 -0.987 . . . . 0.0 109.346 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -75.33 -31.56 60.64 Favored 'General case' 0 N--CA 1.508 2.469 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.744 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 16.8 m170 -82.84 -33.83 27.03 Favored 'General case' 0 N--CA 1.507 2.407 0 O-C-N 120.962 -1.086 . . . . 0.0 111.475 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 396' ' ' PHE . . . . . 0.421 ' CD1' ' N ' ' A' ' 396' ' ' PHE . 68.7 m-85 -124.05 141.95 51.61 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.934 -1.104 . . . . 0.0 110.838 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.54 170.81 9.87 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 109.089 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -144.62 153.76 55.24 Favored Pre-proline 0 N--CA 1.485 1.285 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.042 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -60.23 138.81 83.65 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 N-CA-C 108.713 -1.303 . . . . 0.0 108.713 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 102.06 -1.12 51.19 Favored Glycine 0 CA--C 1.554 2.477 0 C-N-CA 119.794 -1.193 . . . . 0.0 110.788 -177.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -114.38 165.3 12.86 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 119.788 1.794 . . . . 0.0 108.656 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 8.9 t -70.22 -25.27 63.32 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.186 -0.946 . . . . 0.0 111.39 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -98.38 5.62 48.01 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.696 -1.253 . . . . 0.0 112.908 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 32.6 t80 . . . . . 0 N--CA 1.507 2.413 0 O-C-N 120.434 -1.416 . . . . 0.0 109.188 179.496 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 90.2 t . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 17.8 mttp -87.73 95.82 10.22 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.335 -0.853 . . . . 0.0 109.187 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.69 162.62 6.38 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 120.211 -0.596 . . . . 0.0 109.898 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 4.4 t -89.83 137.91 31.94 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.42 150.84 4.5 Favored 'General case' 0 N--CA 1.517 2.907 0 O-C-N 120.995 -1.066 . . . . 0.0 109.337 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 47.8 t -80.62 150.59 29.41 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 120.95 -1.094 . . . . 0.0 111.442 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 46.7 mtm -48.21 -30.32 4.58 Favored 'General case' 0 N--CA 1.519 2.983 0 O-C-N 121.283 -0.886 . . . . 0.0 111.709 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -140.54 36.15 1.84 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.183 -0.948 . . . . 0.0 109.369 178.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -37.62 -42.64 1.03 Allowed Glycine 0 N--CA 1.507 3.374 0 O-C-N 121.196 -0.94 . . . . 0.0 113.333 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -60.04 -30.24 69.05 Favored 'General case' 0 N--CA 1.508 2.448 0 O-C-N 121.03 -1.277 . . . . 0.0 110.538 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -134.63 26.06 3.71 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.063 -1.023 . . . . 0.0 111.075 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 35.8 t -49.11 92.2 0.01 OUTLIER 'General case' 0 N--CA 1.519 2.981 0 O-C-N 120.788 -1.195 . . . . 0.0 111.692 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -68.75 -39.04 80.52 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 121.074 -1.016 . . . . 0.0 110.176 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.86 148.43 51.8 Favored 'General case' 0 N--CA 1.508 2.466 0 O-C-N 121.21 -0.931 . . . . 0.0 109.511 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.74 90.81 1.73 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.175 -0.953 . . . . 0.0 110.935 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -100.29 168.54 9.24 Favored Pre-proline 0 N--CA 1.499 2.019 0 O-C-N 120.666 -1.271 . . . . 0.0 110.263 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -75.99 -26.34 9.49 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 O-C-N 123.538 1.283 . . . . 0.0 110.894 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 76.5 t -101.75 -19.57 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 O-C-N 121.074 -1.016 . . . . 0.0 111.779 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 41.5 t60 -63.05 -40.29 97.28 Favored 'General case' 0 N--CA 1.51 2.526 0 O-C-N 120.53 -1.356 . . . . 0.0 110.217 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -56.68 -34.26 67.22 Favored 'General case' 0 N--CA 1.51 2.568 0 O-C-N 121.134 -0.979 . . . . 0.0 109.113 178.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -72.82 -31.32 64.71 Favored 'General case' 0 N--CA 1.507 2.4 0 C-N-CA 119.109 -1.036 . . . . 0.0 111.15 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 20.9 m170 -87.38 -31.94 19.85 Favored 'General case' 0 N--CA 1.508 2.439 0 O-C-N 121.019 -1.051 . . . . 0.0 111.748 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -121.38 144.03 48.89 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.847 -1.158 . . . . 0.0 111.255 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 397' ' ' SER . . . . . 0.409 ' HB2' ' HA ' ' A' ' 404' ' ' TYR . 0.0 OUTLIER -88.54 173.02 8.9 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.386 -0.821 . . . . 0.0 109.39 178.931 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -144.88 155.86 55.64 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.419 -0.801 . . . . 0.0 109.771 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -60.72 136.64 67.91 Favored 'Trans proline' 0 C--N 1.318 -1.07 0 N-CA-C 109.126 -1.144 . . . . 0.0 109.126 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 104.08 -2.46 44.21 Favored Glycine 0 CA--C 1.553 2.455 0 C-N-CA 119.962 -1.113 . . . . 0.0 110.715 -178.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -116.6 150.92 37.27 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 119.62 1.71 . . . . 0.0 108.884 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 2.1 p -58.16 -28.07 64.4 Favored 'General case' 0 N--CA 1.503 2.186 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.318 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -88.18 -0.71 57.42 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 120.727 -1.233 . . . . 0.0 113.349 -178.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 404' ' ' TYR . . . . . 0.409 ' HA ' ' HB2' ' A' ' 397' ' ' SER . 16.5 t80 . . . . . 0 N--CA 1.522 3.156 0 CA-C-N 120.379 1.445 . . . . 0.0 111.756 -178.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 10.8 p . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.797 0.332 . . . . 0.0 110.55 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? -89.47 99.05 12.13 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.285 -0.884 . . . . 0.0 108.646 178.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 376' ' ' ARG . . . . . 0.443 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 0.0 OUTLIER -68.66 168.17 13.7 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.63 -0.669 . . . . 0.0 110.22 -179.747 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 5.1 t -85.77 139.9 30.93 Favored 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 119.651 -0.819 . . . . 0.0 110.395 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 378' ' ' SER . . . . . 0.429 ' OG ' ' CE1' ' A' ' 404' ' ' TYR . 9.8 t -59.74 123.21 16.23 Favored 'General case' 0 N--CA 1.512 2.659 0 O-C-N 121.254 -0.904 . . . . 0.0 111.007 -178.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 16.9 t -44.12 144.04 1.04 Allowed 'General case' 0 N--CA 1.508 2.471 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -178.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 57.4 mtm -42.51 -35.86 1.18 Allowed 'General case' 0 N--CA 1.518 2.931 0 O-C-N 122.129 -0.357 . . . . 0.0 110.984 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -133.88 37.35 3.25 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 121.389 -0.82 . . . . 0.0 109.407 178.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -36.94 -47.35 1.29 Allowed Glycine 0 N--CA 1.51 3.625 0 O-C-N 120.902 -1.124 . . . . 0.0 113.346 -178.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -59.2 -24.75 63.38 Favored 'General case' 0 N--CA 1.514 2.761 0 CA-C-N 118.924 1.362 . . . . 0.0 111.159 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -136.07 25.37 3.29 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.92 -1.113 . . . . 0.0 111.105 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 46.9 t -51.92 90.76 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.894 0 O-C-N 120.814 -1.178 . . . . 0.0 111.168 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 386' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 20.0 p90 -66.01 -36.58 83.65 Favored 'General case' 0 N--CA 1.506 2.364 0 O-C-N 121.074 -1.016 . . . . 0.0 111.052 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.428 ' HD3' ' CE1' ' A' ' 392' ' ' HIS . 14.1 ptm180 -64.92 161.96 17.38 Favored 'General case' 0 N--CA 1.511 2.583 0 O-C-N 120.918 -1.114 . . . . 0.0 110.356 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.59 84.86 1.18 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.133 -0.98 . . . . 0.0 111.505 -178.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -103.18 164.73 14.91 Favored Pre-proline 0 N--CA 1.502 2.174 0 O-C-N 120.543 -1.348 . . . . 0.0 110.356 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -76.83 -29.96 5.05 Favored 'Trans proline' 0 N--CA 1.489 1.223 0 O-C-N 123.47 1.247 . . . . 0.0 111.046 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 58.8 t -97.71 -24.63 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 O-C-N 120.985 -1.072 . . . . 0.0 111.51 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 392' ' ' HIS . . . . . 0.428 ' CE1' ' HD3' ' A' ' 387' ' ' ARG . 40.3 t60 -57.53 -37.51 73.17 Favored 'General case' 0 N--CA 1.509 2.51 0 O-C-N 120.794 -1.191 . . . . 0.0 110.05 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -58.73 -33.57 70.38 Favored 'General case' 0 N--CA 1.505 2.291 0 C-N-CA 119.253 -0.979 . . . . 0.0 108.84 178.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -75.08 -35.12 61.82 Favored 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 119.097 -1.041 . . . . 0.0 110.421 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 395' ' ' HIS . . . . . 0.423 ' HB3' ' CE1' ' A' ' 396' ' ' PHE . 8.4 m170 -74.56 -29.73 61.46 Favored 'General case' 0 N--CA 1.511 2.621 0 O-C-N 120.996 -1.065 . . . . 0.0 111.903 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 396' ' ' PHE . . . . . 0.423 ' CE1' ' HB3' ' A' ' 395' ' ' HIS . 70.2 m-85 -132.97 143.12 49.24 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.705 -1.247 . . . . 0.0 110.739 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 397' ' ' SER . . . . . 0.443 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 74.9 m -83.14 170.78 14.39 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -144.18 157.56 56.69 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.051 -1.031 . . . . 0.0 109.468 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.58 139.37 69.65 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 N-CA-C 108.648 -1.328 . . . . 0.0 108.648 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 96.74 -1.34 61.52 Favored Glycine 0 N--CA 1.494 2.536 0 C-N-CA 119.493 -1.337 . . . . 0.0 111.176 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -115.4 173.14 6.67 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 119.577 1.689 . . . . 0.0 108.271 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 74.8 p -75.03 -31.78 61.43 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 118.869 -1.133 . . . . 0.0 110.284 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -80.37 -6.05 57.4 Favored 'General case' 0 N--CA 1.508 2.442 0 O-C-N 120.777 -1.202 . . . . 0.0 114.087 -176.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 404' ' ' TYR . . . . . 0.429 ' CE1' ' OG ' ' A' ' 378' ' ' SER . 5.8 t80 . . . . . 0 N--CA 1.528 3.463 0 CA-C-N 120.679 1.581 . . . . 0.0 111.076 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 72.1 t . . . . . 0 N--CA 1.494 1.744 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -82.95 83.22 7.89 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.223 -0.923 . . . . 0.0 109.165 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 376' ' ' ARG . . . . . 0.433 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 1.3 mmt180 -62.16 151.81 34.86 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.831 -0.748 . . . . 0.0 109.977 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 1.9 m -70.48 139.31 51.65 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 14.6 t -55.43 168.94 0.33 Allowed 'General case' 0 N--CA 1.512 2.655 0 O-C-N 120.866 -1.146 . . . . 0.0 109.101 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 50.1 t -86.54 155.09 20.62 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 120.93 -1.106 . . . . 0.0 109.377 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -50.57 -35.61 30.74 Favored 'General case' 0 N--CA 1.515 2.81 0 O-C-N 121.126 -0.984 . . . . 0.0 111.293 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -131.38 36.59 3.77 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.34 -0.85 . . . . 0.0 109.62 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -37.35 -46.59 1.43 Allowed Glycine 0 N--CA 1.509 3.501 0 O-C-N 121.143 -0.973 . . . . 0.0 113.518 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -58.52 -26.74 63.82 Favored 'General case' 0 N--CA 1.512 2.667 0 CA-C-N 118.964 1.382 . . . . 0.0 110.923 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 384' ' ' ASN . . . . . 0.446 ' O ' ' N ' ' A' ' 386' ' ' TYR . 8.0 m120 -136.53 24.95 3.17 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.939 -1.101 . . . . 0.0 111.182 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 36.2 t -50.18 87.93 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.052 0 O-C-N 120.9 -1.125 . . . . 0.0 111.356 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 386' ' ' TYR . . . . . 0.46 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 21.9 p90 -60.73 -38.28 84.6 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.041 -1.037 . . . . 0.0 111.16 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.46 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 14.1 ptm180 -59.23 149.59 28.04 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 121.176 -0.953 . . . . 0.0 110.225 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.98 76.09 1.61 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.323 -0.861 . . . . 0.0 110.933 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -114.3 152.74 46.26 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.071 -1.018 . . . . 0.0 109.29 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -71.59 -76.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.316 -1.183 0 O-C-N 123.408 1.215 . . . . 0.0 110.193 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 11.2 p -38.68 -33.16 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.524 3.258 0 O-C-N 120.888 -1.133 . . . . 0.0 112.639 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 392' ' ' HIS . . . . . 0.416 ' CE1' ' HD3' ' A' ' 387' ' ' ARG . 37.3 t60 -65.22 -37.87 88.64 Favored 'General case' 0 N--CA 1.511 2.598 0 O-C-N 121.092 -1.005 . . . . 0.0 109.552 178.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -59.06 -34.21 71.68 Favored 'General case' 0 N--CA 1.508 2.464 0 O-C-N 121.082 -1.011 . . . . 0.0 108.887 177.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -77.43 -30.94 53.66 Favored 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.242 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 14.9 m170 -78.12 -25.63 47.56 Favored 'General case' 0 N--CA 1.511 2.598 0 O-C-N 121.075 -1.016 . . . . 0.0 111.95 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -135.89 147.07 48.01 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.686 -1.259 . . . . 0.0 110.556 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 397' ' ' SER . . . . . 0.433 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 54.6 m -89.21 160.78 16.78 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.365 -0.834 . . . . 0.0 109.772 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -136.55 156.38 76.38 Favored Pre-proline 0 N--CA 1.485 1.279 0 C-N-CA 119.786 -0.766 . . . . 0.0 110.051 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -62.57 137.97 67.41 Favored 'Trans proline' 0 C--N 1.319 -1.023 0 N-CA-C 108.303 -1.46 . . . . 0.0 108.303 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 98.51 0.11 58.09 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.471 -1.347 . . . . 0.0 110.64 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -111.57 177.54 4.62 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 119.561 1.68 . . . . 0.0 108.597 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -81.06 -25.41 37.12 Favored 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 119.081 -1.047 . . . . 0.0 110.93 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -97.13 4.75 51.09 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 120.621 -1.299 . . . . 0.0 114.469 -177.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 4.3 t80 . . . . . 0 N--CA 1.53 3.57 0 CA-C-N 120.676 1.58 . . . . 0.0 110.965 -179.81 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 89.1 t . . . . . 0 N--CA 1.493 1.714 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.67 83.1 7.76 Favored 'General case' 0 N--CA 1.504 2.238 0 C-N-CA 119.311 -0.956 . . . . 0.0 108.444 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 376' ' ' ARG . . . . . 0.437 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 2.3 mmt180 -60.56 154.34 21.25 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 119.949 -0.7 . . . . 0.0 110.103 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 1.8 m -71.32 140.67 50.35 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 29.2 t -52.48 166.5 0.18 Allowed 'General case' 0 N--CA 1.511 2.613 0 C-N-CA 119.239 -0.984 . . . . 0.0 109.349 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 50.9 t -90.17 154.86 19.44 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 120.837 -1.164 . . . . 0.0 109.613 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 56.0 mtm -49.65 -32.07 12.3 Favored 'General case' 0 N--CA 1.519 2.995 0 O-C-N 121.279 -0.888 . . . . 0.0 111.726 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -138.5 38.31 2.25 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.229 -0.919 . . . . 0.0 109.552 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -37.65 -49.65 1.86 Allowed Glycine 0 N--CA 1.508 3.473 0 O-C-N 121.231 -0.918 . . . . 0.0 113.032 -178.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -55.24 -27.21 44.69 Favored 'General case' 0 N--CA 1.51 2.53 0 O-C-N 120.997 -1.296 . . . . 0.0 111.231 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 384' ' ' ASN . . . . . 0.436 ' O ' ' N ' ' A' ' 386' ' ' TYR . 7.4 m120 -138.1 29.31 2.52 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.95 -1.094 . . . . 0.0 110.936 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 37.8 t -53.54 85.89 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.988 0 O-C-N 120.98 -1.075 . . . . 0.0 111.516 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 386' ' ' TYR . . . . . 0.436 ' N ' ' O ' ' A' ' 384' ' ' ASN . 17.3 p90 -61.24 -31.17 70.96 Favored 'General case' 0 N--CA 1.51 2.565 0 O-C-N 121.005 -1.059 . . . . 0.0 111.64 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.416 ' NH1' ' HB2' ' A' ' 387' ' ' ARG . 3.6 ptm85 -79.79 160.63 26.09 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 120.977 -1.077 . . . . 0.0 110.943 -179.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.405 ' O ' ' HG3' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -156.74 112.75 2.97 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.329 -0.857 . . . . 0.0 110.909 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -121.42 169.54 8.97 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.847 -1.158 . . . . 0.0 109.785 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.9 -30.66 8.98 Favored 'Trans proline' 0 C--N 1.314 -1.27 0 O-C-N 123.473 1.249 . . . . 0.0 110.609 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 73.9 t -100.38 -22.65 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.094 -1.004 . . . . 0.0 111.772 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 41.2 t60 -61.5 -39.38 90.76 Favored 'General case' 0 N--CA 1.51 2.525 0 O-C-N 120.528 -1.358 . . . . 0.0 109.829 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -55.73 -33.15 63.98 Favored 'General case' 0 N--CA 1.507 2.416 0 C-N-CA 119.294 -0.962 . . . . 0.0 108.916 178.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.406 ' O ' ' NE ' ' A' ' 376' ' ' ARG . 1.0 OUTLIER -78.43 -32.09 48.4 Favored 'General case' 0 N--CA 1.504 2.237 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.556 179.791 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 395' ' ' HIS . . . . . 0.404 ' HB3' ' CE2' ' A' ' 396' ' ' PHE . 9.1 m-70 -79.93 -17.83 52.03 Favored 'General case' 0 N--CA 1.513 2.699 0 O-C-N 120.927 -1.108 . . . . 0.0 112.976 -178.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 396' ' ' PHE . . . . . 0.404 ' CE2' ' HB3' ' A' ' 395' ' ' HIS . 70.3 m-85 -145.09 142.61 29.83 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.442 -1.411 . . . . 0.0 110.725 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 397' ' ' SER . . . . . 0.437 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 19.9 m -85.05 170.54 12.87 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.255 -0.903 . . . . 0.0 110.506 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -143.7 151.5 53.69 Favored Pre-proline 0 N--CA 1.482 1.153 0 C-N-CA 119.831 -0.748 . . . . 0.0 109.645 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -60.73 139.51 85.91 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 N-CA-C 107.767 -1.667 . . . . 0.0 107.767 178.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.18 2.43 55.83 Favored Glycine 0 CA--C 1.548 2.131 0 C-N-CA 119.331 -1.414 . . . . 0.0 110.44 -177.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.52 158.92 26.25 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 119.77 1.785 . . . . 0.0 108.681 177.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 39.8 t -62.93 -30.77 71.82 Favored 'General case' 0 N--CA 1.501 2.091 0 C-N-CA 118.995 -1.082 . . . . 0.0 110.819 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -89.42 -2.73 58.5 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 120.64 -1.287 . . . . 0.0 113.732 -177.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 34.8 t80 . . . . . 0 N--CA 1.516 2.859 0 CA-C-N 120.492 1.496 . . . . 0.0 110.491 -179.522 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 120.627 0.251 . . . . 0.0 110.43 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.7 84.73 6.19 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.283 -0.886 . . . . 0.0 109.411 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 376' ' ' ARG . . . . . 0.453 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 1.2 mmt180 -60.83 148.92 37.62 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.664 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 5.5 t -67.77 140.93 56.69 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 1.3 p -54.16 158.93 2.04 Favored 'General case' 0 N--CA 1.507 2.379 0 C-N-CA 119.311 -0.956 . . . . 0.0 109.374 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 53.6 t -84.08 154.73 23.03 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 120.996 -1.065 . . . . 0.0 110.139 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 51.5 mtm -51.74 -30.82 24.04 Favored 'General case' 0 N--CA 1.515 2.821 0 O-C-N 121.306 -0.872 . . . . 0.0 111.82 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 381' ' ' TYR . . . . . 0.422 ' O ' ' N ' ' A' ' 385' ' ' CYS . 22.3 m-85 -137.11 36.73 2.55 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.063 -1.023 . . . . 0.0 109.3 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -40.31 -46.84 3.53 Favored Glycine 0 N--CA 1.506 3.3 0 O-C-N 121.34 -0.85 . . . . 0.0 112.901 -178.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -59.22 -28.26 66.5 Favored 'General case' 0 N--CA 1.509 2.486 0 CA-C-N 118.789 1.295 . . . . 0.0 110.957 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -136.92 28.82 2.87 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.818 -1.176 . . . . 0.0 111.039 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 385' ' ' CYS . . . . . 0.422 ' N ' ' O ' ' A' ' 381' ' ' TYR . 9.9 t -47.44 140.24 5.94 Favored 'General case' 0 N--CA 1.518 2.967 0 O-C-N 120.961 -1.087 . . . . 0.0 111.722 -178.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 386' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 4.1 p90 -113.05 -39.78 4.12 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.192 -0.942 . . . . 0.0 110.654 178.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.438 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 13.6 ptm180 -69.53 155.46 40.45 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 120.9 -1.125 . . . . 0.0 109.626 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.33 97.21 2.51 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.153 -0.967 . . . . 0.0 110.871 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -113.76 169.25 6.7 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 120.752 -1.217 . . . . 0.0 110.502 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -75.44 -25.76 10.89 Favored 'Trans proline' 0 CA--C 1.549 1.226 0 O-C-N 123.54 1.284 . . . . 0.0 110.466 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.8 t -100.87 -23.04 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 O-C-N 121.115 -0.99 . . . . 0.0 112.14 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 392' ' ' HIS . . . . . 0.401 ' CE1' ' HD3' ' A' ' 387' ' ' ARG . 40.9 t60 -62.85 -38.3 90.28 Favored 'General case' 0 N--CA 1.515 2.782 0 O-C-N 120.529 -1.357 . . . . 0.0 110.013 -178.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -56.31 -32.16 64.36 Favored 'General case' 0 N--CA 1.508 2.43 0 C-N-CA 119.175 -1.01 . . . . 0.0 108.927 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.42 ' O ' ' NE ' ' A' ' 376' ' ' ARG . 1.0 OUTLIER -80.73 -32.69 35.65 Favored 'General case' 0 N--CA 1.505 2.314 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.149 179.461 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 395' ' ' HIS . . . . . 0.427 ' HB3' ' CE2' ' A' ' 396' ' ' PHE . 16.5 m170 -72.92 -30.76 64.16 Favored 'General case' 0 N--CA 1.509 2.519 0 O-C-N 121.069 -1.019 . . . . 0.0 111.01 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 396' ' ' PHE . . . . . 0.427 ' CE2' ' HB3' ' A' ' 395' ' ' HIS . 47.6 m-85 -138.01 148.04 44.76 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.83 -1.169 . . . . 0.0 110.53 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 397' ' ' SER . . . . . 0.453 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 3.0 m -90.05 172.24 8.98 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.481 -0.762 . . . . 0.0 110.409 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -142.46 151.03 56.66 Favored Pre-proline 0 N--CA 1.487 1.38 0 C-N-CA 119.656 -0.818 . . . . 0.0 110.816 -178.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -61.96 139.44 79.32 Favored 'Trans proline' 0 C--N 1.321 -0.902 0 N-CA-C 107.489 -1.774 . . . . 0.0 107.489 178.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 98.54 0.57 57.93 Favored Glycine 0 CA--C 1.552 2.382 0 C-N-CA 119.37 -1.395 . . . . 0.0 110.203 -177.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -114.85 165.23 13.06 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 119.529 1.664 . . . . 0.0 107.933 177.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.85 -25.35 62.78 Favored 'General case' 0 N--CA 1.506 2.361 0 C-N-CA 119.086 -1.046 . . . . 0.0 111.615 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -99.51 8.57 44.39 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 120.576 -1.328 . . . . 0.0 113.133 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 404' ' ' TYR . . . . . 0.413 ' HA ' ' HB3' ' A' ' 397' ' ' SER . 21.2 t80 . . . . . 0 N--CA 1.516 2.847 0 CA-C-N 120.279 1.399 . . . . 0.0 110.652 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 90.6 t . . . . . 0 N--CA 1.495 1.788 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 26.6 tttm -83.77 84.87 7.4 Favored 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 119.223 -0.991 . . . . 0.0 109.202 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 376' ' ' ARG . . . . . 0.482 ' HB3' ' OG ' ' A' ' 397' ' ' SER . 1.9 mmt180 -69.07 152.78 44.78 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.277 -0.969 . . . . 0.0 108.925 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 6.5 t -70.62 144.37 51.17 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 119.486 -0.886 . . . . 0.0 108.903 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.34 158.66 4.07 Favored 'General case' 0 N--CA 1.509 2.487 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 44.1 t -78.91 157.58 28.22 Favored 'General case' 0 N--CA 1.508 2.445 0 O-C-N 120.712 -1.243 . . . . 0.0 110.384 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 55.0 mtm -48.67 -29.5 4.45 Favored 'General case' 0 N--CA 1.513 2.721 0 O-C-N 121.211 -0.93 . . . . 0.0 112.242 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -121.83 17.83 11.03 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.967 -1.083 . . . . 0.0 112.447 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 46.42 -114.41 1.44 Allowed Glycine 0 N--CA 1.499 2.834 0 O-C-N 120.782 -1.199 . . . . 0.0 112.487 177.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 383' ' ' ALA . . . . . 0.531 ' HB2' ' HG3' ' A' ' 399' ' ' PRO . . . -76.83 -18.31 58.46 Favored 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.488 -1.007 . . . . 0.0 112.585 -178.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 384' ' ' ASN . . . . . 0.443 ' O ' ' N ' ' A' ' 386' ' ' TYR . 33.6 m-80 -84.9 0.69 50.24 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 120.546 -1.346 . . . . 0.0 111.871 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 49.2 t -49.67 87.5 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.935 0 O-C-N 120.775 -1.203 . . . . 0.0 111.585 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 386' ' ' TYR . . . . . 0.443 ' N ' ' O ' ' A' ' 384' ' ' ASN . 31.8 p90 -66.14 -36.41 83.07 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 120.848 -1.157 . . . . 0.0 110.865 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -71.19 160.99 31.85 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.193 -0.942 . . . . 0.0 110.072 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 36.4 pttt -159.5 110.97 2.04 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.336 -0.853 . . . . 0.0 110.534 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -117.73 170.83 5.67 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 120.949 -1.095 . . . . 0.0 110.355 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -74.28 -27.93 11.01 Favored 'Trans proline' 0 N--CA 1.489 1.238 0 O-C-N 123.486 1.256 . . . . 0.0 110.875 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 58.3 t -103.12 -18.86 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 120.987 -1.071 . . . . 0.0 111.933 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 34.3 t60 -65.12 -39.42 93.06 Favored 'General case' 0 N--CA 1.508 2.471 0 O-C-N 120.559 -1.338 . . . . 0.0 109.961 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -55.15 -37.18 66.65 Favored 'General case' 0 N--CA 1.51 2.568 0 C-N-CA 119.215 -0.994 . . . . 0.0 108.467 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.42 ' O ' ' NE ' ' A' ' 376' ' ' ARG . 1.2 mp0 -74.84 -31.01 61.55 Favored 'General case' 0 N--CA 1.502 2.16 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.076 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 23.2 m170 -75.72 -27.09 58.05 Favored 'General case' 0 N--CA 1.509 2.522 0 O-C-N 120.975 -1.078 . . . . 0.0 111.61 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -140.19 150.72 44.53 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.821 -1.174 . . . . 0.0 110.612 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 397' ' ' SER . . . . . 0.482 ' OG ' ' HB3' ' A' ' 376' ' ' ARG . 3.1 m -89.46 171.74 9.5 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.467 -0.771 . . . . 0.0 109.836 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -144.56 153.03 54.56 Favored Pre-proline 0 N--CA 1.487 1.415 0 O-C-N 121.437 -0.79 . . . . 0.0 108.903 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 399' ' ' PRO . . . . . 0.531 ' HG3' ' HB2' ' A' ' 383' ' ' ALA . 35.7 Cg_endo -60.72 137.75 75.1 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 N-CA-C 109.0 -1.192 . . . . 0.0 109.0 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 104.07 -1.2 44.23 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.619 -1.277 . . . . 0.0 111.566 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -112.87 176.2 5.11 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 119.987 1.894 . . . . 0.0 109.3 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 2.7 t -79.15 -25.57 42.86 Favored 'General case' 0 N--CA 1.506 2.332 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.864 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -98.1 1.48 47.63 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.66 -1.275 . . . . 0.0 112.498 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 31.5 t80 . . . . . 0 N--CA 1.515 2.817 0 CA-C-N 120.096 1.316 . . . . 0.0 110.738 -179.923 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 57.7 t . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 375' ' ' LYS . 0.0 OUTLIER -89.05 100.11 12.96 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 122.089 0.947 . . . . 0.0 109.078 179.093 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.46 -177.22 0.06 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.484 -0.76 . . . . 0.0 111.109 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 3.3 m -108.24 130.84 55.14 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 378' ' ' SER . . . . . 0.432 ' OG ' ' CE1' ' A' ' 404' ' ' TYR . 30.7 t -48.91 118.44 2.6 Favored 'General case' 0 N--CA 1.515 2.802 0 O-C-N 121.656 -0.653 . . . . 0.0 110.724 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 379' ' ' CYS . . . . . 0.436 ' HB2' ' CD2' ' A' ' 398' ' ' HIS . 9.3 t -38.56 151.35 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.731 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -178.086 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 53.9 mtm -46.27 -34.6 4.57 Favored 'General case' 0 N--CA 1.509 2.513 0 O-C-N 121.838 -0.539 . . . . 0.0 111.117 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -114.52 9.33 16.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.123 -0.985 . . . . 0.0 113.163 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 57.82 -120.44 21.55 Favored Glycine 0 N--CA 1.491 2.361 0 O-C-N 120.175 -1.578 . . . . 0.0 112.159 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -75.6 -13.38 60.34 Favored 'General case' 0 N--CA 1.51 2.531 0 O-C-N 121.485 -1.009 . . . . 0.0 112.655 -178.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 384' ' ' ASN . . . . . 0.402 ' O ' ' N ' ' A' ' 386' ' ' TYR . 58.1 m-20 -86.01 -2.35 58.22 Favored 'General case' 0 N--CA 1.507 2.407 0 O-C-N 120.575 -1.328 . . . . 0.0 111.12 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 52.7 t -47.02 89.54 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.998 0 O-C-N 120.825 -1.172 . . . . 0.0 111.872 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 386' ' ' TYR . . . . . 0.402 ' N ' ' O ' ' A' ' 384' ' ' ASN . 31.3 p90 -70.34 -38.19 74.8 Favored 'General case' 0 N--CA 1.508 2.428 0 O-C-N 120.892 -1.13 . . . . 0.0 110.956 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.422 ' HD3' ' CE1' ' A' ' 392' ' ' HIS . 14.1 ptm180 -57.79 152.26 16.08 Favored 'General case' 0 N--CA 1.51 2.532 0 O-C-N 121.028 -1.045 . . . . 0.0 110.262 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -142.16 79.16 1.66 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.244 -0.91 . . . . 0.0 111.058 -179.071 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -97.26 160.64 28.45 Favored Pre-proline 0 N--CA 1.502 2.137 0 O-C-N 120.977 -1.077 . . . . 0.0 110.534 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -75.96 -29.2 6.98 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 O-C-N 123.547 1.288 . . . . 0.0 111.214 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 57.3 t -99.15 -22.38 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 O-C-N 121.236 -0.915 . . . . 0.0 111.594 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 392' ' ' HIS . . . . . 0.422 ' CE1' ' HD3' ' A' ' 387' ' ' ARG . 38.4 t60 -59.19 -37.76 78.2 Favored 'General case' 0 N--CA 1.51 2.542 0 O-C-N 120.611 -1.305 . . . . 0.0 110.152 -179.173 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -59.39 -33.72 71.55 Favored 'General case' 0 N--CA 1.505 2.295 0 C-N-CA 119.112 -1.035 . . . . 0.0 108.805 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -72.19 -33.34 67.59 Favored 'General case' 0 N--CA 1.503 2.19 0 C-N-CA 119.206 -0.997 . . . . 0.0 110.828 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 27.2 m170 -79.64 -34.81 40.2 Favored 'General case' 0 N--CA 1.509 2.485 0 O-C-N 120.983 -1.073 . . . . 0.0 111.224 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -121.92 158.51 28.87 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.029 -1.044 . . . . 0.0 110.304 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.45 173.77 6.16 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 178.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 398' ' ' HIS . . . . . 0.436 ' CD2' ' HB2' ' A' ' 379' ' ' CYS . 76.6 m80 -145.74 157.35 51.47 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 120.891 -1.131 . . . . 0.0 108.871 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -62.69 140.57 81.49 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 N-CA-C 108.892 -1.234 . . . . 0.0 108.892 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.88 -3.63 55.9 Favored Glycine 0 N--CA 1.496 2.689 0 C-N-CA 119.684 -1.246 . . . . 0.0 111.299 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -112.14 177.17 4.73 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 119.544 1.672 . . . . 0.0 108.689 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 1.4 p -79.36 -28.34 41.97 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.099 -1.04 . . . . 0.0 110.556 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -88.29 -4.45 58.69 Favored 'General case' 0 N--CA 1.509 2.501 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -176.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 404' ' ' TYR . . . . . 0.432 ' CE1' ' OG ' ' A' ' 378' ' ' SER . 7.9 t80 . . . . . 0 N--CA 1.533 3.679 0 CA-C-N 120.742 1.61 . . . . 0.0 111.869 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 120.598 0.237 . . . . 0.0 110.595 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.23 97.62 10.03 Favored 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 119.337 -0.945 . . . . 0.0 108.533 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 376' ' ' ARG . . . . . 0.4 ' NE ' ' HA ' ' A' ' 376' ' ' ARG . 0.2 OUTLIER -68.64 148.14 50.88 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.641 -0.824 . . . . 0.0 109.919 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 5.8 t -69.08 142.59 54.44 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 19.0 p -55.65 156.49 4.79 Favored 'General case' 0 N--CA 1.508 2.427 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 48.5 t -80.31 154.08 28.03 Favored 'General case' 0 N--CA 1.507 2.419 0 O-C-N 120.763 -1.211 . . . . 0.0 111.039 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 60.4 mtm -49.34 -33.26 13.03 Favored 'General case' 0 N--CA 1.516 2.844 0 O-C-N 121.303 -0.873 . . . . 0.0 111.288 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -136.36 39.13 2.69 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.208 -0.932 . . . . 0.0 108.831 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -39.02 -43.07 1.72 Allowed Glycine 0 N--CA 1.509 3.504 0 O-C-N 121.521 -0.737 . . . . 0.0 113.064 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -62.01 -29.53 70.34 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.015 -1.285 . . . . 0.0 110.745 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 384' ' ' ASN . . . . . 0.4 ' O ' ' N ' ' A' ' 386' ' ' TYR . 8.7 m120 -133.66 25.14 4.05 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.955 -1.091 . . . . 0.0 111.803 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 17.1 t -47.81 90.12 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.022 0 O-C-N 120.788 -1.195 . . . . 0.0 112.269 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 386' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 24.8 p90 -62.92 -41.92 99.63 Favored 'General case' 0 N--CA 1.51 2.569 0 O-C-N 120.832 -1.168 . . . . 0.0 110.289 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.451 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.2 OUTLIER -63.98 157.07 26.02 Favored 'General case' 0 N--CA 1.509 2.499 0 O-C-N 121.134 -0.979 . . . . 0.0 110.231 -179.531 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.38 92.23 1.58 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.314 -0.866 . . . . 0.0 110.805 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -106.84 162.68 18.9 Favored Pre-proline 0 N--CA 1.5 2.059 0 O-C-N 121.138 -0.976 . . . . 0.0 110.44 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -74.17 -26.53 12.6 Favored 'Trans proline' 0 CA--C 1.545 1.072 0 O-C-N 123.56 1.295 . . . . 0.0 111.264 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 60.8 t -99.86 -24.8 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 O-C-N 121.141 -0.974 . . . . 0.0 111.492 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 392' ' ' HIS . . . . . 0.433 ' CE1' ' NH1' ' A' ' 387' ' ' ARG . 44.8 t60 -61.36 -36.93 81.56 Favored 'General case' 0 N--CA 1.511 2.588 0 O-C-N 120.633 -1.292 . . . . 0.0 110.19 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -56.49 -34.27 66.8 Favored 'General case' 0 N--CA 1.507 2.4 0 C-N-CA 119.117 -1.033 . . . . 0.0 108.492 177.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.72 -32.85 58.1 Favored 'General case' 0 N--CA 1.506 2.36 0 C-N-CA 119.454 -0.899 . . . . 0.0 111.087 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -75.74 -34.41 60.29 Favored 'General case' 0 N--CA 1.509 2.524 0 O-C-N 121.133 -0.979 . . . . 0.0 110.938 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -128.56 151.27 49.65 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.985 -1.072 . . . . 0.0 110.528 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.33 168.83 11.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.577 -0.702 . . . . 0.0 109.322 178.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -140.94 152.93 66.7 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.357 -0.839 . . . . 0.0 109.728 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 399' ' ' PRO . . . . . 0.442 ' HA ' ' CD2' ' A' ' 404' ' ' TYR . 36.3 Cg_endo -59.43 136.87 74.55 Favored 'Trans proline' 0 C--N 1.316 -1.153 0 N-CA-C 108.839 -1.254 . . . . 0.0 108.839 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 102.41 0.04 50.16 Favored Glycine 0 CA--C 1.55 2.244 0 C-N-CA 119.635 -1.269 . . . . 0.0 111.419 -179.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -111.28 171.91 7.2 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 119.954 1.877 . . . . 0.0 109.451 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 50.5 m -75.5 -24.48 56.88 Favored 'General case' 0 N--CA 1.505 2.323 0 C-N-CA 119.246 -0.982 . . . . 0.0 111.103 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -102.14 5.89 40.57 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 120.644 -1.285 . . . . 0.0 112.728 -178.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 404' ' ' TYR . . . . . 0.442 ' CD2' ' HA ' ' A' ' 399' ' ' PRO . 14.0 t80 . . . . . 0 N--CA 1.515 2.815 0 O-C-N 120.688 -1.258 . . . . 0.0 112.483 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 60.0 t . . . . . 0 N--CA 1.493 1.693 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 31.6 mtpt -88.71 94.32 9.87 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 119.618 -0.833 . . . . 0.0 109.732 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 376' ' ' ARG . . . . . 0.434 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 42.1 mtm-85 -55.81 146.01 22.83 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.706 -0.621 . . . . 0.0 110.573 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 2.3 m -69.28 137.48 53.08 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 87.4 p -52.84 157.3 1.7 Allowed 'General case' 0 N--CA 1.512 2.656 0 O-C-N 121.054 -1.029 . . . . 0.0 109.749 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 12.7 t -80.74 158.52 25.49 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 120.854 -1.154 . . . . 0.0 109.107 179.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -55.59 -39.12 70.3 Favored 'General case' 0 N--CA 1.513 2.688 0 O-C-N 121.149 -0.97 . . . . 0.0 109.946 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 381' ' ' TYR . . . . . 0.404 ' CD1' ' N ' ' A' ' 381' ' ' TYR . 8.5 m-85 -128.29 38.29 4.01 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.126 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -38.04 -44.87 1.58 Allowed Glycine 0 N--CA 1.507 3.373 0 O-C-N 121.321 -0.862 . . . . 0.0 113.13 -177.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -59.35 -27.86 66.32 Favored 'General case' 0 N--CA 1.507 2.422 0 CA-C-N 118.653 1.226 . . . . 0.0 110.703 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 384' ' ' ASN . . . . . 0.419 ' O ' ' N ' ' A' ' 386' ' ' TYR . 8.7 m120 -133.14 19.82 4.06 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.843 -1.161 . . . . 0.0 112.109 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 33.7 t -43.75 88.78 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.367 0 CA-C-N 119.787 1.176 . . . . 0.0 112.775 -178.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 386' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 20.4 p90 -63.17 -40.59 97.96 Favored 'General case' 0 N--CA 1.509 2.504 0 O-C-N 120.95 -1.094 . . . . 0.0 111.537 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.455 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 15.1 ptm180 -56.02 151.15 12.41 Favored 'General case' 0 N--CA 1.513 2.708 0 O-C-N 120.821 -1.175 . . . . 0.0 110.376 -179.032 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -133.34 72.68 1.49 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.142 -0.974 . . . . 0.0 110.725 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -106.71 149.27 38.22 Favored Pre-proline 0 N--CA 1.498 1.972 0 O-C-N 121.094 -1.004 . . . . 0.0 109.547 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -69.73 -83.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.316 -1.173 0 O-C-N 123.498 1.262 . . . . 0.0 108.94 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 88.2 t -38.64 -26.48 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.526 3.358 0 O-C-N 120.833 -1.167 . . . . 0.0 113.288 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 392' ' ' HIS . . . . . 0.426 ' CE1' ' HD3' ' A' ' 387' ' ' ARG . 25.9 t60 -64.15 -39.36 93.84 Favored 'General case' 0 N--CA 1.512 2.626 0 O-C-N 120.312 -1.493 . . . . 0.0 108.504 177.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -59.87 -37.42 79.26 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.291 -0.881 . . . . 0.0 109.228 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -70.01 -26.55 64.12 Favored 'General case' 0 N--CA 1.507 2.393 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.215 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -90.99 -34.6 15.08 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.757 -1.214 . . . . 0.0 110.605 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -117.33 144.45 44.88 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.048 -1.033 . . . . 0.0 110.355 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 397' ' ' SER . . . . . 0.434 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 0.1 OUTLIER -98.0 167.03 11.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 110.528 179.611 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -140.07 153.57 69.43 Favored Pre-proline 0 N--CA 1.488 1.431 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.894 -178.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -62.28 137.9 68.53 Favored 'Trans proline' 0 N--CA 1.484 0.954 0 N-CA-C 108.038 -1.562 . . . . 0.0 108.038 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.37 -2.35 56.22 Favored Glycine 0 CA--C 1.551 2.343 0 C-N-CA 119.695 -1.24 . . . . 0.0 110.384 -177.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -115.47 140.07 49.48 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 119.649 1.725 . . . . 0.0 108.499 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 5.8 m -49.43 -25.61 2.69 Favored 'General case' 0 N--CA 1.509 2.512 0 O-C-N 121.11 -0.994 . . . . 0.0 113.201 -178.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -99.32 11.1 40.04 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 120.28 -1.513 . . . . 0.0 113.551 -177.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 6.1 t80 . . . . . 0 N--CA 1.515 2.816 0 O-C-N 120.365 -1.46 . . . . 0.0 109.487 179.556 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.73 148.53 46.85 Favored 'Trans proline' 0 C--N 1.317 -1.108 0 O-C-N 123.378 1.199 . . . . 0.0 110.411 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 1.1 tp -142.96 -172.91 3.76 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.202 -0.936 . . . . 0.0 110.147 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 112.08 56.67 0.46 Allowed Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 38.7 p -142.82 57.31 1.42 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.214 -1.168 . . . . 0.0 110.208 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -117.97 104.36 1.13 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 1.4 t -143.07 108.65 5.09 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.217 -1.167 . . . . 0.0 110.292 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -114.87 110.77 20.18 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.19 -0.944 . . . . 0.0 110.068 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -69.08 -78.71 0.32 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -153.72 37.16 0.46 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.198 -1.178 . . . . 0.0 110.687 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 373' ' ' LYS . . . . . 0.46 ' C ' HG23 ' A' ' 374' ' ' VAL . 1.3 ttpt -158.29 40.49 0.26 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.151 -0.968 . . . . 0.0 110.835 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 374' ' ' VAL . . . . . 0.46 HG23 ' C ' ' A' ' 373' ' ' LYS . 98.4 t -149.0 161.04 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.428 -0.795 . . . . 0.0 109.617 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 14.3 mttm -78.66 90.82 4.59 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 121.162 -0.961 . . . . 0.0 109.431 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 43.2 mtm-85 -61.51 154.39 24.77 Favored 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.389 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 4.7 t -79.25 138.49 37.81 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 10.8 p -53.39 151.17 5.73 Favored 'General case' 0 N--CA 1.515 2.798 0 O-C-N 120.882 -1.136 . . . . 0.0 108.52 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 23.4 t -79.82 156.12 27.54 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 120.887 -1.133 . . . . 0.0 111.618 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 65.7 mtm -48.32 -30.94 5.37 Favored 'General case' 0 N--CA 1.519 2.985 0 O-C-N 121.288 -0.882 . . . . 0.0 111.067 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 381' ' ' TYR . . . . . 0.444 ' CD1' ' N3 ' ' A' 1002 ' ' ADN . 14.7 m-85 -140.61 37.37 1.84 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.199 -0.938 . . . . 0.0 109.081 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -38.4 -46.07 1.95 Allowed Glycine 0 N--CA 1.506 3.334 0 O-C-N 121.206 -0.933 . . . . 0.0 113.112 -178.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -58.59 -28.69 65.81 Favored 'General case' 0 N--CA 1.51 2.529 0 CA-C-N 118.808 1.304 . . . . 0.0 110.687 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 384' ' ' ASN . . . . . 0.476 ' HB2' HN62 ' A' 1002 ' ' ADN . 7.3 m120 -135.11 28.77 3.44 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.028 -1.045 . . . . 0.0 110.977 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 19.2 t -53.02 88.74 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.807 0 O-C-N 121.091 -1.006 . . . . 0.0 110.957 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 386' ' ' TYR . . . . . 0.415 ' N ' ' O ' ' A' ' 384' ' ' ASN . 20.1 p90 -62.73 -35.94 81.41 Favored 'General case' 0 N--CA 1.507 2.418 0 O-C-N 120.988 -1.07 . . . . 0.0 111.138 -178.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.511 ' HD2' " H3'" ' A' 1003 ' ' RIB . 5.6 ptm85 -75.99 163.22 27.38 Favored 'General case' 0 N--CA 1.505 2.284 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.538 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -161.04 111.98 1.78 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.328 -0.857 . . . . 0.0 110.967 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -118.93 169.76 7.56 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.103 -0.998 . . . . 0.0 109.691 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -74.56 -29.35 9.13 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 O-C-N 123.463 1.244 . . . . 0.0 110.629 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 60.9 t -100.37 -21.52 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 121.084 -1.01 . . . . 0.0 111.718 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 37.2 t60 -61.95 -38.15 87.41 Favored 'General case' 0 N--CA 1.506 2.374 0 O-C-N 120.625 -1.297 . . . . 0.0 110.056 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -58.95 -31.86 69.09 Favored 'General case' 0 N--CA 1.506 2.365 0 C-N-CA 119.231 -0.987 . . . . 0.0 109.346 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -75.33 -31.56 60.64 Favored 'General case' 0 N--CA 1.508 2.469 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.744 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 16.8 m170 -82.84 -33.83 27.03 Favored 'General case' 0 N--CA 1.507 2.407 0 O-C-N 120.962 -1.086 . . . . 0.0 111.475 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 396' ' ' PHE . . . . . 0.421 ' CD1' ' N ' ' A' ' 396' ' ' PHE . 68.7 m-85 -124.05 141.95 51.61 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.934 -1.104 . . . . 0.0 110.838 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.54 170.81 9.87 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 109.089 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -144.62 153.76 55.24 Favored Pre-proline 0 N--CA 1.485 1.285 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.042 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -60.23 138.81 83.65 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 N-CA-C 108.713 -1.303 . . . . 0.0 108.713 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 102.06 -1.12 51.19 Favored Glycine 0 CA--C 1.554 2.477 0 C-N-CA 119.794 -1.193 . . . . 0.0 110.788 -177.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -114.38 165.3 12.86 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 119.788 1.794 . . . . 0.0 108.656 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 8.9 t -70.22 -25.27 63.32 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.186 -0.946 . . . . 0.0 111.39 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -98.38 5.62 48.01 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.696 -1.253 . . . . 0.0 112.908 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -55.98 143.4 32.32 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 120.434 -1.416 . . . . 0.0 109.188 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -158.23 41.85 0.51 Allowed Glycine 0 N--CA 1.496 2.668 0 C-N-CA 119.547 -1.311 . . . . 0.0 110.045 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . -99.99 -54.01 1.07 Allowed Glycine 0 N--CA 1.482 1.749 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.513 ' O ' HG12 ' A' ' 407' ' ' VAL . 86.5 t 44.4 66.23 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.739 -0.86 . . . . 0.0 111.631 178.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.431 HE21 ' HB2' ' A' ' 408' ' ' GLN . 0.0 OUTLIER -105.32 71.87 0.96 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.29 -0.881 . . . . 0.0 110.08 -179.653 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.621 HG23 ' CD ' ' A' ' 412' ' ' GLN . 46.7 mm 50.81 71.96 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 120.978 -1.076 . . . . 0.0 110.956 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 63.5 t -113.75 80.22 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.335 -0.853 . . . . 0.0 108.781 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 79.08 58.72 2.9 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 108.345 -1.902 . . . . 0.0 108.345 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 412' ' ' GLN . . . . . 0.621 ' CD ' HG23 ' A' ' 409' ' ' ILE . 7.9 mt-30 -49.4 -66.41 0.4 Allowed 'General case' 0 N--CA 1.511 2.616 0 O-C-N 121.335 -1.097 . . . . 0.0 110.948 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -159.27 39.46 0.21 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.179 -0.951 . . . . 0.0 110.836 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -115.01 40.52 2.62 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.135 -0.978 . . . . 0.0 110.239 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.32 65.28 0.94 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.238 -0.914 . . . . 0.0 109.935 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -118.2 41.72 2.86 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.3 -0.875 . . . . 0.0 110.207 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.494 1.754 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.211 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A 1002 ' ' ADN . . . . . 0.476 HN62 ' HB2' ' A' ' 384' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1003 ' ' RIB . . . . . 0.511 " H3'" ' HD2' ' A' ' 387' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.68 -171.23 0.71 Allowed 'Trans proline' 0 C--N 1.316 -1.154 0 O-C-N 123.44 1.232 . . . . 0.0 110.339 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 42.6 mt -115.32 105.13 12.51 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.173 -0.954 . . . . 0.0 110.183 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 120.18 103.84 1.99 Allowed Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 4.2 t -117.03 117.04 28.56 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.131 -1.217 . . . . 0.0 110.256 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -137.63 168.48 24.45 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 1.7 m -123.85 120.58 32.99 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.147 -1.208 . . . . 0.0 110.157 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -138.5 85.61 2.1 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.185 -0.947 . . . . 0.0 110.269 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -139.52 42.29 1.25 Allowed Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -145.29 -65.9 0.32 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.183 -1.186 . . . . 0.0 110.252 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 2.3 tptp -142.2 65.14 1.37 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.223 -0.923 . . . . 0.0 110.08 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 90.2 t -145.82 161.0 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -0.908 . . . . 0.0 109.985 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 17.8 mttp -87.73 95.82 10.22 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.335 -0.853 . . . . 0.0 109.187 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.69 162.62 6.38 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 120.211 -0.596 . . . . 0.0 109.898 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 4.4 t -89.83 137.91 31.94 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.42 150.84 4.5 Favored 'General case' 0 N--CA 1.517 2.907 0 O-C-N 120.995 -1.066 . . . . 0.0 109.337 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 47.8 t -80.62 150.59 29.41 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 120.95 -1.094 . . . . 0.0 111.442 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 46.7 mtm -48.21 -30.32 4.58 Favored 'General case' 0 N--CA 1.519 2.983 0 O-C-N 121.283 -0.886 . . . . 0.0 111.709 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 381' ' ' TYR . . . . . 0.524 ' HA ' HG13 ' A' ' 410' ' ' VAL . 20.6 m-85 -140.54 36.15 1.84 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.183 -0.948 . . . . 0.0 109.369 178.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -37.62 -42.64 1.03 Allowed Glycine 0 N--CA 1.507 3.374 0 O-C-N 121.196 -0.94 . . . . 0.0 113.333 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -60.04 -30.24 69.05 Favored 'General case' 0 N--CA 1.508 2.448 0 O-C-N 121.03 -1.277 . . . . 0.0 110.538 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 384' ' ' ASN . . . . . 0.473 ' HB2' HN62 ' A' 1002 ' ' ADN . 7.6 m120 -134.63 26.06 3.71 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.063 -1.023 . . . . 0.0 111.075 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 35.8 t -49.11 92.2 0.01 OUTLIER 'General case' 0 N--CA 1.519 2.981 0 O-C-N 120.788 -1.195 . . . . 0.0 111.692 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -68.75 -39.04 80.52 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 121.074 -1.016 . . . . 0.0 110.176 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.86 148.43 51.8 Favored 'General case' 0 N--CA 1.508 2.466 0 O-C-N 121.21 -0.931 . . . . 0.0 109.511 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.74 90.81 1.73 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.175 -0.953 . . . . 0.0 110.935 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -100.29 168.54 9.24 Favored Pre-proline 0 N--CA 1.499 2.019 0 O-C-N 120.666 -1.271 . . . . 0.0 110.263 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -75.99 -26.34 9.49 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 O-C-N 123.538 1.283 . . . . 0.0 110.894 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 76.5 t -101.75 -19.57 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 O-C-N 121.074 -1.016 . . . . 0.0 111.779 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 41.5 t60 -63.05 -40.29 97.28 Favored 'General case' 0 N--CA 1.51 2.526 0 O-C-N 120.53 -1.356 . . . . 0.0 110.217 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -56.68 -34.26 67.22 Favored 'General case' 0 N--CA 1.51 2.568 0 O-C-N 121.134 -0.979 . . . . 0.0 109.113 178.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -72.82 -31.32 64.71 Favored 'General case' 0 N--CA 1.507 2.4 0 C-N-CA 119.109 -1.036 . . . . 0.0 111.15 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 20.9 m170 -87.38 -31.94 19.85 Favored 'General case' 0 N--CA 1.508 2.439 0 O-C-N 121.019 -1.051 . . . . 0.0 111.748 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -121.38 144.03 48.89 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.847 -1.158 . . . . 0.0 111.255 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 397' ' ' SER . . . . . 0.409 ' HB2' ' HA ' ' A' ' 404' ' ' TYR . 0.0 OUTLIER -88.54 173.02 8.9 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.386 -0.821 . . . . 0.0 109.39 178.931 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -144.88 155.86 55.64 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.419 -0.801 . . . . 0.0 109.771 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -60.72 136.64 67.91 Favored 'Trans proline' 0 C--N 1.318 -1.07 0 N-CA-C 109.126 -1.144 . . . . 0.0 109.126 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 104.08 -2.46 44.21 Favored Glycine 0 CA--C 1.553 2.455 0 C-N-CA 119.962 -1.113 . . . . 0.0 110.715 -178.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -116.6 150.92 37.27 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 119.62 1.71 . . . . 0.0 108.884 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 2.1 p -58.16 -28.07 64.4 Favored 'General case' 0 N--CA 1.503 2.186 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.318 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -88.18 -0.71 57.42 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 120.727 -1.233 . . . . 0.0 113.349 -178.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 404' ' ' TYR . . . . . 0.409 ' HA ' ' HB2' ' A' ' 397' ' ' SER . 16.5 t80 -43.6 120.3 1.93 Allowed 'General case' 0 N--CA 1.522 3.156 0 CA-C-N 120.379 1.445 . . . . 0.0 111.756 -178.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -54.33 -48.17 65.47 Favored Glycine 0 N--CA 1.497 2.719 0 O-C-N 121.305 -0.872 . . . . 0.0 111.251 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 141.89 -143.71 13.33 Favored Glycine 0 N--CA 1.477 1.369 0 N-CA-C 107.571 -2.212 . . . . 0.0 107.571 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 73.5 t -111.53 92.82 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.297 -1.12 . . . . 0.0 110.614 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -108.81 84.01 1.86 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.34 -0.85 . . . . 0.0 110.062 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.51 HG22 ' O ' ' A' ' 409' ' ' ILE . 4.6 mp 51.59 67.78 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.04 -1.038 . . . . 0.0 110.549 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 410' ' ' VAL . . . . . 0.524 HG13 ' HA ' ' A' ' 381' ' ' TYR . 62.7 t -121.63 65.75 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 93.94 51.81 2.04 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 108.109 -1.996 . . . . 0.0 108.109 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 412' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -46.98 -60.66 2.3 Favored 'General case' 0 N--CA 1.512 2.666 0 O-C-N 121.478 -1.013 . . . . 0.0 111.333 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -144.55 42.67 1.37 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.263 -0.898 . . . . 0.0 110.424 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -124.29 39.65 3.92 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.151 -0.968 . . . . 0.0 110.261 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.58 60.72 1.68 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.261 -0.899 . . . . 0.0 109.796 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -137.05 40.14 2.51 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.167 -0.958 . . . . 0.0 110.348 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.366 179.967 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A 1002 ' ' ADN . . . . . 0.606 ' H8 ' " O5'" ' A' 1002 ' ' ADN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1003 ' ' RIB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.91 105.97 2.05 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 O-C-N 123.315 1.166 . . . . 0.0 110.35 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -136.28 48.43 2.15 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.212 -0.93 . . . . 0.0 110.229 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 118.26 -82.19 0.33 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 54.2 p -120.9 71.7 0.95 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.222 -1.164 . . . . 0.0 110.197 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -140.96 107.87 0.53 Allowed Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 66.4 m -117.31 56.48 0.82 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.291 -1.123 . . . . 0.0 110.135 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -143.13 -172.0 3.59 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.188 -0.945 . . . . 0.0 110.198 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -81.44 -98.11 0.41 Allowed Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -132.05 71.95 1.48 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.217 -1.167 . . . . 0.0 110.101 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 52.51 61.25 3.29 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 120.959 -1.088 . . . . 0.0 110.469 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 10.8 p -142.92 162.73 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.216 -0.927 . . . . 0.0 110.55 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? -89.47 99.05 12.13 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.285 -0.884 . . . . 0.0 108.646 178.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 376' ' ' ARG . . . . . 0.443 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 0.0 OUTLIER -68.66 168.17 13.7 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.63 -0.669 . . . . 0.0 110.22 -179.747 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 5.1 t -85.77 139.9 30.93 Favored 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 119.651 -0.819 . . . . 0.0 110.395 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 378' ' ' SER . . . . . 0.432 ' HB2' ' N ' ' A' ' 406' ' ' GLY . 9.8 t -59.74 123.21 16.23 Favored 'General case' 0 N--CA 1.512 2.659 0 O-C-N 121.254 -0.904 . . . . 0.0 111.007 -178.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 16.9 t -44.12 144.04 1.04 Allowed 'General case' 0 N--CA 1.508 2.471 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -178.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 57.4 mtm -42.51 -35.86 1.18 Allowed 'General case' 0 N--CA 1.518 2.931 0 O-C-N 122.129 -0.357 . . . . 0.0 110.984 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 381' ' ' TYR . . . . . 0.426 ' CD1' ' N3 ' ' A' 1002 ' ' ADN . 13.9 m-85 -133.88 37.35 3.25 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 121.389 -0.82 . . . . 0.0 109.407 178.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -36.94 -47.35 1.29 Allowed Glycine 0 N--CA 1.51 3.625 0 O-C-N 120.902 -1.124 . . . . 0.0 113.346 -178.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -59.2 -24.75 63.38 Favored 'General case' 0 N--CA 1.514 2.761 0 CA-C-N 118.924 1.362 . . . . 0.0 111.159 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 384' ' ' ASN . . . . . 0.463 ' CB ' HN62 ' A' 1002 ' ' ADN . 9.0 m120 -136.07 25.37 3.29 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.92 -1.113 . . . . 0.0 111.105 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 46.9 t -51.92 90.76 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.894 0 O-C-N 120.814 -1.178 . . . . 0.0 111.168 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 386' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 20.0 p90 -66.01 -36.58 83.65 Favored 'General case' 0 N--CA 1.506 2.364 0 O-C-N 121.074 -1.016 . . . . 0.0 111.052 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.428 ' HD3' ' CE1' ' A' ' 392' ' ' HIS . 14.1 ptm180 -64.92 161.96 17.38 Favored 'General case' 0 N--CA 1.511 2.583 0 O-C-N 120.918 -1.114 . . . . 0.0 110.356 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.59 84.86 1.18 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.133 -0.98 . . . . 0.0 111.505 -178.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -103.18 164.73 14.91 Favored Pre-proline 0 N--CA 1.502 2.174 0 O-C-N 120.543 -1.348 . . . . 0.0 110.356 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -76.83 -29.96 5.05 Favored 'Trans proline' 0 N--CA 1.489 1.223 0 O-C-N 123.47 1.247 . . . . 0.0 111.046 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 58.8 t -97.71 -24.63 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 O-C-N 120.985 -1.072 . . . . 0.0 111.51 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 392' ' ' HIS . . . . . 0.428 ' CE1' ' HD3' ' A' ' 387' ' ' ARG . 40.3 t60 -57.53 -37.51 73.17 Favored 'General case' 0 N--CA 1.509 2.51 0 O-C-N 120.794 -1.191 . . . . 0.0 110.05 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -58.73 -33.57 70.38 Favored 'General case' 0 N--CA 1.505 2.291 0 C-N-CA 119.253 -0.979 . . . . 0.0 108.84 178.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -75.08 -35.12 61.82 Favored 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 119.097 -1.041 . . . . 0.0 110.421 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 395' ' ' HIS . . . . . 0.423 ' HB3' ' CE1' ' A' ' 396' ' ' PHE . 8.4 m170 -74.56 -29.73 61.46 Favored 'General case' 0 N--CA 1.511 2.621 0 O-C-N 120.996 -1.065 . . . . 0.0 111.903 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 396' ' ' PHE . . . . . 0.423 ' CE1' ' HB3' ' A' ' 395' ' ' HIS . 70.2 m-85 -132.97 143.12 49.24 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.705 -1.247 . . . . 0.0 110.739 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 397' ' ' SER . . . . . 0.443 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 74.9 m -83.14 170.78 14.39 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -144.18 157.56 56.69 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.051 -1.031 . . . . 0.0 109.468 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.58 139.37 69.65 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 N-CA-C 108.648 -1.328 . . . . 0.0 108.648 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 96.74 -1.34 61.52 Favored Glycine 0 N--CA 1.494 2.536 0 C-N-CA 119.493 -1.337 . . . . 0.0 111.176 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -115.4 173.14 6.67 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 119.577 1.689 . . . . 0.0 108.271 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 74.8 p -75.03 -31.78 61.43 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 118.869 -1.133 . . . . 0.0 110.284 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -80.37 -6.05 57.4 Favored 'General case' 0 N--CA 1.508 2.442 0 O-C-N 120.777 -1.202 . . . . 0.0 114.087 -176.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 404' ' ' TYR . . . . . 0.429 ' CE1' ' OG ' ' A' ' 378' ' ' SER . 5.8 t80 -40.85 119.96 1.22 Allowed 'General case' 0 N--CA 1.528 3.463 0 CA-C-N 120.679 1.581 . . . . 0.0 111.076 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -174.02 76.04 0.08 OUTLIER Glycine 0 N--CA 1.502 3.05 0 C-N-CA 119.531 -1.318 . . . . 0.0 110.823 -178.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 406' ' ' GLY . . . . . 0.432 ' N ' ' HB2' ' A' ' 378' ' ' SER . . . -146.2 -55.13 0.02 OUTLIER Glycine 0 N--CA 1.5 2.944 0 C-N-CA 119.882 -1.151 . . . . 0.0 111.391 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.573 ' O ' HG13 ' A' ' 407' ' ' VAL . 14.6 p -115.58 64.89 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.136 -1.214 . . . . 0.0 110.698 -179.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -136.08 91.86 2.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.896 . . . . 0.0 109.982 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.41 HG22 ' O ' ' A' ' 409' ' ' ILE . 51.2 mm -103.71 65.57 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.325 -0.86 . . . . 0.0 109.566 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 64.0 t -112.67 77.99 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 83.74 57.95 2.34 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 108.089 -2.004 . . . . 0.0 108.089 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 412' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -56.1 -39.69 72.56 Favored 'General case' 0 N--CA 1.509 2.488 0 O-C-N 121.316 -1.109 . . . . 0.0 110.291 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -114.62 34.74 4.59 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.171 -0.956 . . . . 0.0 110.274 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 50.75 52.09 15.62 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.888 -1.132 . . . . 0.0 110.976 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -113.55 66.38 0.66 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.216 -0.928 . . . . 0.0 110.187 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -118.24 81.16 1.63 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.364 -0.835 . . . . 0.0 110.122 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.214 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A 1002 ' ' ADN . . . . . 0.463 HN62 ' CB ' ' A' ' 384' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1003 ' ' RIB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.7 133.05 19.64 Favored 'Trans proline' 0 C--N 1.316 -1.135 0 O-C-N 123.49 1.258 . . . . 0.0 110.434 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 365' ' ' LEU . . . . . 0.447 ' HA ' HD13 ' A' ' 365' ' ' LEU . 1.9 mm? -116.43 -65.26 1.21 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.205 -0.935 . . . . 0.0 110.159 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -134.06 136.52 8.67 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.53 89.39 2.21 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.214 -1.168 . . . . 0.0 110.209 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -132.67 63.73 0.62 Allowed Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 58.5 m -144.84 125.65 14.31 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.237 -1.155 . . . . 0.0 110.318 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -140.74 -164.39 1.72 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.129 -0.982 . . . . 0.0 109.998 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 84.46 41.51 7.82 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -138.53 -63.83 0.54 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.221 -1.164 . . . . 0.0 110.363 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 373' ' ' LYS . . . . . 0.427 ' C ' HG23 ' A' ' 374' ' ' VAL . 0.0 OUTLIER -139.71 54.93 1.67 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.066 -1.021 . . . . 0.0 110.246 179.828 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 374' ' ' VAL . . . . . 0.427 HG23 ' C ' ' A' ' 373' ' ' LYS . 72.1 t -148.01 158.38 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.212 -0.93 . . . . 0.0 110.279 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -82.95 83.22 7.89 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.223 -0.923 . . . . 0.0 109.165 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 376' ' ' ARG . . . . . 0.433 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 1.3 mmt180 -62.16 151.81 34.86 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.831 -0.748 . . . . 0.0 109.977 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 1.9 m -70.48 139.31 51.65 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 378' ' ' SER . . . . . 0.44 ' HB2' ' N ' ' A' ' 406' ' ' GLY . 14.6 t -55.43 168.94 0.33 Allowed 'General case' 0 N--CA 1.512 2.655 0 O-C-N 120.866 -1.146 . . . . 0.0 109.101 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 50.1 t -86.54 155.09 20.62 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 120.93 -1.106 . . . . 0.0 109.377 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -50.57 -35.61 30.74 Favored 'General case' 0 N--CA 1.515 2.81 0 O-C-N 121.126 -0.984 . . . . 0.0 111.293 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 381' ' ' TYR . . . . . 0.434 ' CD1' ' N3 ' ' A' 1002 ' ' ADN . 22.8 m-85 -131.38 36.59 3.77 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.34 -0.85 . . . . 0.0 109.62 178.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -37.35 -46.59 1.43 Allowed Glycine 0 N--CA 1.509 3.501 0 O-C-N 121.143 -0.973 . . . . 0.0 113.518 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -58.52 -26.74 63.82 Favored 'General case' 0 N--CA 1.512 2.667 0 CA-C-N 118.964 1.382 . . . . 0.0 110.923 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 384' ' ' ASN . . . . . 0.469 ' HB2' HN62 ' A' 1002 ' ' ADN . 8.0 m120 -136.53 24.95 3.17 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.939 -1.101 . . . . 0.0 111.182 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 36.2 t -50.18 87.93 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.052 0 O-C-N 120.9 -1.125 . . . . 0.0 111.356 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 386' ' ' TYR . . . . . 0.46 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 21.9 p90 -60.73 -38.28 84.6 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.041 -1.037 . . . . 0.0 111.16 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.46 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 14.1 ptm180 -59.23 149.59 28.04 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 121.176 -0.953 . . . . 0.0 110.225 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.98 76.09 1.61 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.323 -0.861 . . . . 0.0 110.933 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -114.3 152.74 46.26 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.071 -1.018 . . . . 0.0 109.29 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -71.59 -76.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.316 -1.183 0 O-C-N 123.408 1.215 . . . . 0.0 110.193 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 11.2 p -38.68 -33.16 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.524 3.258 0 O-C-N 120.888 -1.133 . . . . 0.0 112.639 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 392' ' ' HIS . . . . . 0.416 ' CE1' ' HD3' ' A' ' 387' ' ' ARG . 37.3 t60 -65.22 -37.87 88.64 Favored 'General case' 0 N--CA 1.511 2.598 0 O-C-N 121.092 -1.005 . . . . 0.0 109.552 178.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -59.06 -34.21 71.68 Favored 'General case' 0 N--CA 1.508 2.464 0 O-C-N 121.082 -1.011 . . . . 0.0 108.887 177.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -77.43 -30.94 53.66 Favored 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.242 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 14.9 m170 -78.12 -25.63 47.56 Favored 'General case' 0 N--CA 1.511 2.598 0 O-C-N 121.075 -1.016 . . . . 0.0 111.95 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -135.89 147.07 48.01 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.686 -1.259 . . . . 0.0 110.556 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 397' ' ' SER . . . . . 0.433 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 54.6 m -89.21 160.78 16.78 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.365 -0.834 . . . . 0.0 109.772 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -136.55 156.38 76.38 Favored Pre-proline 0 N--CA 1.485 1.279 0 C-N-CA 119.786 -0.766 . . . . 0.0 110.051 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -62.57 137.97 67.41 Favored 'Trans proline' 0 C--N 1.319 -1.023 0 N-CA-C 108.303 -1.46 . . . . 0.0 108.303 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 98.51 0.11 58.09 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.471 -1.347 . . . . 0.0 110.64 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -111.57 177.54 4.62 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 119.561 1.68 . . . . 0.0 108.597 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -81.06 -25.41 37.12 Favored 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 119.081 -1.047 . . . . 0.0 110.93 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -97.13 4.75 51.09 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 120.621 -1.299 . . . . 0.0 114.469 -177.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 404' ' ' TYR . . . . . 0.511 ' CE2' ' HB3' ' A' ' 408' ' ' GLN . 4.3 t80 -40.2 121.29 1.33 Allowed 'General case' 0 N--CA 1.53 3.57 0 CA-C-N 120.676 1.58 . . . . 0.0 110.965 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -168.61 80.15 0.1 Allowed Glycine 0 N--CA 1.495 2.602 0 C-N-CA 119.37 -1.395 . . . . 0.0 111.033 -178.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 406' ' ' GLY . . . . . 0.44 ' N ' ' HB2' ' A' ' 378' ' ' SER . . . -171.64 -55.22 0.04 OUTLIER Glycine 0 N--CA 1.499 2.858 0 C-N-CA 119.274 -1.441 . . . . 0.0 112.571 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.599 ' O ' HG13 ' A' ' 407' ' ' VAL . 7.1 p -138.96 92.2 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-N 118.943 1.371 . . . . 0.0 111.048 -178.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.511 ' HB3' ' CE2' ' A' ' 404' ' ' TYR . 5.8 pt20 -152.6 83.03 1.23 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.17 -0.957 . . . . 0.0 110.663 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.738 HG23 ' CD ' ' A' ' 412' ' ' GLN . 28.7 mt -110.26 76.32 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.427 -0.796 . . . . 0.0 109.792 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 410' ' ' VAL . . . . . 0.574 HG13 ' O ' ' A' ' 410' ' ' VAL . 9.8 p -115.79 69.35 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.369 -0.832 . . . . 0.0 109.197 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 93.78 56.31 1.43 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.116 -1.994 . . . . 0.0 108.116 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 412' ' ' GLN . . . . . 0.738 ' CD ' HG23 ' A' ' 409' ' ' ILE . 13.3 mt-30 -48.85 -66.42 0.4 Allowed 'General case' 0 N--CA 1.511 2.62 0 O-C-N 121.45 -1.029 . . . . 0.0 110.891 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -169.15 44.26 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.188 -0.945 . . . . 0.0 110.763 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -124.42 63.34 1.1 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.178 -0.951 . . . . 0.0 110.306 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 415' ' ' THR . . . . . 0.428 ' O ' HG23 ' A' ' 415' ' ' THR . 6.0 t -132.64 62.16 1.66 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.143 -0.973 . . . . 0.0 110.196 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -103.48 38.83 1.7 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.164 -0.96 . . . . 0.0 109.871 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 1.4 t70 . . . . . 0 N--CA 1.494 1.774 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.356 179.974 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A 1002 ' ' ADN . . . . . 0.469 HN62 ' HB2' ' A' ' 384' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1003 ' ' RIB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.63 144.36 39.67 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 O-C-N 123.473 1.249 . . . . 0.0 110.455 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 1.6 mp -123.66 104.77 9.21 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.256 -0.902 . . . . 0.0 110.178 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -128.34 179.6 16.47 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 69.8 p -122.23 45.0 2.45 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.139 -1.212 . . . . 0.0 110.228 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -105.9 170.76 17.26 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 1.8 m -140.2 39.81 1.93 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.165 -1.197 . . . . 0.0 110.354 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -157.85 159.23 36.45 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.279 -0.888 . . . . 0.0 110.687 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -87.61 -56.48 2.11 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 372' ' ' ASN . . . . . 0.409 ' O ' HG23 ' A' ' 374' ' ' VAL . 7.1 m120 -145.91 65.18 1.22 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.144 -1.209 . . . . 0.0 110.411 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 373' ' ' LYS . . . . . 0.437 ' C ' HG23 ' A' ' 374' ' ' VAL . 4.0 mptp? 52.63 75.67 0.22 Allowed 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.954 -1.091 . . . . 0.0 110.674 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 374' ' ' VAL . . . . . 0.437 HG23 ' C ' ' A' ' 373' ' ' LYS . 89.1 t -148.39 158.98 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.217 -0.927 . . . . 0.0 110.229 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.67 83.1 7.76 Favored 'General case' 0 N--CA 1.504 2.238 0 C-N-CA 119.311 -0.956 . . . . 0.0 108.444 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 376' ' ' ARG . . . . . 0.437 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 2.3 mmt180 -60.56 154.34 21.25 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 119.949 -0.7 . . . . 0.0 110.103 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 1.8 m -71.32 140.67 50.35 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 378' ' ' SER . . . . . 0.476 ' CB ' ' HA3' ' A' ' 406' ' ' GLY . 29.2 t -52.48 166.5 0.18 Allowed 'General case' 0 N--CA 1.511 2.613 0 C-N-CA 119.239 -0.984 . . . . 0.0 109.349 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 50.9 t -90.17 154.86 19.44 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 120.837 -1.164 . . . . 0.0 109.613 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 56.0 mtm -49.65 -32.07 12.3 Favored 'General case' 0 N--CA 1.519 2.995 0 O-C-N 121.279 -0.888 . . . . 0.0 111.726 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 381' ' ' TYR . . . . . 0.438 ' CD1' ' N3 ' ' A' 1002 ' ' ADN . 24.3 m-85 -138.5 38.31 2.25 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.229 -0.919 . . . . 0.0 109.552 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -37.65 -49.65 1.86 Allowed Glycine 0 N--CA 1.508 3.473 0 O-C-N 121.231 -0.918 . . . . 0.0 113.032 -178.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -55.24 -27.21 44.69 Favored 'General case' 0 N--CA 1.51 2.53 0 O-C-N 120.997 -1.296 . . . . 0.0 111.231 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 384' ' ' ASN . . . . . 0.518 ' HB2' HN62 ' A' 1002 ' ' ADN . 7.4 m120 -138.1 29.31 2.52 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.95 -1.094 . . . . 0.0 110.936 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 37.8 t -53.54 85.89 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.988 0 O-C-N 120.98 -1.075 . . . . 0.0 111.516 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 386' ' ' TYR . . . . . 0.436 ' N ' ' O ' ' A' ' 384' ' ' ASN . 17.3 p90 -61.24 -31.17 70.96 Favored 'General case' 0 N--CA 1.51 2.565 0 O-C-N 121.005 -1.059 . . . . 0.0 111.64 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.447 ' HD2' " H3'" ' A' 1003 ' ' RIB . 3.6 ptm85 -79.79 160.63 26.09 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 120.977 -1.077 . . . . 0.0 110.943 -179.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.405 ' O ' ' HG3' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -156.74 112.75 2.97 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.329 -0.857 . . . . 0.0 110.909 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -121.42 169.54 8.97 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.847 -1.158 . . . . 0.0 109.785 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.9 -30.66 8.98 Favored 'Trans proline' 0 C--N 1.314 -1.27 0 O-C-N 123.473 1.249 . . . . 0.0 110.609 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 73.9 t -100.38 -22.65 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.094 -1.004 . . . . 0.0 111.772 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 41.2 t60 -61.5 -39.38 90.76 Favored 'General case' 0 N--CA 1.51 2.525 0 O-C-N 120.528 -1.358 . . . . 0.0 109.829 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -55.73 -33.15 63.98 Favored 'General case' 0 N--CA 1.507 2.416 0 C-N-CA 119.294 -0.962 . . . . 0.0 108.916 178.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.406 ' O ' ' NE ' ' A' ' 376' ' ' ARG . 1.0 OUTLIER -78.43 -32.09 48.4 Favored 'General case' 0 N--CA 1.504 2.237 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.556 179.791 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 395' ' ' HIS . . . . . 0.404 ' HB3' ' CE2' ' A' ' 396' ' ' PHE . 9.1 m-70 -79.93 -17.83 52.03 Favored 'General case' 0 N--CA 1.513 2.699 0 O-C-N 120.927 -1.108 . . . . 0.0 112.976 -178.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 396' ' ' PHE . . . . . 0.404 ' CE2' ' HB3' ' A' ' 395' ' ' HIS . 70.3 m-85 -145.09 142.61 29.83 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.442 -1.411 . . . . 0.0 110.725 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 397' ' ' SER . . . . . 0.437 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 19.9 m -85.05 170.54 12.87 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.255 -0.903 . . . . 0.0 110.506 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -143.7 151.5 53.69 Favored Pre-proline 0 N--CA 1.482 1.153 0 C-N-CA 119.831 -0.748 . . . . 0.0 109.645 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -60.73 139.51 85.91 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 N-CA-C 107.767 -1.667 . . . . 0.0 107.767 178.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.18 2.43 55.83 Favored Glycine 0 CA--C 1.548 2.131 0 C-N-CA 119.331 -1.414 . . . . 0.0 110.44 -177.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.52 158.92 26.25 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 119.77 1.785 . . . . 0.0 108.681 177.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 39.8 t -62.93 -30.77 71.82 Favored 'General case' 0 N--CA 1.501 2.091 0 C-N-CA 118.995 -1.082 . . . . 0.0 110.819 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -89.42 -2.73 58.5 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 120.64 -1.287 . . . . 0.0 113.732 -177.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -48.82 138.61 10.96 Favored 'General case' 0 N--CA 1.516 2.859 0 CA-C-N 120.492 1.496 . . . . 0.0 110.491 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -167.57 58.42 0.22 Allowed Glycine 0 N--CA 1.501 2.992 0 C-N-CA 119.536 -1.316 . . . . 0.0 110.43 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 406' ' ' GLY . . . . . 0.476 ' HA3' ' CB ' ' A' ' 378' ' ' SER . . . -110.61 -60.12 0.49 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.528 ' O ' HG12 ' A' ' 407' ' ' VAL . 91.1 t 34.52 63.95 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 122.414 -0.463 . . . . 0.0 111.983 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 11.6 mp0 -103.05 92.75 4.68 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.361 -0.837 . . . . 0.0 110.526 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.525 HG23 ' CD ' ' A' ' 412' ' ' GLN . 84.1 mt -111.31 67.24 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.25 -0.906 . . . . 0.0 109.685 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 61.7 t -115.18 73.5 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 83.5 55.31 2.89 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.168 -1.973 . . . . 0.0 108.168 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 412' ' ' GLN . . . . . 0.525 ' CD ' HG23 ' A' ' 409' ' ' ILE . 4.9 mt-30 -47.83 -63.31 1.1 Allowed 'General case' 0 N--CA 1.513 2.724 0 O-C-N 121.477 -1.013 . . . . 0.0 110.932 -179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -138.37 37.59 2.28 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.307 -0.871 . . . . 0.0 110.429 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -141.93 69.84 1.33 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.177 -0.952 . . . . 0.0 110.133 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 7.5 t -133.69 49.2 2.3 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.126 -0.984 . . . . 0.0 110.189 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 3.2 t70 51.05 34.25 10.52 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.101 -0.999 . . . . 0.0 111.108 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 17.8 t0 . . . . . 0 N--CA 1.494 1.734 0 O-C-N 121.032 -1.042 . . . . 0.0 110.171 179.981 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A 1002 ' ' ADN . . . . . 0.518 HN62 ' HB2' ' A' ' 384' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1003 ' ' RIB . . . . . 0.447 " H3'" ' HD2' ' A' ' 387' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -72.97 147.81 44.21 Favored 'Trans proline' 0 C--N 1.317 -1.114 0 O-C-N 123.428 1.225 . . . . 0.0 110.456 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.62 -59.79 0.44 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.186 -0.946 . . . . 0.0 110.277 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -142.35 121.31 1.76 Allowed Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 33.5 m -143.26 87.71 1.98 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.268 -1.137 . . . . 0.0 110.241 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -79.55 81.08 1.49 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.39 56.44 1.45 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.117 -1.225 . . . . 0.0 110.183 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -159.57 178.43 9.87 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.17 -0.956 . . . . 0.0 110.946 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -76.29 -89.56 0.26 Allowed Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -136.75 67.65 1.44 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.169 -1.194 . . . . 0.0 110.111 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 52.4 65.77 1.41 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.007 -1.058 . . . . 0.0 110.61 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 11.1 p -143.38 162.3 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.319 -0.863 . . . . 0.0 110.43 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.7 84.73 6.19 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.283 -0.886 . . . . 0.0 109.411 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 376' ' ' ARG . . . . . 0.453 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 1.2 mmt180 -60.83 148.92 37.62 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.664 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 5.5 t -67.77 140.93 56.69 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 1.3 p -54.16 158.93 2.04 Favored 'General case' 0 N--CA 1.507 2.379 0 C-N-CA 119.311 -0.956 . . . . 0.0 109.374 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 53.6 t -84.08 154.73 23.03 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 120.996 -1.065 . . . . 0.0 110.139 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 51.5 mtm -51.74 -30.82 24.04 Favored 'General case' 0 N--CA 1.515 2.821 0 O-C-N 121.306 -0.872 . . . . 0.0 111.82 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 381' ' ' TYR . . . . . 0.422 ' O ' ' N ' ' A' ' 385' ' ' CYS . 22.3 m-85 -137.11 36.73 2.55 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.063 -1.023 . . . . 0.0 109.3 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -40.31 -46.84 3.53 Favored Glycine 0 N--CA 1.506 3.3 0 O-C-N 121.34 -0.85 . . . . 0.0 112.901 -178.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -59.22 -28.26 66.5 Favored 'General case' 0 N--CA 1.509 2.486 0 CA-C-N 118.789 1.295 . . . . 0.0 110.957 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -136.92 28.82 2.87 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.818 -1.176 . . . . 0.0 111.039 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 385' ' ' CYS . . . . . 0.422 ' N ' ' O ' ' A' ' 381' ' ' TYR . 9.9 t -47.44 140.24 5.94 Favored 'General case' 0 N--CA 1.518 2.967 0 O-C-N 120.961 -1.087 . . . . 0.0 111.722 -178.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 386' ' ' TYR . . . . . 0.445 ' HE2' " H2'" ' A' 1002 ' ' ADN . 4.1 p90 -113.05 -39.78 4.12 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.192 -0.942 . . . . 0.0 110.654 178.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.438 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 13.6 ptm180 -69.53 155.46 40.45 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 120.9 -1.125 . . . . 0.0 109.626 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.33 97.21 2.51 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.153 -0.967 . . . . 0.0 110.871 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -113.76 169.25 6.7 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 120.752 -1.217 . . . . 0.0 110.502 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -75.44 -25.76 10.89 Favored 'Trans proline' 0 CA--C 1.549 1.226 0 O-C-N 123.54 1.284 . . . . 0.0 110.466 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.8 t -100.87 -23.04 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 O-C-N 121.115 -0.99 . . . . 0.0 112.14 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 392' ' ' HIS . . . . . 0.401 ' CE1' ' HD3' ' A' ' 387' ' ' ARG . 40.9 t60 -62.85 -38.3 90.28 Favored 'General case' 0 N--CA 1.515 2.782 0 O-C-N 120.529 -1.357 . . . . 0.0 110.013 -178.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -56.31 -32.16 64.36 Favored 'General case' 0 N--CA 1.508 2.43 0 C-N-CA 119.175 -1.01 . . . . 0.0 108.927 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.42 ' O ' ' NE ' ' A' ' 376' ' ' ARG . 1.0 OUTLIER -80.73 -32.69 35.65 Favored 'General case' 0 N--CA 1.505 2.314 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.149 179.461 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 395' ' ' HIS . . . . . 0.427 ' HB3' ' CE2' ' A' ' 396' ' ' PHE . 16.5 m170 -72.92 -30.76 64.16 Favored 'General case' 0 N--CA 1.509 2.519 0 O-C-N 121.069 -1.019 . . . . 0.0 111.01 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 396' ' ' PHE . . . . . 0.427 ' CE2' ' HB3' ' A' ' 395' ' ' HIS . 47.6 m-85 -138.01 148.04 44.76 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.83 -1.169 . . . . 0.0 110.53 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 397' ' ' SER . . . . . 0.453 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 3.0 m -90.05 172.24 8.98 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.481 -0.762 . . . . 0.0 110.409 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -142.46 151.03 56.66 Favored Pre-proline 0 N--CA 1.487 1.38 0 C-N-CA 119.656 -0.818 . . . . 0.0 110.816 -178.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -61.96 139.44 79.32 Favored 'Trans proline' 0 C--N 1.321 -0.902 0 N-CA-C 107.489 -1.774 . . . . 0.0 107.489 178.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 98.54 0.57 57.93 Favored Glycine 0 CA--C 1.552 2.382 0 C-N-CA 119.37 -1.395 . . . . 0.0 110.203 -177.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -114.85 165.23 13.06 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 119.529 1.664 . . . . 0.0 107.933 177.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.85 -25.35 62.78 Favored 'General case' 0 N--CA 1.506 2.361 0 C-N-CA 119.086 -1.046 . . . . 0.0 111.615 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -99.51 8.57 44.39 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 120.576 -1.328 . . . . 0.0 113.133 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 404' ' ' TYR . . . . . 0.413 ' HA ' ' HB3' ' A' ' 397' ' ' SER . 21.2 t80 -47.08 130.3 12.46 Favored 'General case' 0 N--CA 1.516 2.847 0 CA-C-N 120.279 1.399 . . . . 0.0 110.652 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -72.94 -34.39 58.93 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 115.18 -121.89 5.44 Favored Glycine 0 C--O 1.216 -0.997 0 N-CA-C 106.778 -2.529 . . . . 0.0 106.778 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 98.1 t -136.3 99.26 2.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 O-C-N 121.741 -0.858 . . . . 0.0 109.644 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -110.6 48.85 0.89 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.284 -0.885 . . . . 0.0 110.613 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.547 ' N ' HD12 ' A' ' 409' ' ' ILE . 5.2 mp 46.4 66.01 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.38 -0.825 . . . . 0.0 111.142 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 410' ' ' VAL . . . . . 0.565 HG13 ' O ' ' A' ' 410' ' ' VAL . 8.3 p -119.39 68.37 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 104.44 56.63 0.72 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.17 -1.972 . . . . 0.0 108.17 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 412' ' ' GLN . . . . . 0.498 ' CD ' HG23 ' A' ' 409' ' ' ILE . 8.2 mt-30 -54.26 -63.83 1.02 Allowed 'General case' 0 N--CA 1.509 2.479 0 O-C-N 121.386 -1.067 . . . . 0.0 110.313 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -160.08 40.25 0.18 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.15 -0.969 . . . . 0.0 110.629 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -114.26 62.26 0.66 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.241 -0.912 . . . . 0.0 110.066 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 415' ' ' THR . . . . . 0.63 HG22 " O5'" ' A' 1002 ' ' ADN . 0.2 OUTLIER -113.09 65.21 0.64 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.217 -0.927 . . . . 0.0 110.005 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -140.57 40.44 1.87 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.246 -0.909 . . . . 0.0 110.267 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 118.099 -0.953 . . . . 0.0 110.206 -179.999 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A 1002 ' ' ADN . . . . . 0.63 " O5'" HG22 ' A' ' 415' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1003 ' ' RIB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -72.84 167.58 26.89 Favored 'Trans proline' 0 C--N 1.317 -1.09 0 O-C-N 123.427 1.224 . . . . 0.0 110.381 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 365' ' ' LEU . . . . . 0.446 HD22 ' HA ' ' A' ' 365' ' ' LEU . 0.2 OUTLIER 53.14 78.42 0.14 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.045 -1.034 . . . . 0.0 110.782 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 102.21 119.51 4.57 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 8.0 t 54.55 99.59 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.145 -1.209 . . . . 0.0 110.806 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 151.94 -121.54 1.21 Allowed Glycine 0 N--CA 1.497 2.709 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 5.8 t -116.2 96.53 5.59 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.227 -1.161 . . . . 0.0 110.417 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -142.48 67.36 1.32 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.241 -0.912 . . . . 0.0 109.992 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -139.48 41.66 1.31 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.14 -58.75 0.27 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.259 -1.142 . . . . 0.0 110.358 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 373' ' ' LYS . . . . . 0.457 ' C ' HG23 ' A' ' 374' ' ' VAL . 0.0 OUTLIER -129.68 56.08 1.74 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.167 -0.958 . . . . 0.0 110.473 -179.899 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 374' ' ' VAL . . . . . 0.457 HG23 ' C ' ' A' ' 373' ' ' LYS . 90.6 t -149.65 160.9 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.182 -0.949 . . . . 0.0 110.168 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 26.6 tttm -83.77 84.87 7.4 Favored 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 119.223 -0.991 . . . . 0.0 109.202 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 376' ' ' ARG . . . . . 0.482 ' HB3' ' OG ' ' A' ' 397' ' ' SER . 1.9 mmt180 -69.07 152.78 44.78 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.277 -0.969 . . . . 0.0 108.925 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 6.5 t -70.62 144.37 51.17 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 119.486 -0.886 . . . . 0.0 108.903 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 378' ' ' SER . . . . . 0.412 ' HB2' ' N ' ' A' ' 406' ' ' GLY . 0.1 OUTLIER -56.34 158.66 4.07 Favored 'General case' 0 N--CA 1.509 2.487 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.793 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 44.1 t -78.91 157.58 28.22 Favored 'General case' 0 N--CA 1.508 2.445 0 O-C-N 120.712 -1.243 . . . . 0.0 110.384 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 55.0 mtm -48.67 -29.5 4.45 Favored 'General case' 0 N--CA 1.513 2.721 0 O-C-N 121.211 -0.93 . . . . 0.0 112.242 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -121.83 17.83 11.03 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.967 -1.083 . . . . 0.0 112.447 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 46.42 -114.41 1.44 Allowed Glycine 0 N--CA 1.499 2.834 0 O-C-N 120.782 -1.199 . . . . 0.0 112.487 177.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 383' ' ' ALA . . . . . 0.531 ' HB2' ' HG3' ' A' ' 399' ' ' PRO . . . -76.83 -18.31 58.46 Favored 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.488 -1.007 . . . . 0.0 112.585 -178.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 384' ' ' ASN . . . . . 0.583 ' CB ' HN62 ' A' 1002 ' ' ADN . 33.6 m-80 -84.9 0.69 50.24 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 120.546 -1.346 . . . . 0.0 111.871 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 49.2 t -49.67 87.5 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.935 0 O-C-N 120.775 -1.203 . . . . 0.0 111.585 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 386' ' ' TYR . . . . . 0.443 ' N ' ' O ' ' A' ' 384' ' ' ASN . 31.8 p90 -66.14 -36.41 83.07 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 120.848 -1.157 . . . . 0.0 110.865 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.615 ' HD2' " H3'" ' A' 1003 ' ' RIB . 10.6 ptm180 -71.19 160.99 31.85 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.193 -0.942 . . . . 0.0 110.072 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 36.4 pttt -159.5 110.97 2.04 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.336 -0.853 . . . . 0.0 110.534 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -117.73 170.83 5.67 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 120.949 -1.095 . . . . 0.0 110.355 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -74.28 -27.93 11.01 Favored 'Trans proline' 0 N--CA 1.489 1.238 0 O-C-N 123.486 1.256 . . . . 0.0 110.875 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 58.3 t -103.12 -18.86 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 120.987 -1.071 . . . . 0.0 111.933 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 34.3 t60 -65.12 -39.42 93.06 Favored 'General case' 0 N--CA 1.508 2.471 0 O-C-N 120.559 -1.338 . . . . 0.0 109.961 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -55.15 -37.18 66.65 Favored 'General case' 0 N--CA 1.51 2.568 0 C-N-CA 119.215 -0.994 . . . . 0.0 108.467 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.42 ' O ' ' NE ' ' A' ' 376' ' ' ARG . 1.2 mp0 -74.84 -31.01 61.55 Favored 'General case' 0 N--CA 1.502 2.16 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.076 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 23.2 m170 -75.72 -27.09 58.05 Favored 'General case' 0 N--CA 1.509 2.522 0 O-C-N 120.975 -1.078 . . . . 0.0 111.61 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -140.19 150.72 44.53 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.821 -1.174 . . . . 0.0 110.612 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 397' ' ' SER . . . . . 0.482 ' OG ' ' HB3' ' A' ' 376' ' ' ARG . 3.1 m -89.46 171.74 9.5 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.467 -0.771 . . . . 0.0 109.836 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -144.56 153.03 54.56 Favored Pre-proline 0 N--CA 1.487 1.415 0 O-C-N 121.437 -0.79 . . . . 0.0 108.903 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 399' ' ' PRO . . . . . 0.531 ' HG3' ' HB2' ' A' ' 383' ' ' ALA . 35.7 Cg_endo -60.72 137.75 75.1 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 N-CA-C 109.0 -1.192 . . . . 0.0 109.0 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 104.07 -1.2 44.23 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.619 -1.277 . . . . 0.0 111.566 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -112.87 176.2 5.11 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 119.987 1.894 . . . . 0.0 109.3 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 2.7 t -79.15 -25.57 42.86 Favored 'General case' 0 N--CA 1.506 2.332 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.864 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -98.1 1.48 47.63 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.66 -1.275 . . . . 0.0 112.498 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -46.16 137.62 5.94 Favored 'General case' 0 N--CA 1.515 2.817 0 CA-C-N 120.096 1.316 . . . . 0.0 110.738 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.412 ' O ' ' HG3' ' A' ' 408' ' ' GLN . . . -139.56 20.85 2.92 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.461 -1.352 . . . . 0.0 112.196 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 406' ' ' GLY . . . . . 0.412 ' N ' ' HB2' ' A' ' 378' ' ' SER . . . -56.23 -26.16 49.52 Favored Glycine 0 N--CA 1.492 2.379 0 CA-C-N 119.959 1.879 . . . . 0.0 111.185 179.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.48 ' O ' HG12 ' A' ' 407' ' ' VAL . 84.9 t -102.83 70.79 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.342 -1.093 . . . . 0.0 110.256 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.412 ' HG3' ' O ' ' A' ' 405' ' ' GLY . 4.4 mp0 -77.48 81.67 3.94 Favored 'General case' 0 N--CA 1.513 2.694 0 O-C-N 120.978 -1.076 . . . . 0.0 110.074 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.592 HG23 ' CD ' ' A' ' 412' ' ' GLN . 88.3 mt -114.12 69.61 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.994 -1.066 . . . . 0.0 110.118 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 410' ' ' VAL . . . . . 0.554 HG13 ' O ' ' A' ' 410' ' ' VAL . 10.6 p -118.87 63.93 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.427 -0.796 . . . . 0.0 108.863 178.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 93.78 52.27 1.99 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 107.931 -2.068 . . . . 0.0 107.931 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 412' ' ' GLN . . . . . 0.592 ' CD ' HG23 ' A' ' 409' ' ' ILE . 12.5 mt-30 -47.83 -68.11 0.22 Allowed 'General case' 0 N--CA 1.512 2.652 0 O-C-N 121.46 -1.024 . . . . 0.0 111.265 -178.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -172.25 46.31 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.037 -1.039 . . . . 0.0 110.917 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -116.1 49.8 1.09 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.145 -0.972 . . . . 0.0 110.443 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.35 66.38 0.71 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.291 -0.881 . . . . 0.0 109.884 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -137.92 41.39 2.31 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.258 -0.901 . . . . 0.0 110.225 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.195 179.981 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A 1002 ' ' ADN . . . . . 0.583 HN62 ' CB ' ' A' ' 384' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1003 ' ' RIB . . . . . 0.615 " H3'" ' HD2' ' A' ' 387' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -72.62 169.15 22.58 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 O-C-N 123.45 1.237 . . . . 0.0 110.429 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.13 -176.37 3.33 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.289 -0.882 . . . . 0.0 110.143 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 83.31 -176.69 52.86 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 1.3 p -116.43 -57.87 2.15 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.205 -1.174 . . . . 0.0 110.239 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -138.37 53.2 0.72 Allowed Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 3.1 t -131.02 94.23 3.55 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.134 -1.215 . . . . 0.0 110.316 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -119.06 106.35 12.32 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.174 -0.954 . . . . 0.0 109.979 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -143.04 41.37 1.17 Allowed Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -146.57 -66.12 0.28 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.202 -1.175 . . . . 0.0 110.587 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 373' ' ' LYS . . . . . 0.412 ' C ' HG23 ' A' ' 374' ' ' VAL . 0.0 OUTLIER -158.06 73.28 0.67 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.174 -0.954 . . . . 0.0 110.86 -179.71 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 374' ' ' VAL . . . . . 0.412 HG23 ' C ' ' A' ' 373' ' ' LYS . 57.7 t -146.83 159.75 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.122 -0.986 . . . . 0.0 110.158 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 375' ' ' LYS . 0.0 OUTLIER -89.05 100.11 12.96 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 122.089 0.947 . . . . 0.0 109.078 179.093 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.46 -177.22 0.06 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.484 -0.76 . . . . 0.0 111.109 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 3.3 m -108.24 130.84 55.14 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 378' ' ' SER . . . . . 0.484 ' HB3' ' HA3' ' A' ' 406' ' ' GLY . 30.7 t -48.91 118.44 2.6 Favored 'General case' 0 N--CA 1.515 2.802 0 O-C-N 121.656 -0.653 . . . . 0.0 110.724 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 379' ' ' CYS . . . . . 0.436 ' HB2' ' CD2' ' A' ' 398' ' ' HIS . 9.3 t -38.56 151.35 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.731 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -178.086 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 53.9 mtm -46.27 -34.6 4.57 Favored 'General case' 0 N--CA 1.509 2.513 0 O-C-N 121.838 -0.539 . . . . 0.0 111.117 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -114.52 9.33 16.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.123 -0.985 . . . . 0.0 113.163 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 57.82 -120.44 21.55 Favored Glycine 0 N--CA 1.491 2.361 0 O-C-N 120.175 -1.578 . . . . 0.0 112.159 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -75.6 -13.38 60.34 Favored 'General case' 0 N--CA 1.51 2.531 0 O-C-N 121.485 -1.009 . . . . 0.0 112.655 -178.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 384' ' ' ASN . . . . . 0.591 ' CB ' HN62 ' A' 1002 ' ' ADN . 58.1 m-20 -86.01 -2.35 58.22 Favored 'General case' 0 N--CA 1.507 2.407 0 O-C-N 120.575 -1.328 . . . . 0.0 111.12 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 52.7 t -47.02 89.54 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.998 0 O-C-N 120.825 -1.172 . . . . 0.0 111.872 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 386' ' ' TYR . . . . . 0.402 ' N ' ' O ' ' A' ' 384' ' ' ASN . 31.3 p90 -70.34 -38.19 74.8 Favored 'General case' 0 N--CA 1.508 2.428 0 O-C-N 120.892 -1.13 . . . . 0.0 110.956 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.422 ' HD3' ' CE1' ' A' ' 392' ' ' HIS . 14.1 ptm180 -57.79 152.26 16.08 Favored 'General case' 0 N--CA 1.51 2.532 0 O-C-N 121.028 -1.045 . . . . 0.0 110.262 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -142.16 79.16 1.66 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.244 -0.91 . . . . 0.0 111.058 -179.071 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -97.26 160.64 28.45 Favored Pre-proline 0 N--CA 1.502 2.137 0 O-C-N 120.977 -1.077 . . . . 0.0 110.534 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -75.96 -29.2 6.98 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 O-C-N 123.547 1.288 . . . . 0.0 111.214 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 57.3 t -99.15 -22.38 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 O-C-N 121.236 -0.915 . . . . 0.0 111.594 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 392' ' ' HIS . . . . . 0.422 ' CE1' ' HD3' ' A' ' 387' ' ' ARG . 38.4 t60 -59.19 -37.76 78.2 Favored 'General case' 0 N--CA 1.51 2.542 0 O-C-N 120.611 -1.305 . . . . 0.0 110.152 -179.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -59.39 -33.72 71.55 Favored 'General case' 0 N--CA 1.505 2.295 0 C-N-CA 119.112 -1.035 . . . . 0.0 108.805 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -72.19 -33.34 67.59 Favored 'General case' 0 N--CA 1.503 2.19 0 C-N-CA 119.206 -0.997 . . . . 0.0 110.828 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 27.2 m170 -79.64 -34.81 40.2 Favored 'General case' 0 N--CA 1.509 2.485 0 O-C-N 120.983 -1.073 . . . . 0.0 111.224 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -121.92 158.51 28.87 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.029 -1.044 . . . . 0.0 110.304 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.45 173.77 6.16 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 178.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 398' ' ' HIS . . . . . 0.436 ' CD2' ' HB2' ' A' ' 379' ' ' CYS . 76.6 m80 -145.74 157.35 51.47 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 120.891 -1.131 . . . . 0.0 108.871 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -62.69 140.57 81.49 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 N-CA-C 108.892 -1.234 . . . . 0.0 108.892 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.88 -3.63 55.9 Favored Glycine 0 N--CA 1.496 2.689 0 C-N-CA 119.684 -1.246 . . . . 0.0 111.299 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -112.14 177.17 4.73 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 119.544 1.672 . . . . 0.0 108.689 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 1.4 p -79.36 -28.34 41.97 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.099 -1.04 . . . . 0.0 110.556 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -88.29 -4.45 58.69 Favored 'General case' 0 N--CA 1.509 2.501 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -176.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 404' ' ' TYR . . . . . 0.432 ' CE1' ' OG ' ' A' ' 378' ' ' SER . 7.9 t80 -39.06 125.07 1.52 Allowed 'General case' 0 N--CA 1.533 3.679 0 CA-C-N 120.742 1.61 . . . . 0.0 111.869 -178.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -177.05 75.83 0.07 OUTLIER Glycine 0 N--CA 1.501 2.986 0 C-N-CA 119.308 -1.425 . . . . 0.0 111.327 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 406' ' ' GLY . . . . . 0.484 ' HA3' ' HB3' ' A' ' 378' ' ' SER . . . -144.62 -55.66 0.02 OUTLIER Glycine 0 N--CA 1.505 3.263 0 C-N-CA 119.501 -1.333 . . . . 0.0 111.933 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.583 ' O ' HG13 ' A' ' 407' ' ' VAL . 11.5 p -105.72 61.3 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-N 118.713 1.256 . . . . 0.0 110.312 -179.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -134.0 92.89 3.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.396 -0.815 . . . . 0.0 109.601 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.531 HG23 ' CD ' ' A' ' 412' ' ' GLN . 77.8 mt -99.59 68.84 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.245 -0.909 . . . . 0.0 109.559 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 57.8 t -119.86 70.96 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 97.59 53.83 1.29 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 108.379 -1.889 . . . . 0.0 108.379 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 412' ' ' GLN . . . . . 0.531 ' CD ' HG23 ' A' ' 409' ' ' ILE . 6.6 mt-30 -49.27 -62.73 1.38 Allowed 'General case' 0 N--CA 1.511 2.615 0 O-C-N 121.348 -1.089 . . . . 0.0 110.711 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -141.39 36.01 1.68 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.269 -0.894 . . . . 0.0 110.343 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -113.22 43.29 1.76 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.152 -0.967 . . . . 0.0 110.142 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -116.72 66.9 0.72 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.293 -0.88 . . . . 0.0 109.902 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 53.41 41.13 32.15 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.11 -0.994 . . . . 0.0 110.643 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 27.5 t0 . . . . . 0 N--CA 1.501 2.094 0 O-C-N 121.066 -1.021 . . . . 0.0 110.761 179.979 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A 1002 ' ' ADN . . . . . 0.591 HN62 ' CB ' ' A' ' 384' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1003 ' ' RIB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.317 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -72.78 -40.45 1.94 Allowed 'Trans proline' 0 C--N 1.317 -1.12 0 O-C-N 123.4 1.21 . . . . 0.0 110.4 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 365' ' ' LEU . . . . . 0.413 HD22 ' HA ' ' A' ' 365' ' ' LEU . 0.1 OUTLIER -133.75 -60.23 0.83 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.143 -0.973 . . . . 0.0 110.171 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 96.72 -82.79 0.76 Allowed Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 2.4 t -116.92 -57.23 2.19 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.224 -1.162 . . . . 0.0 110.141 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 135.88 148.61 5.61 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 17.4 m -116.16 44.08 2.03 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.217 -1.167 . . . . 0.0 109.916 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -114.42 -54.68 2.56 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.332 -0.855 . . . . 0.0 110.547 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 155.59 -78.65 0.19 Allowed Glycine 0 N--CA 1.497 2.722 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -143.17 60.56 1.41 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.183 -1.186 . . . . 0.0 110.348 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 52.01 65.03 1.62 Allowed 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.057 -1.027 . . . . 0.0 110.626 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 11.1 p -143.67 160.66 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.259 -0.901 . . . . 0.0 110.595 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.23 97.62 10.03 Favored 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 119.337 -0.945 . . . . 0.0 108.533 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 376' ' ' ARG . . . . . 0.4 ' NE ' ' HA ' ' A' ' 376' ' ' ARG . 0.2 OUTLIER -68.64 148.14 50.88 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.641 -0.824 . . . . 0.0 109.919 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 5.8 t -69.08 142.59 54.44 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 19.0 p -55.65 156.49 4.79 Favored 'General case' 0 N--CA 1.508 2.427 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 48.5 t -80.31 154.08 28.03 Favored 'General case' 0 N--CA 1.507 2.419 0 O-C-N 120.763 -1.211 . . . . 0.0 111.039 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 60.4 mtm -49.34 -33.26 13.03 Favored 'General case' 0 N--CA 1.516 2.844 0 O-C-N 121.303 -0.873 . . . . 0.0 111.288 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 381' ' ' TYR . . . . . 0.431 ' CD1' ' N3 ' ' A' 1002 ' ' ADN . 16.0 m-85 -136.36 39.13 2.69 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.208 -0.932 . . . . 0.0 108.831 178.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -39.02 -43.07 1.72 Allowed Glycine 0 N--CA 1.509 3.504 0 O-C-N 121.521 -0.737 . . . . 0.0 113.064 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -62.01 -29.53 70.34 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.015 -1.285 . . . . 0.0 110.745 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 384' ' ' ASN . . . . . 0.474 ' HB2' HN62 ' A' 1002 ' ' ADN . 8.7 m120 -133.66 25.14 4.05 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.955 -1.091 . . . . 0.0 111.803 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 17.1 t -47.81 90.12 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.022 0 O-C-N 120.788 -1.195 . . . . 0.0 112.269 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 386' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 24.8 p90 -62.92 -41.92 99.63 Favored 'General case' 0 N--CA 1.51 2.569 0 O-C-N 120.832 -1.168 . . . . 0.0 110.289 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.451 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.2 OUTLIER -63.98 157.07 26.02 Favored 'General case' 0 N--CA 1.509 2.499 0 O-C-N 121.134 -0.979 . . . . 0.0 110.231 -179.531 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.38 92.23 1.58 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.314 -0.866 . . . . 0.0 110.805 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -106.84 162.68 18.9 Favored Pre-proline 0 N--CA 1.5 2.059 0 O-C-N 121.138 -0.976 . . . . 0.0 110.44 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -74.17 -26.53 12.6 Favored 'Trans proline' 0 CA--C 1.545 1.072 0 O-C-N 123.56 1.295 . . . . 0.0 111.264 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 60.8 t -99.86 -24.8 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 O-C-N 121.141 -0.974 . . . . 0.0 111.492 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 392' ' ' HIS . . . . . 0.433 ' CE1' ' NH1' ' A' ' 387' ' ' ARG . 44.8 t60 -61.36 -36.93 81.56 Favored 'General case' 0 N--CA 1.511 2.588 0 O-C-N 120.633 -1.292 . . . . 0.0 110.19 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -56.49 -34.27 66.8 Favored 'General case' 0 N--CA 1.507 2.4 0 C-N-CA 119.117 -1.033 . . . . 0.0 108.492 177.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.72 -32.85 58.1 Favored 'General case' 0 N--CA 1.506 2.36 0 C-N-CA 119.454 -0.899 . . . . 0.0 111.087 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -75.74 -34.41 60.29 Favored 'General case' 0 N--CA 1.509 2.524 0 O-C-N 121.133 -0.979 . . . . 0.0 110.938 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -128.56 151.27 49.65 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.985 -1.072 . . . . 0.0 110.528 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.33 168.83 11.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.577 -0.702 . . . . 0.0 109.322 178.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -140.94 152.93 66.7 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.357 -0.839 . . . . 0.0 109.728 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 399' ' ' PRO . . . . . 0.442 ' HA ' ' CD2' ' A' ' 404' ' ' TYR . 36.3 Cg_endo -59.43 136.87 74.55 Favored 'Trans proline' 0 C--N 1.316 -1.153 0 N-CA-C 108.839 -1.254 . . . . 0.0 108.839 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 102.41 0.04 50.16 Favored Glycine 0 CA--C 1.55 2.244 0 C-N-CA 119.635 -1.269 . . . . 0.0 111.419 -179.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -111.28 171.91 7.2 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 119.954 1.877 . . . . 0.0 109.451 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 50.5 m -75.5 -24.48 56.88 Favored 'General case' 0 N--CA 1.505 2.323 0 C-N-CA 119.246 -0.982 . . . . 0.0 111.103 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -102.14 5.89 40.57 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 120.644 -1.285 . . . . 0.0 112.728 -178.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 404' ' ' TYR . . . . . 0.442 ' CD2' ' HA ' ' A' ' 399' ' ' PRO . 14.0 t80 -44.65 133.46 5.91 Favored 'General case' 0 N--CA 1.515 2.815 0 O-C-N 120.688 -1.258 . . . . 0.0 112.483 -179.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -72.26 -34.13 61.28 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.209 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 109.13 94.6 2.33 Favored Glycine 0 N--CA 1.496 2.643 0 CA-C-N 119.236 1.518 . . . . 0.0 110.902 179.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.616 ' O ' HG13 ' A' ' 407' ' ' VAL . 14.9 p -23.36 102.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.433 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -144.57 72.04 1.33 Allowed 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 176.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.483 HG23 ' CD ' ' A' ' 412' ' ' GLN . 70.2 mt -81.26 67.66 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 O-C-N 121.325 -0.859 . . . . 0.0 110.564 -178.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 410' ' ' VAL . . . . . 0.433 HG12 ' O ' ' A' ' 410' ' ' VAL . 81.5 t -125.49 63.02 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 96.41 52.38 1.59 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 107.868 -2.093 . . . . 0.0 107.868 -177.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 412' ' ' GLN . . . . . 0.483 ' CD ' HG23 ' A' ' 409' ' ' ILE . 2.6 mt-30 -49.51 -62.71 1.4 Allowed 'General case' 0 N--CA 1.512 2.67 0 O-C-N 121.385 -1.067 . . . . 0.0 110.733 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -129.41 41.16 3.5 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.21 -0.931 . . . . 0.0 109.758 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 53.0 39.39 29.36 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.133 -0.979 . . . . 0.0 110.615 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.44 64.86 0.94 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.288 -0.882 . . . . 0.0 110.044 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -119.49 43.07 2.72 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.256 -0.903 . . . . 0.0 110.172 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.142 -179.934 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A 1002 ' ' ADN . . . . . 0.474 HN62 ' HB2' ' A' ' 384' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1003 ' ' RIB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.347 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.74 109.29 2.75 Favored 'Trans proline' 0 C--N 1.318 -1.036 0 O-C-N 123.482 1.253 . . . . 0.0 110.442 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 4.0 tp -128.93 129.33 45.33 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.215 -0.928 . . . . 0.0 110.174 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 84.7 -109.47 3.26 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 1.9 t -134.23 78.94 1.78 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.21 -1.171 . . . . 0.0 110.168 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -132.72 84.58 0.29 Allowed Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 6.2 t -142.48 129.47 20.72 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.174 -1.191 . . . . 0.0 110.195 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -142.68 88.14 2.04 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.191 -0.943 . . . . 0.0 110.174 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -144.32 41.03 1.13 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -137.27 -65.0 0.55 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.23 -1.159 . . . . 0.0 110.029 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.49 62.34 1.42 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.194 -0.941 . . . . 0.0 110.227 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 60.0 t -144.61 160.51 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.202 -0.936 . . . . 0.0 109.917 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 31.6 mtpt -88.71 94.32 9.87 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 119.618 -0.833 . . . . 0.0 109.732 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 376' ' ' ARG . . . . . 0.434 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 42.1 mtm-85 -55.81 146.01 22.83 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.706 -0.621 . . . . 0.0 110.573 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 2.3 m -69.28 137.48 53.08 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 87.4 p -52.84 157.3 1.7 Allowed 'General case' 0 N--CA 1.512 2.656 0 O-C-N 121.054 -1.029 . . . . 0.0 109.749 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 12.7 t -80.74 158.52 25.49 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 120.854 -1.154 . . . . 0.0 109.107 179.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -55.59 -39.12 70.3 Favored 'General case' 0 N--CA 1.513 2.688 0 O-C-N 121.149 -0.97 . . . . 0.0 109.946 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 381' ' ' TYR . . . . . 0.42 ' HB2' ' N1 ' ' A' 1002 ' ' ADN . 8.5 m-85 -128.29 38.29 4.01 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.126 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -38.04 -44.87 1.58 Allowed Glycine 0 N--CA 1.507 3.373 0 O-C-N 121.321 -0.862 . . . . 0.0 113.13 -177.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -59.35 -27.86 66.32 Favored 'General case' 0 N--CA 1.507 2.422 0 CA-C-N 118.653 1.226 . . . . 0.0 110.703 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 384' ' ' ASN . . . . . 0.432 ' HB2' HN62 ' A' 1002 ' ' ADN . 8.7 m120 -133.14 19.82 4.06 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.843 -1.161 . . . . 0.0 112.109 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 33.7 t -43.75 88.78 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.367 0 CA-C-N 119.787 1.176 . . . . 0.0 112.775 -178.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 386' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 20.4 p90 -63.17 -40.59 97.96 Favored 'General case' 0 N--CA 1.509 2.504 0 O-C-N 120.95 -1.094 . . . . 0.0 111.537 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.455 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 15.1 ptm180 -56.02 151.15 12.41 Favored 'General case' 0 N--CA 1.513 2.708 0 O-C-N 120.821 -1.175 . . . . 0.0 110.376 -179.032 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -133.34 72.68 1.49 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.142 -0.974 . . . . 0.0 110.725 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -106.71 149.27 38.22 Favored Pre-proline 0 N--CA 1.498 1.972 0 O-C-N 121.094 -1.004 . . . . 0.0 109.547 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -69.73 -83.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.316 -1.173 0 O-C-N 123.498 1.262 . . . . 0.0 108.94 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 88.2 t -38.64 -26.48 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.526 3.358 0 O-C-N 120.833 -1.167 . . . . 0.0 113.288 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 392' ' ' HIS . . . . . 0.426 ' CE1' ' HD3' ' A' ' 387' ' ' ARG . 25.9 t60 -64.15 -39.36 93.84 Favored 'General case' 0 N--CA 1.512 2.626 0 O-C-N 120.312 -1.493 . . . . 0.0 108.504 177.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -59.87 -37.42 79.26 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.291 -0.881 . . . . 0.0 109.228 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -70.01 -26.55 64.12 Favored 'General case' 0 N--CA 1.507 2.393 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.215 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -90.99 -34.6 15.08 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.757 -1.214 . . . . 0.0 110.605 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -117.33 144.45 44.88 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.048 -1.033 . . . . 0.0 110.355 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 397' ' ' SER . . . . . 0.434 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 0.1 OUTLIER -98.0 167.03 11.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 110.528 179.611 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -140.07 153.57 69.43 Favored Pre-proline 0 N--CA 1.488 1.431 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.894 -178.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -62.28 137.9 68.53 Favored 'Trans proline' 0 N--CA 1.484 0.954 0 N-CA-C 108.038 -1.562 . . . . 0.0 108.038 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.37 -2.35 56.22 Favored Glycine 0 CA--C 1.551 2.343 0 C-N-CA 119.695 -1.24 . . . . 0.0 110.384 -177.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -115.47 140.07 49.48 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 119.649 1.725 . . . . 0.0 108.499 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 5.8 m -49.43 -25.61 2.69 Favored 'General case' 0 N--CA 1.509 2.512 0 O-C-N 121.11 -0.994 . . . . 0.0 113.201 -178.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -99.32 11.1 40.04 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 120.28 -1.513 . . . . 0.0 113.551 -177.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 404' ' ' TYR . . . . . 0.476 ' CE2' ' O ' ' A' ' 406' ' ' GLY . 6.1 t80 -51.91 142.73 14.88 Favored 'General case' 0 N--CA 1.515 2.816 0 O-C-N 120.365 -1.46 . . . . 0.0 109.487 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -135.26 29.2 2.94 Favored Glycine 0 N--CA 1.499 2.895 0 C-N-CA 119.267 -1.444 . . . . 0.0 112.157 -178.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 406' ' ' GLY . . . . . 0.476 ' O ' ' CE2' ' A' ' 404' ' ' TYR . . . -141.71 142.54 12.03 Favored Glycine 0 C--O 1.209 -1.464 0 N-CA-C 107.544 -2.222 . . . . 0.0 107.544 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 95.4 t -129.02 72.82 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 O-C-N 121.264 -1.139 . . . . 0.0 108.558 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -79.87 88.92 5.26 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.928 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 61.8 mt -103.08 78.08 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.105 -0.997 . . . . 0.0 109.912 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 410' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 410' ' ' VAL . 59.1 t -113.53 63.67 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.234 -0.916 . . . . 0.0 109.612 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 118.42 -46.34 1.15 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 412' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 65.85 -66.08 0.17 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.713 -0.875 . . . . 0.0 110.93 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -159.69 39.55 0.19 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.111 -0.993 . . . . 0.0 110.961 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 51.52 41.88 28.96 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.953 -1.092 . . . . 0.0 110.888 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 415' ' ' THR . . . . . 0.455 ' O ' HG23 ' A' ' 415' ' ' THR . 6.1 t -131.94 62.65 1.63 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.272 -0.893 . . . . 0.0 110.116 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -102.87 39.25 1.57 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.223 -0.923 . . . . 0.0 109.944 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 . . . . . 0 N--CA 1.495 1.824 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.342 179.933 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A 1002 ' ' ADN . . . . . 0.432 HN62 ' HB2' ' A' ' 384' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1003 ' ' RIB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 98.4 t . . . . . 0 N--CA 1.493 1.714 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 14.3 mttm -78.66 90.82 4.59 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 121.162 -0.961 . . . . 0.0 109.431 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 43.2 mtm-85 -61.51 154.39 24.77 Favored 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.389 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 4.7 t -79.25 138.49 37.81 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 10.8 p -53.39 151.17 5.73 Favored 'General case' 0 N--CA 1.515 2.798 0 O-C-N 120.882 -1.136 . . . . 0.0 108.52 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 23.4 t -79.82 156.12 27.54 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 120.887 -1.133 . . . . 0.0 111.618 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 65.7 mtm -48.32 -30.94 5.37 Favored 'General case' 0 N--CA 1.519 2.985 0 O-C-N 121.288 -0.882 . . . . 0.0 111.067 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -140.61 37.37 1.84 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.199 -0.938 . . . . 0.0 109.081 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -38.4 -46.07 1.95 Allowed Glycine 0 N--CA 1.506 3.334 0 O-C-N 121.206 -0.933 . . . . 0.0 113.112 -178.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -58.59 -28.69 65.81 Favored 'General case' 0 N--CA 1.51 2.529 0 CA-C-N 118.808 1.304 . . . . 0.0 110.687 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . 0.415 ' O ' ' N ' ' A' ' 386' ' ' TYR . 4.8 m-80 -135.11 28.77 3.44 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.028 -1.045 . . . . 0.0 110.977 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 19.2 t -53.02 88.74 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.807 0 O-C-N 121.091 -1.006 . . . . 0.0 110.957 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 386' ' ' TYR . . . . . 0.415 ' N ' ' O ' ' A' ' 384' ' ' ASN . 20.1 p90 -62.73 -35.94 81.41 Favored 'General case' 0 N--CA 1.507 2.418 0 O-C-N 120.988 -1.07 . . . . 0.0 111.138 -178.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.404 ' HB2' ' NH1' ' A' ' 387' ' ' ARG . 5.6 ptm85 -75.99 163.22 27.38 Favored 'General case' 0 N--CA 1.505 2.284 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.538 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -161.04 111.98 1.78 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.328 -0.857 . . . . 0.0 110.967 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -118.93 169.76 7.56 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.103 -0.998 . . . . 0.0 109.691 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -74.56 -29.35 9.13 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 O-C-N 123.463 1.244 . . . . 0.0 110.629 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 60.9 t -100.37 -21.52 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 121.084 -1.01 . . . . 0.0 111.718 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 37.2 t60 -61.95 -38.15 87.41 Favored 'General case' 0 N--CA 1.506 2.374 0 O-C-N 120.625 -1.297 . . . . 0.0 110.056 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -58.95 -31.86 69.09 Favored 'General case' 0 N--CA 1.506 2.365 0 C-N-CA 119.231 -0.987 . . . . 0.0 109.346 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -75.33 -31.56 60.64 Favored 'General case' 0 N--CA 1.508 2.469 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.744 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 16.8 m170 -82.84 -33.83 27.03 Favored 'General case' 0 N--CA 1.507 2.407 0 O-C-N 120.962 -1.086 . . . . 0.0 111.475 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 396' ' ' PHE . . . . . 0.421 ' N ' ' CD1' ' A' ' 396' ' ' PHE . 68.7 m-85 -124.05 141.95 51.61 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.934 -1.104 . . . . 0.0 110.838 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.54 170.81 9.87 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 109.089 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -144.62 153.76 55.24 Favored Pre-proline 0 N--CA 1.485 1.285 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.042 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -60.23 138.81 83.65 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 N-CA-C 108.713 -1.303 . . . . 0.0 108.713 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 102.06 -1.12 51.19 Favored Glycine 0 CA--C 1.554 2.477 0 C-N-CA 119.794 -1.193 . . . . 0.0 110.788 -177.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -114.38 165.3 12.86 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 119.788 1.794 . . . . 0.0 108.656 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 8.9 t -70.22 -25.27 63.32 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.186 -0.946 . . . . 0.0 111.39 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -98.38 5.62 48.01 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.696 -1.253 . . . . 0.0 112.908 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 32.6 t80 . . . . . 0 N--CA 1.507 2.413 0 O-C-N 120.434 -1.416 . . . . 0.0 109.188 179.496 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 90.2 t . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 17.8 mttp -87.73 95.82 10.22 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.335 -0.853 . . . . 0.0 109.187 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.69 162.62 6.38 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 120.211 -0.596 . . . . 0.0 109.898 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 4.4 t -89.83 137.91 31.94 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.42 150.84 4.5 Favored 'General case' 0 N--CA 1.517 2.907 0 O-C-N 120.995 -1.066 . . . . 0.0 109.337 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 47.8 t -80.62 150.59 29.41 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 120.95 -1.094 . . . . 0.0 111.442 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 46.7 mtm -48.21 -30.32 4.58 Favored 'General case' 0 N--CA 1.519 2.983 0 O-C-N 121.283 -0.886 . . . . 0.0 111.709 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -140.54 36.15 1.84 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.183 -0.948 . . . . 0.0 109.369 178.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -37.62 -42.64 1.03 Allowed Glycine 0 N--CA 1.507 3.374 0 O-C-N 121.196 -0.94 . . . . 0.0 113.333 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -60.04 -30.24 69.05 Favored 'General case' 0 N--CA 1.508 2.448 0 O-C-N 121.03 -1.277 . . . . 0.0 110.538 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -134.63 26.06 3.71 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.063 -1.023 . . . . 0.0 111.075 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 35.8 t -49.11 92.2 0.01 OUTLIER 'General case' 0 N--CA 1.519 2.981 0 O-C-N 120.788 -1.195 . . . . 0.0 111.692 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -68.75 -39.04 80.52 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 121.074 -1.016 . . . . 0.0 110.176 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.86 148.43 51.8 Favored 'General case' 0 N--CA 1.508 2.466 0 O-C-N 121.21 -0.931 . . . . 0.0 109.511 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.74 90.81 1.73 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.175 -0.953 . . . . 0.0 110.935 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -100.29 168.54 9.24 Favored Pre-proline 0 N--CA 1.499 2.019 0 O-C-N 120.666 -1.271 . . . . 0.0 110.263 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -75.99 -26.34 9.49 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 O-C-N 123.538 1.283 . . . . 0.0 110.894 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 76.5 t -101.75 -19.57 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 O-C-N 121.074 -1.016 . . . . 0.0 111.779 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 41.5 t60 -63.05 -40.29 97.28 Favored 'General case' 0 N--CA 1.51 2.526 0 O-C-N 120.53 -1.356 . . . . 0.0 110.217 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -56.68 -34.26 67.22 Favored 'General case' 0 N--CA 1.51 2.568 0 O-C-N 121.134 -0.979 . . . . 0.0 109.113 178.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -72.82 -31.32 64.71 Favored 'General case' 0 N--CA 1.507 2.4 0 C-N-CA 119.109 -1.036 . . . . 0.0 111.15 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 20.9 m170 -87.38 -31.94 19.85 Favored 'General case' 0 N--CA 1.508 2.439 0 O-C-N 121.019 -1.051 . . . . 0.0 111.748 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -121.38 144.03 48.89 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.847 -1.158 . . . . 0.0 111.255 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . 0.409 ' HB2' ' HA ' ' A' ' 404' ' ' TYR . 0.0 OUTLIER -88.54 173.02 8.9 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.386 -0.821 . . . . 0.0 109.39 178.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -144.88 155.86 55.64 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.419 -0.801 . . . . 0.0 109.771 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -60.72 136.64 67.91 Favored 'Trans proline' 0 C--N 1.318 -1.07 0 N-CA-C 109.126 -1.144 . . . . 0.0 109.126 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 104.08 -2.46 44.21 Favored Glycine 0 CA--C 1.553 2.455 0 C-N-CA 119.962 -1.113 . . . . 0.0 110.715 -178.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -116.6 150.92 37.27 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 119.62 1.71 . . . . 0.0 108.884 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 2.1 p -58.16 -28.07 64.4 Favored 'General case' 0 N--CA 1.503 2.186 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.318 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -88.18 -0.71 57.42 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 120.727 -1.233 . . . . 0.0 113.349 -178.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . 0.409 ' HA ' ' HB2' ' A' ' 397' ' ' SER . 16.5 t80 . . . . . 0 N--CA 1.522 3.156 0 CA-C-N 120.379 1.445 . . . . 0.0 111.756 -178.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 10.8 p . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.797 0.332 . . . . 0.0 110.55 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? -89.47 99.05 12.13 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.285 -0.884 . . . . 0.0 108.646 178.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 376' ' ' ARG . . . . . 0.443 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 0.0 OUTLIER -68.66 168.17 13.7 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.63 -0.669 . . . . 0.0 110.22 -179.747 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 5.1 t -85.77 139.9 30.93 Favored 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 119.651 -0.819 . . . . 0.0 110.395 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . 0.429 ' OG ' ' CE1' ' A' ' 404' ' ' TYR . 9.8 t -59.74 123.21 16.23 Favored 'General case' 0 N--CA 1.512 2.659 0 O-C-N 121.254 -0.904 . . . . 0.0 111.007 -178.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 16.9 t -44.12 144.04 1.04 Allowed 'General case' 0 N--CA 1.508 2.471 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -178.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 57.4 mtm -42.51 -35.86 1.18 Allowed 'General case' 0 N--CA 1.518 2.931 0 O-C-N 122.129 -0.357 . . . . 0.0 110.984 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -133.88 37.35 3.25 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 121.389 -0.82 . . . . 0.0 109.407 178.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -36.94 -47.35 1.29 Allowed Glycine 0 N--CA 1.51 3.625 0 O-C-N 120.902 -1.124 . . . . 0.0 113.346 -178.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -59.2 -24.75 63.38 Favored 'General case' 0 N--CA 1.514 2.761 0 CA-C-N 118.924 1.362 . . . . 0.0 111.159 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -136.07 25.37 3.29 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.92 -1.113 . . . . 0.0 111.105 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 46.9 t -51.92 90.76 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.894 0 O-C-N 120.814 -1.178 . . . . 0.0 111.168 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 386' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 20.0 p90 -66.01 -36.58 83.65 Favored 'General case' 0 N--CA 1.506 2.364 0 O-C-N 121.074 -1.016 . . . . 0.0 111.052 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.428 ' HD3' ' CE1' ' A' ' 392' ' ' HIS . 14.1 ptm180 -64.92 161.96 17.38 Favored 'General case' 0 N--CA 1.511 2.583 0 O-C-N 120.918 -1.114 . . . . 0.0 110.356 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.59 84.86 1.18 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.133 -0.98 . . . . 0.0 111.505 -178.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -103.18 164.73 14.91 Favored Pre-proline 0 N--CA 1.502 2.174 0 O-C-N 120.543 -1.348 . . . . 0.0 110.356 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -76.83 -29.96 5.05 Favored 'Trans proline' 0 N--CA 1.489 1.223 0 O-C-N 123.47 1.247 . . . . 0.0 111.046 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 58.8 t -97.71 -24.63 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 O-C-N 120.985 -1.072 . . . . 0.0 111.51 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 392' ' ' HIS . . . . . 0.428 ' CE1' ' HD3' ' A' ' 387' ' ' ARG . 40.3 t60 -57.53 -37.51 73.17 Favored 'General case' 0 N--CA 1.509 2.51 0 O-C-N 120.794 -1.191 . . . . 0.0 110.05 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -58.73 -33.57 70.38 Favored 'General case' 0 N--CA 1.505 2.291 0 C-N-CA 119.253 -0.979 . . . . 0.0 108.84 178.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -75.08 -35.12 61.82 Favored 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 119.097 -1.041 . . . . 0.0 110.421 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 395' ' ' HIS . . . . . 0.423 ' HB3' ' CE1' ' A' ' 396' ' ' PHE . 8.4 m170 -74.56 -29.73 61.46 Favored 'General case' 0 N--CA 1.511 2.621 0 O-C-N 120.996 -1.065 . . . . 0.0 111.903 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 396' ' ' PHE . . . . . 0.423 ' CE1' ' HB3' ' A' ' 395' ' ' HIS . 70.2 m-85 -132.97 143.12 49.24 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.705 -1.247 . . . . 0.0 110.739 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . 0.443 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 74.9 m -83.14 170.78 14.39 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -144.18 157.56 56.69 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.051 -1.031 . . . . 0.0 109.468 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.58 139.37 69.65 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 N-CA-C 108.648 -1.328 . . . . 0.0 108.648 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 96.74 -1.34 61.52 Favored Glycine 0 N--CA 1.494 2.536 0 C-N-CA 119.493 -1.337 . . . . 0.0 111.176 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -115.4 173.14 6.67 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 119.577 1.689 . . . . 0.0 108.271 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 74.8 p -75.03 -31.78 61.43 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 118.869 -1.133 . . . . 0.0 110.284 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -80.37 -6.05 57.4 Favored 'General case' 0 N--CA 1.508 2.442 0 O-C-N 120.777 -1.202 . . . . 0.0 114.087 -176.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . 0.429 ' CE1' ' OG ' ' A' ' 378' ' ' SER . 5.8 t80 . . . . . 0 N--CA 1.528 3.463 0 CA-C-N 120.679 1.581 . . . . 0.0 111.076 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 72.1 t . . . . . 0 N--CA 1.494 1.744 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -82.95 83.22 7.89 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.223 -0.923 . . . . 0.0 109.165 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 376' ' ' ARG . . . . . 0.433 ' HD3' ' HA ' ' A' ' 376' ' ' ARG . 1.3 mmt180 -62.16 151.81 34.86 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.831 -0.748 . . . . 0.0 109.977 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 1.9 m -70.48 139.31 51.65 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 14.6 t -55.43 168.94 0.33 Allowed 'General case' 0 N--CA 1.512 2.655 0 O-C-N 120.866 -1.146 . . . . 0.0 109.101 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 50.1 t -86.54 155.09 20.62 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 120.93 -1.106 . . . . 0.0 109.377 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -50.57 -35.61 30.74 Favored 'General case' 0 N--CA 1.515 2.81 0 O-C-N 121.126 -0.984 . . . . 0.0 111.293 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -131.38 36.59 3.77 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.34 -0.85 . . . . 0.0 109.62 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -37.35 -46.59 1.43 Allowed Glycine 0 N--CA 1.509 3.501 0 O-C-N 121.143 -0.973 . . . . 0.0 113.518 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -58.52 -26.74 63.82 Favored 'General case' 0 N--CA 1.512 2.667 0 CA-C-N 118.964 1.382 . . . . 0.0 110.923 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . 0.446 ' O ' ' N ' ' A' ' 386' ' ' TYR . 5.5 m-80 -136.53 24.95 3.17 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.939 -1.101 . . . . 0.0 111.182 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 36.2 t -50.18 87.93 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.052 0 O-C-N 120.9 -1.125 . . . . 0.0 111.356 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 386' ' ' TYR . . . . . 0.46 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 21.9 p90 -60.73 -38.28 84.6 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.041 -1.037 . . . . 0.0 111.16 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.46 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 14.1 ptm180 -59.23 149.59 28.04 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 121.176 -0.953 . . . . 0.0 110.225 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.98 76.09 1.61 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.323 -0.861 . . . . 0.0 110.933 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -114.3 152.74 46.26 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.071 -1.018 . . . . 0.0 109.29 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -71.59 -76.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.316 -1.183 0 O-C-N 123.408 1.215 . . . . 0.0 110.193 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 11.2 p -38.68 -33.16 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.524 3.258 0 O-C-N 120.888 -1.133 . . . . 0.0 112.639 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 392' ' ' HIS . . . . . 0.416 ' CE1' ' HD3' ' A' ' 387' ' ' ARG . 37.3 t60 -65.22 -37.87 88.64 Favored 'General case' 0 N--CA 1.511 2.598 0 O-C-N 121.092 -1.005 . . . . 0.0 109.552 178.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -59.06 -34.21 71.68 Favored 'General case' 0 N--CA 1.508 2.464 0 O-C-N 121.082 -1.011 . . . . 0.0 108.887 177.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -77.43 -30.94 53.66 Favored 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.242 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 14.9 m170 -78.12 -25.63 47.56 Favored 'General case' 0 N--CA 1.511 2.598 0 O-C-N 121.075 -1.016 . . . . 0.0 111.95 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -135.89 147.07 48.01 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.686 -1.259 . . . . 0.0 110.556 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . 0.433 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 54.6 m -89.21 160.78 16.78 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.365 -0.834 . . . . 0.0 109.772 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -136.55 156.38 76.38 Favored Pre-proline 0 N--CA 1.485 1.279 0 C-N-CA 119.786 -0.766 . . . . 0.0 110.051 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -62.57 137.97 67.41 Favored 'Trans proline' 0 C--N 1.319 -1.023 0 N-CA-C 108.303 -1.46 . . . . 0.0 108.303 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 98.51 0.11 58.09 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.471 -1.347 . . . . 0.0 110.64 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -111.57 177.54 4.62 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 119.561 1.68 . . . . 0.0 108.597 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -81.06 -25.41 37.12 Favored 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 119.081 -1.047 . . . . 0.0 110.93 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -97.13 4.75 51.09 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 120.621 -1.299 . . . . 0.0 114.469 -177.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 4.3 t80 . . . . . 0 N--CA 1.53 3.57 0 CA-C-N 120.676 1.58 . . . . 0.0 110.965 -179.81 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 89.1 t . . . . . 0 N--CA 1.493 1.714 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.67 83.1 7.76 Favored 'General case' 0 N--CA 1.504 2.238 0 C-N-CA 119.311 -0.956 . . . . 0.0 108.444 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 376' ' ' ARG . . . . . 0.437 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 2.3 mmt180 -60.56 154.34 21.25 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 119.949 -0.7 . . . . 0.0 110.103 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 1.8 m -71.32 140.67 50.35 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 29.2 t -52.48 166.5 0.18 Allowed 'General case' 0 N--CA 1.511 2.613 0 C-N-CA 119.239 -0.984 . . . . 0.0 109.349 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 50.9 t -90.17 154.86 19.44 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 120.837 -1.164 . . . . 0.0 109.613 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 56.0 mtm -49.65 -32.07 12.3 Favored 'General case' 0 N--CA 1.519 2.995 0 O-C-N 121.279 -0.888 . . . . 0.0 111.726 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -138.5 38.31 2.25 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.229 -0.919 . . . . 0.0 109.552 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -37.65 -49.65 1.86 Allowed Glycine 0 N--CA 1.508 3.473 0 O-C-N 121.231 -0.918 . . . . 0.0 113.032 -178.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -55.24 -27.21 44.69 Favored 'General case' 0 N--CA 1.51 2.53 0 O-C-N 120.997 -1.296 . . . . 0.0 111.231 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . 0.436 ' O ' ' N ' ' A' ' 386' ' ' TYR . 4.9 m-80 -138.1 29.31 2.52 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.95 -1.094 . . . . 0.0 110.936 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 37.8 t -53.54 85.89 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.988 0 O-C-N 120.98 -1.075 . . . . 0.0 111.516 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 386' ' ' TYR . . . . . 0.436 ' N ' ' O ' ' A' ' 384' ' ' ASN . 17.3 p90 -61.24 -31.17 70.96 Favored 'General case' 0 N--CA 1.51 2.565 0 O-C-N 121.005 -1.059 . . . . 0.0 111.64 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.416 ' NH1' ' HB2' ' A' ' 387' ' ' ARG . 3.6 ptm85 -79.79 160.63 26.09 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 120.977 -1.077 . . . . 0.0 110.943 -179.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.405 ' O ' ' HG3' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -156.74 112.75 2.97 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.329 -0.857 . . . . 0.0 110.909 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -121.42 169.54 8.97 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.847 -1.158 . . . . 0.0 109.785 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.9 -30.66 8.98 Favored 'Trans proline' 0 C--N 1.314 -1.27 0 O-C-N 123.473 1.249 . . . . 0.0 110.609 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 73.9 t -100.38 -22.65 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.094 -1.004 . . . . 0.0 111.772 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 41.2 t60 -61.5 -39.38 90.76 Favored 'General case' 0 N--CA 1.51 2.525 0 O-C-N 120.528 -1.358 . . . . 0.0 109.829 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -55.73 -33.15 63.98 Favored 'General case' 0 N--CA 1.507 2.416 0 C-N-CA 119.294 -0.962 . . . . 0.0 108.916 178.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.406 ' O ' ' NE ' ' A' ' 376' ' ' ARG . 1.0 OUTLIER -78.43 -32.09 48.4 Favored 'General case' 0 N--CA 1.504 2.237 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.556 179.791 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 395' ' ' HIS . . . . . 0.404 ' HB3' ' CE2' ' A' ' 396' ' ' PHE . 9.1 m-70 -79.93 -17.83 52.03 Favored 'General case' 0 N--CA 1.513 2.699 0 O-C-N 120.927 -1.108 . . . . 0.0 112.976 -178.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 396' ' ' PHE . . . . . 0.404 ' CE2' ' HB3' ' A' ' 395' ' ' HIS . 70.3 m-85 -145.09 142.61 29.83 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.442 -1.411 . . . . 0.0 110.725 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . 0.437 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 19.9 m -85.05 170.54 12.87 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.255 -0.903 . . . . 0.0 110.506 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -143.7 151.5 53.69 Favored Pre-proline 0 N--CA 1.482 1.153 0 C-N-CA 119.831 -0.748 . . . . 0.0 109.645 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -60.73 139.51 85.91 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 N-CA-C 107.767 -1.667 . . . . 0.0 107.767 178.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.18 2.43 55.83 Favored Glycine 0 CA--C 1.548 2.131 0 C-N-CA 119.331 -1.414 . . . . 0.0 110.44 -177.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.52 158.92 26.25 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 119.77 1.785 . . . . 0.0 108.681 177.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 39.8 t -62.93 -30.77 71.82 Favored 'General case' 0 N--CA 1.501 2.091 0 C-N-CA 118.995 -1.082 . . . . 0.0 110.819 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -89.42 -2.73 58.5 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 120.64 -1.287 . . . . 0.0 113.732 -177.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 34.8 t80 . . . . . 0 N--CA 1.516 2.859 0 CA-C-N 120.492 1.496 . . . . 0.0 110.491 -179.522 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 120.627 0.251 . . . . 0.0 110.43 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.7 84.73 6.19 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.283 -0.886 . . . . 0.0 109.411 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 376' ' ' ARG . . . . . 0.453 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 1.2 mmt180 -60.83 148.92 37.62 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.664 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 5.5 t -67.77 140.93 56.69 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 1.3 p -54.16 158.93 2.04 Favored 'General case' 0 N--CA 1.507 2.379 0 C-N-CA 119.311 -0.956 . . . . 0.0 109.374 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 53.6 t -84.08 154.73 23.03 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 120.996 -1.065 . . . . 0.0 110.139 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 51.5 mtm -51.74 -30.82 24.04 Favored 'General case' 0 N--CA 1.515 2.821 0 O-C-N 121.306 -0.872 . . . . 0.0 111.82 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . 0.422 ' O ' ' N ' ' A' ' 385' ' ' CYS . 22.3 m-85 -137.11 36.73 2.55 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.063 -1.023 . . . . 0.0 109.3 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -40.31 -46.84 3.53 Favored Glycine 0 N--CA 1.506 3.3 0 O-C-N 121.34 -0.85 . . . . 0.0 112.901 -178.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -59.22 -28.26 66.5 Favored 'General case' 0 N--CA 1.509 2.486 0 CA-C-N 118.789 1.295 . . . . 0.0 110.957 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -136.92 28.82 2.87 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.818 -1.176 . . . . 0.0 111.039 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . 0.422 ' N ' ' O ' ' A' ' 381' ' ' TYR . 9.9 t -47.44 140.24 5.94 Favored 'General case' 0 N--CA 1.518 2.967 0 O-C-N 120.961 -1.087 . . . . 0.0 111.722 -178.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 386' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 4.1 p90 -113.05 -39.78 4.12 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.192 -0.942 . . . . 0.0 110.654 178.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.438 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 13.6 ptm180 -69.53 155.46 40.45 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 120.9 -1.125 . . . . 0.0 109.626 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.33 97.21 2.51 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.153 -0.967 . . . . 0.0 110.871 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -113.76 169.25 6.7 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 120.752 -1.217 . . . . 0.0 110.502 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -75.44 -25.76 10.89 Favored 'Trans proline' 0 CA--C 1.549 1.226 0 O-C-N 123.54 1.284 . . . . 0.0 110.466 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.8 t -100.87 -23.04 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 O-C-N 121.115 -0.99 . . . . 0.0 112.14 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 392' ' ' HIS . . . . . 0.401 ' CE1' ' HD3' ' A' ' 387' ' ' ARG . 40.9 t60 -62.85 -38.3 90.28 Favored 'General case' 0 N--CA 1.515 2.782 0 O-C-N 120.529 -1.357 . . . . 0.0 110.013 -178.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -56.31 -32.16 64.36 Favored 'General case' 0 N--CA 1.508 2.43 0 C-N-CA 119.175 -1.01 . . . . 0.0 108.927 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.42 ' O ' ' NE ' ' A' ' 376' ' ' ARG . 1.0 OUTLIER -80.73 -32.69 35.65 Favored 'General case' 0 N--CA 1.505 2.314 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.149 179.461 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 395' ' ' HIS . . . . . 0.427 ' HB3' ' CE2' ' A' ' 396' ' ' PHE . 16.5 m170 -72.92 -30.76 64.16 Favored 'General case' 0 N--CA 1.509 2.519 0 O-C-N 121.069 -1.019 . . . . 0.0 111.01 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 396' ' ' PHE . . . . . 0.427 ' CE2' ' HB3' ' A' ' 395' ' ' HIS . 47.6 m-85 -138.01 148.04 44.76 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.83 -1.169 . . . . 0.0 110.53 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . 0.453 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 3.0 m -90.05 172.24 8.98 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.481 -0.762 . . . . 0.0 110.409 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -142.46 151.03 56.66 Favored Pre-proline 0 N--CA 1.487 1.38 0 C-N-CA 119.656 -0.818 . . . . 0.0 110.816 -178.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -61.96 139.44 79.32 Favored 'Trans proline' 0 C--N 1.321 -0.902 0 N-CA-C 107.489 -1.774 . . . . 0.0 107.489 178.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 98.54 0.57 57.93 Favored Glycine 0 CA--C 1.552 2.382 0 C-N-CA 119.37 -1.395 . . . . 0.0 110.203 -177.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -114.85 165.23 13.06 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 119.529 1.664 . . . . 0.0 107.933 177.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.85 -25.35 62.78 Favored 'General case' 0 N--CA 1.506 2.361 0 C-N-CA 119.086 -1.046 . . . . 0.0 111.615 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -99.51 8.57 44.39 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 120.576 -1.328 . . . . 0.0 113.133 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . 0.413 ' HA ' ' HB3' ' A' ' 397' ' ' SER . 21.2 t80 . . . . . 0 N--CA 1.516 2.847 0 CA-C-N 120.279 1.399 . . . . 0.0 110.652 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 90.6 t . . . . . 0 N--CA 1.495 1.788 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 26.6 tttm -83.77 84.87 7.4 Favored 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 119.223 -0.991 . . . . 0.0 109.202 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 376' ' ' ARG . . . . . 0.482 ' HB3' ' OG ' ' A' ' 397' ' ' SER . 1.9 mmt180 -69.07 152.78 44.78 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.277 -0.969 . . . . 0.0 108.925 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 6.5 t -70.62 144.37 51.17 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 119.486 -0.886 . . . . 0.0 108.903 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.34 158.66 4.07 Favored 'General case' 0 N--CA 1.509 2.487 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 44.1 t -78.91 157.58 28.22 Favored 'General case' 0 N--CA 1.508 2.445 0 O-C-N 120.712 -1.243 . . . . 0.0 110.384 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 55.0 mtm -48.67 -29.5 4.45 Favored 'General case' 0 N--CA 1.513 2.721 0 O-C-N 121.211 -0.93 . . . . 0.0 112.242 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -121.83 17.83 11.03 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.967 -1.083 . . . . 0.0 112.447 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 46.42 -114.41 1.44 Allowed Glycine 0 N--CA 1.499 2.834 0 O-C-N 120.782 -1.199 . . . . 0.0 112.487 177.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . 0.531 ' HB2' ' HG3' ' A' ' 399' ' ' PRO . . . -76.83 -18.31 58.46 Favored 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.488 -1.007 . . . . 0.0 112.585 -178.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . 0.443 ' O ' ' N ' ' A' ' 386' ' ' TYR . 33.6 m-80 -84.9 0.69 50.24 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 120.546 -1.346 . . . . 0.0 111.871 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 49.2 t -49.67 87.5 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.935 0 O-C-N 120.775 -1.203 . . . . 0.0 111.585 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 386' ' ' TYR . . . . . 0.443 ' N ' ' O ' ' A' ' 384' ' ' ASN . 31.8 p90 -66.14 -36.41 83.07 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 120.848 -1.157 . . . . 0.0 110.865 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -71.19 160.99 31.85 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.193 -0.942 . . . . 0.0 110.072 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 36.4 pttt -159.5 110.97 2.04 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.336 -0.853 . . . . 0.0 110.534 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -117.73 170.83 5.67 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 120.949 -1.095 . . . . 0.0 110.355 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -74.28 -27.93 11.01 Favored 'Trans proline' 0 N--CA 1.489 1.238 0 O-C-N 123.486 1.256 . . . . 0.0 110.875 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 58.3 t -103.12 -18.86 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 120.987 -1.071 . . . . 0.0 111.933 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 34.3 t60 -65.12 -39.42 93.06 Favored 'General case' 0 N--CA 1.508 2.471 0 O-C-N 120.559 -1.338 . . . . 0.0 109.961 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -55.15 -37.18 66.65 Favored 'General case' 0 N--CA 1.51 2.568 0 C-N-CA 119.215 -0.994 . . . . 0.0 108.467 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.42 ' O ' ' NE ' ' A' ' 376' ' ' ARG . 1.2 mp0 -74.84 -31.01 61.55 Favored 'General case' 0 N--CA 1.502 2.16 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.076 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 23.2 m170 -75.72 -27.09 58.05 Favored 'General case' 0 N--CA 1.509 2.522 0 O-C-N 120.975 -1.078 . . . . 0.0 111.61 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -140.19 150.72 44.53 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.821 -1.174 . . . . 0.0 110.612 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . 0.482 ' OG ' ' HB3' ' A' ' 376' ' ' ARG . 3.1 m -89.46 171.74 9.5 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.467 -0.771 . . . . 0.0 109.836 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -144.56 153.03 54.56 Favored Pre-proline 0 N--CA 1.487 1.415 0 O-C-N 121.437 -0.79 . . . . 0.0 108.903 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . 0.531 ' HG3' ' HB2' ' A' ' 383' ' ' ALA . 35.7 Cg_endo -60.72 137.75 75.1 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 N-CA-C 109.0 -1.192 . . . . 0.0 109.0 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 104.07 -1.2 44.23 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.619 -1.277 . . . . 0.0 111.566 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -112.87 176.2 5.11 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 119.987 1.894 . . . . 0.0 109.3 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 2.7 t -79.15 -25.57 42.86 Favored 'General case' 0 N--CA 1.506 2.332 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.864 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -98.1 1.48 47.63 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.66 -1.275 . . . . 0.0 112.498 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 31.5 t80 . . . . . 0 N--CA 1.515 2.817 0 CA-C-N 120.096 1.316 . . . . 0.0 110.738 -179.923 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 57.7 t . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 375' ' ' LYS . 0.0 OUTLIER -89.05 100.11 12.96 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 122.089 0.947 . . . . 0.0 109.078 179.093 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.46 -177.22 0.06 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.484 -0.76 . . . . 0.0 111.109 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 3.3 m -108.24 130.84 55.14 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . 0.432 ' OG ' ' CE1' ' A' ' 404' ' ' TYR . 30.7 t -48.91 118.44 2.6 Favored 'General case' 0 N--CA 1.515 2.802 0 O-C-N 121.656 -0.653 . . . . 0.0 110.724 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . 0.436 ' HB2' ' CD2' ' A' ' 398' ' ' HIS . 9.3 t -38.56 151.35 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.731 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -178.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 53.9 mtm -46.27 -34.6 4.57 Favored 'General case' 0 N--CA 1.509 2.513 0 O-C-N 121.838 -0.539 . . . . 0.0 111.117 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -114.52 9.33 16.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.123 -0.985 . . . . 0.0 113.163 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 57.82 -120.44 21.55 Favored Glycine 0 N--CA 1.491 2.361 0 O-C-N 120.175 -1.578 . . . . 0.0 112.159 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -75.6 -13.38 60.34 Favored 'General case' 0 N--CA 1.51 2.531 0 O-C-N 121.485 -1.009 . . . . 0.0 112.655 -178.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . 0.402 ' O ' ' N ' ' A' ' 386' ' ' TYR . 58.1 m-20 -86.01 -2.35 58.22 Favored 'General case' 0 N--CA 1.507 2.407 0 O-C-N 120.575 -1.328 . . . . 0.0 111.12 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 52.7 t -47.02 89.54 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.998 0 O-C-N 120.825 -1.172 . . . . 0.0 111.872 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 386' ' ' TYR . . . . . 0.402 ' N ' ' O ' ' A' ' 384' ' ' ASN . 31.3 p90 -70.34 -38.19 74.8 Favored 'General case' 0 N--CA 1.508 2.428 0 O-C-N 120.892 -1.13 . . . . 0.0 110.956 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.422 ' HD3' ' CE1' ' A' ' 392' ' ' HIS . 14.1 ptm180 -57.79 152.26 16.08 Favored 'General case' 0 N--CA 1.51 2.532 0 O-C-N 121.028 -1.045 . . . . 0.0 110.262 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -142.16 79.16 1.66 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.244 -0.91 . . . . 0.0 111.058 -179.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -97.26 160.64 28.45 Favored Pre-proline 0 N--CA 1.502 2.137 0 O-C-N 120.977 -1.077 . . . . 0.0 110.534 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -75.96 -29.2 6.98 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 O-C-N 123.547 1.288 . . . . 0.0 111.214 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 57.3 t -99.15 -22.38 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 O-C-N 121.236 -0.915 . . . . 0.0 111.594 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 392' ' ' HIS . . . . . 0.422 ' CE1' ' HD3' ' A' ' 387' ' ' ARG . 38.4 t60 -59.19 -37.76 78.2 Favored 'General case' 0 N--CA 1.51 2.542 0 O-C-N 120.611 -1.305 . . . . 0.0 110.152 -179.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -59.39 -33.72 71.55 Favored 'General case' 0 N--CA 1.505 2.295 0 C-N-CA 119.112 -1.035 . . . . 0.0 108.805 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -72.19 -33.34 67.59 Favored 'General case' 0 N--CA 1.503 2.19 0 C-N-CA 119.206 -0.997 . . . . 0.0 110.828 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 27.2 m170 -79.64 -34.81 40.2 Favored 'General case' 0 N--CA 1.509 2.485 0 O-C-N 120.983 -1.073 . . . . 0.0 111.224 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -121.92 158.51 28.87 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.029 -1.044 . . . . 0.0 110.304 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.45 173.77 6.16 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 178.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . 0.436 ' CD2' ' HB2' ' A' ' 379' ' ' CYS . 76.6 m80 -145.74 157.35 51.47 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 120.891 -1.131 . . . . 0.0 108.871 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -62.69 140.57 81.49 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 N-CA-C 108.892 -1.234 . . . . 0.0 108.892 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.88 -3.63 55.9 Favored Glycine 0 N--CA 1.496 2.689 0 C-N-CA 119.684 -1.246 . . . . 0.0 111.299 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -112.14 177.17 4.73 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 119.544 1.672 . . . . 0.0 108.689 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 1.4 p -79.36 -28.34 41.97 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.099 -1.04 . . . . 0.0 110.556 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -88.29 -4.45 58.69 Favored 'General case' 0 N--CA 1.509 2.501 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -176.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . 0.432 ' CE1' ' OG ' ' A' ' 378' ' ' SER . 7.9 t80 . . . . . 0 N--CA 1.533 3.679 0 CA-C-N 120.742 1.61 . . . . 0.0 111.869 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 120.598 0.237 . . . . 0.0 110.595 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.23 97.62 10.03 Favored 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 119.337 -0.945 . . . . 0.0 108.533 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 376' ' ' ARG . . . . . 0.4 ' NE ' ' HA ' ' A' ' 376' ' ' ARG . 0.2 OUTLIER -68.64 148.14 50.88 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.641 -0.824 . . . . 0.0 109.919 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 5.8 t -69.08 142.59 54.44 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 19.0 p -55.65 156.49 4.79 Favored 'General case' 0 N--CA 1.508 2.427 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 48.5 t -80.31 154.08 28.03 Favored 'General case' 0 N--CA 1.507 2.419 0 O-C-N 120.763 -1.211 . . . . 0.0 111.039 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 60.4 mtm -49.34 -33.26 13.03 Favored 'General case' 0 N--CA 1.516 2.844 0 O-C-N 121.303 -0.873 . . . . 0.0 111.288 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -136.36 39.13 2.69 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.208 -0.932 . . . . 0.0 108.831 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -39.02 -43.07 1.72 Allowed Glycine 0 N--CA 1.509 3.504 0 O-C-N 121.521 -0.737 . . . . 0.0 113.064 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -62.01 -29.53 70.34 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.015 -1.285 . . . . 0.0 110.745 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . 0.4 ' O ' ' N ' ' A' ' 386' ' ' TYR . 7.2 m-80 -133.66 25.14 4.05 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.955 -1.091 . . . . 0.0 111.803 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 17.1 t -47.81 90.12 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.022 0 O-C-N 120.788 -1.195 . . . . 0.0 112.269 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 386' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 24.8 p90 -62.92 -41.92 99.63 Favored 'General case' 0 N--CA 1.51 2.569 0 O-C-N 120.832 -1.168 . . . . 0.0 110.289 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.451 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.2 OUTLIER -63.98 157.07 26.02 Favored 'General case' 0 N--CA 1.509 2.499 0 O-C-N 121.134 -0.979 . . . . 0.0 110.231 -179.531 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.38 92.23 1.58 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.314 -0.866 . . . . 0.0 110.805 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -106.84 162.68 18.9 Favored Pre-proline 0 N--CA 1.5 2.059 0 O-C-N 121.138 -0.976 . . . . 0.0 110.44 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -74.17 -26.53 12.6 Favored 'Trans proline' 0 CA--C 1.545 1.072 0 O-C-N 123.56 1.295 . . . . 0.0 111.264 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 60.8 t -99.86 -24.8 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 O-C-N 121.141 -0.974 . . . . 0.0 111.492 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 392' ' ' HIS . . . . . 0.433 ' CE1' ' NH1' ' A' ' 387' ' ' ARG . 44.8 t60 -61.36 -36.93 81.56 Favored 'General case' 0 N--CA 1.511 2.588 0 O-C-N 120.633 -1.292 . . . . 0.0 110.19 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -56.49 -34.27 66.8 Favored 'General case' 0 N--CA 1.507 2.4 0 C-N-CA 119.117 -1.033 . . . . 0.0 108.492 177.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.72 -32.85 58.1 Favored 'General case' 0 N--CA 1.506 2.36 0 C-N-CA 119.454 -0.899 . . . . 0.0 111.087 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -75.74 -34.41 60.29 Favored 'General case' 0 N--CA 1.509 2.524 0 O-C-N 121.133 -0.979 . . . . 0.0 110.938 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -128.56 151.27 49.65 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.985 -1.072 . . . . 0.0 110.528 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.33 168.83 11.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.577 -0.702 . . . . 0.0 109.322 178.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -140.94 152.93 66.7 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.357 -0.839 . . . . 0.0 109.728 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . 0.442 ' HA ' ' CD2' ' A' ' 404' ' ' TYR . 36.3 Cg_endo -59.43 136.87 74.55 Favored 'Trans proline' 0 C--N 1.316 -1.153 0 N-CA-C 108.839 -1.254 . . . . 0.0 108.839 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 102.41 0.04 50.16 Favored Glycine 0 CA--C 1.55 2.244 0 C-N-CA 119.635 -1.269 . . . . 0.0 111.419 -179.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -111.28 171.91 7.2 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 119.954 1.877 . . . . 0.0 109.451 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 50.5 m -75.5 -24.48 56.88 Favored 'General case' 0 N--CA 1.505 2.323 0 C-N-CA 119.246 -0.982 . . . . 0.0 111.103 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -102.14 5.89 40.57 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 120.644 -1.285 . . . . 0.0 112.728 -178.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . 0.442 ' CD2' ' HA ' ' A' ' 399' ' ' PRO . 14.0 t80 . . . . . 0 N--CA 1.515 2.815 0 O-C-N 120.688 -1.258 . . . . 0.0 112.483 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 60.0 t . . . . . 0 N--CA 1.493 1.693 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 31.6 mtpt -88.71 94.32 9.87 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 119.618 -0.833 . . . . 0.0 109.732 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 376' ' ' ARG . . . . . 0.434 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 42.1 mtm-85 -55.81 146.01 22.83 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.706 -0.621 . . . . 0.0 110.573 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 2.3 m -69.28 137.48 53.08 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 87.4 p -52.84 157.3 1.7 Allowed 'General case' 0 N--CA 1.512 2.656 0 O-C-N 121.054 -1.029 . . . . 0.0 109.749 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 12.7 t -80.74 158.52 25.49 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 120.854 -1.154 . . . . 0.0 109.107 179.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -55.59 -39.12 70.3 Favored 'General case' 0 N--CA 1.513 2.688 0 O-C-N 121.149 -0.97 . . . . 0.0 109.946 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . 0.404 ' CD1' ' N ' ' A' ' 381' ' ' TYR . 8.5 m-85 -128.29 38.29 4.01 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -38.04 -44.87 1.58 Allowed Glycine 0 N--CA 1.507 3.373 0 O-C-N 121.321 -0.862 . . . . 0.0 113.13 -177.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -59.35 -27.86 66.32 Favored 'General case' 0 N--CA 1.507 2.422 0 CA-C-N 118.653 1.226 . . . . 0.0 110.703 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . 0.419 ' O ' ' N ' ' A' ' 386' ' ' TYR . 7.4 m-80 -133.14 19.82 4.06 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.843 -1.161 . . . . 0.0 112.109 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 33.7 t -43.75 88.78 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.367 0 CA-C-N 119.787 1.176 . . . . 0.0 112.775 -178.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 386' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 20.4 p90 -63.17 -40.59 97.96 Favored 'General case' 0 N--CA 1.509 2.504 0 O-C-N 120.95 -1.094 . . . . 0.0 111.537 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.455 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 15.1 ptm180 -56.02 151.15 12.41 Favored 'General case' 0 N--CA 1.513 2.708 0 O-C-N 120.821 -1.175 . . . . 0.0 110.376 -179.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -133.34 72.68 1.49 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.142 -0.974 . . . . 0.0 110.725 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -106.71 149.27 38.22 Favored Pre-proline 0 N--CA 1.498 1.972 0 O-C-N 121.094 -1.004 . . . . 0.0 109.547 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -69.73 -83.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.316 -1.173 0 O-C-N 123.498 1.262 . . . . 0.0 108.94 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 88.2 t -38.64 -26.48 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.526 3.358 0 O-C-N 120.833 -1.167 . . . . 0.0 113.288 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 392' ' ' HIS . . . . . 0.426 ' CE1' ' HD3' ' A' ' 387' ' ' ARG . 25.9 t60 -64.15 -39.36 93.84 Favored 'General case' 0 N--CA 1.512 2.626 0 O-C-N 120.312 -1.493 . . . . 0.0 108.504 177.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -59.87 -37.42 79.26 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.291 -0.881 . . . . 0.0 109.228 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -70.01 -26.55 64.12 Favored 'General case' 0 N--CA 1.507 2.393 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.215 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 19.2 m170 -90.99 -34.6 15.08 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.757 -1.214 . . . . 0.0 110.605 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -117.33 144.45 44.88 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.048 -1.033 . . . . 0.0 110.355 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . 0.434 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 0.1 OUTLIER -98.0 167.03 11.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 110.528 179.611 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -140.07 153.57 69.43 Favored Pre-proline 0 N--CA 1.488 1.431 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.894 -178.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -62.28 137.9 68.53 Favored 'Trans proline' 0 N--CA 1.484 0.954 0 N-CA-C 108.038 -1.562 . . . . 0.0 108.038 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.37 -2.35 56.22 Favored Glycine 0 CA--C 1.551 2.343 0 C-N-CA 119.695 -1.24 . . . . 0.0 110.384 -177.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -115.47 140.07 49.48 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 119.649 1.725 . . . . 0.0 108.499 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 5.8 m -49.43 -25.61 2.69 Favored 'General case' 0 N--CA 1.509 2.512 0 O-C-N 121.11 -0.994 . . . . 0.0 113.201 -178.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -99.32 11.1 40.04 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 120.28 -1.513 . . . . 0.0 113.551 -177.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 6.1 t80 . . . . . 0 N--CA 1.515 2.816 0 O-C-N 120.365 -1.46 . . . . 0.0 109.487 179.556 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.73 148.53 46.85 Favored 'Trans proline' 0 C--N 1.317 -1.108 0 O-C-N 123.378 1.199 . . . . 0.0 110.411 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 1.1 tp -142.96 -172.91 3.76 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.202 -0.936 . . . . 0.0 110.147 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 112.08 56.67 0.46 Allowed Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 38.7 p -142.82 57.31 1.42 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.214 -1.168 . . . . 0.0 110.208 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -117.97 104.36 1.13 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 1.4 t -143.07 108.65 5.09 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.217 -1.167 . . . . 0.0 110.292 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -114.87 110.77 20.18 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.19 -0.944 . . . . 0.0 110.068 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -69.08 -78.71 0.32 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -153.72 37.16 0.46 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.198 -1.178 . . . . 0.0 110.687 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . 0.46 ' C ' HG23 ' A' ' 374' ' ' VAL . 1.3 ttpt -158.29 40.49 0.26 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.151 -0.968 . . . . 0.0 110.835 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . 0.46 HG23 ' C ' ' A' ' 373' ' ' LYS . 98.4 t -149.0 161.04 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.428 -0.795 . . . . 0.0 109.617 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 14.3 mttm -78.66 90.82 4.59 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 121.162 -0.961 . . . . 0.0 109.431 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 43.2 mtm-85 -61.51 154.39 24.77 Favored 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.389 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 4.7 t -79.25 138.49 37.81 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 10.8 p -53.39 151.17 5.73 Favored 'General case' 0 N--CA 1.515 2.798 0 O-C-N 120.882 -1.136 . . . . 0.0 108.52 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 23.4 t -79.82 156.12 27.54 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 120.887 -1.133 . . . . 0.0 111.618 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 65.7 mtm -48.32 -30.94 5.37 Favored 'General case' 0 N--CA 1.519 2.985 0 O-C-N 121.288 -0.882 . . . . 0.0 111.067 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . 0.444 ' CD1' ' N3 ' ' A' 1002 ' ' ADN . 14.7 m-85 -140.61 37.37 1.84 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.199 -0.938 . . . . 0.0 109.081 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -38.4 -46.07 1.95 Allowed Glycine 0 N--CA 1.506 3.334 0 O-C-N 121.206 -0.933 . . . . 0.0 113.112 -178.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -58.59 -28.69 65.81 Favored 'General case' 0 N--CA 1.51 2.529 0 CA-C-N 118.808 1.304 . . . . 0.0 110.687 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . 0.476 ' HB2' HN62 ' A' 1002 ' ' ADN . 4.8 m-80 -135.11 28.77 3.44 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.028 -1.045 . . . . 0.0 110.977 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 19.2 t -53.02 88.74 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.807 0 O-C-N 121.091 -1.006 . . . . 0.0 110.957 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' TYR . . . . . 0.415 ' N ' ' O ' ' A' ' 384' ' ' ASN . 20.1 p90 -62.73 -35.94 81.41 Favored 'General case' 0 N--CA 1.507 2.418 0 O-C-N 120.988 -1.07 . . . . 0.0 111.138 -178.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.511 ' HD2' " H3'" ' A' 1003 ' ' RIB . 5.6 ptm85 -75.99 163.22 27.38 Favored 'General case' 0 N--CA 1.505 2.284 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.538 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -161.04 111.98 1.78 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.328 -0.857 . . . . 0.0 110.967 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -118.93 169.76 7.56 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.103 -0.998 . . . . 0.0 109.691 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -74.56 -29.35 9.13 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 O-C-N 123.463 1.244 . . . . 0.0 110.629 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 60.9 t -100.37 -21.52 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 121.084 -1.01 . . . . 0.0 111.718 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 37.2 t60 -61.95 -38.15 87.41 Favored 'General case' 0 N--CA 1.506 2.374 0 O-C-N 120.625 -1.297 . . . . 0.0 110.056 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -58.95 -31.86 69.09 Favored 'General case' 0 N--CA 1.506 2.365 0 C-N-CA 119.231 -0.987 . . . . 0.0 109.346 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -75.33 -31.56 60.64 Favored 'General case' 0 N--CA 1.508 2.469 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.744 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 16.8 m170 -82.84 -33.83 27.03 Favored 'General case' 0 N--CA 1.507 2.407 0 O-C-N 120.962 -1.086 . . . . 0.0 111.475 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' PHE . . . . . 0.421 ' N ' ' CD1' ' A' ' 396' ' ' PHE . 68.7 m-85 -124.05 141.95 51.61 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.934 -1.104 . . . . 0.0 110.838 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.54 170.81 9.87 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 109.089 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -144.62 153.76 55.24 Favored Pre-proline 0 N--CA 1.485 1.285 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.042 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -60.23 138.81 83.65 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 N-CA-C 108.713 -1.303 . . . . 0.0 108.713 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 102.06 -1.12 51.19 Favored Glycine 0 CA--C 1.554 2.477 0 C-N-CA 119.794 -1.193 . . . . 0.0 110.788 -177.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -114.38 165.3 12.86 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 119.788 1.794 . . . . 0.0 108.656 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 8.9 t -70.22 -25.27 63.32 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.186 -0.946 . . . . 0.0 111.39 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -98.38 5.62 48.01 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.696 -1.253 . . . . 0.0 112.908 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -55.98 143.4 32.32 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 120.434 -1.416 . . . . 0.0 109.188 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -158.23 41.85 0.51 Allowed Glycine 0 N--CA 1.496 2.668 0 C-N-CA 119.547 -1.311 . . . . 0.0 110.045 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' GLY . . . . . 0.426 ' HA3' ' NE2' ' A' ' 408' ' ' GLN . . . -99.99 -54.01 1.07 Allowed Glycine 0 N--CA 1.482 1.749 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.513 HG12 ' O ' ' A' ' 407' ' ' VAL . 86.5 t 44.4 66.23 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.739 -0.86 . . . . 0.0 111.631 178.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.426 ' NE2' ' HA3' ' A' ' 406' ' ' GLY . 2.2 mp0 -105.32 71.87 0.96 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.29 -0.881 . . . . 0.0 110.08 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.621 HG23 ' CD ' ' A' ' 412' ' ' GLN . 46.7 mm 50.81 71.96 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 120.978 -1.076 . . . . 0.0 110.956 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 63.5 t -113.75 80.22 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.335 -0.853 . . . . 0.0 108.781 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 79.08 58.72 2.9 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 108.345 -1.902 . . . . 0.0 108.345 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' GLN . . . . . 0.621 ' CD ' HG23 ' A' ' 409' ' ' ILE . 7.9 mt-30 -49.4 -66.41 0.4 Allowed 'General case' 0 N--CA 1.511 2.616 0 O-C-N 121.335 -1.097 . . . . 0.0 110.948 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -159.27 39.46 0.21 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.179 -0.951 . . . . 0.0 110.836 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -115.01 40.52 2.62 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.135 -0.978 . . . . 0.0 110.239 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.32 65.28 0.94 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.238 -0.914 . . . . 0.0 109.935 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -118.2 41.72 2.86 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.3 -0.875 . . . . 0.0 110.207 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.494 1.754 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.211 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A 1002 ' ' ADN . . . . . 0.476 HN62 ' HB2' ' A' ' 384' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1003 ' ' RIB . . . . . 0.511 " H3'" ' HD2' ' A' ' 387' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.68 -171.23 0.71 Allowed 'Trans proline' 0 C--N 1.316 -1.154 0 O-C-N 123.44 1.232 . . . . 0.0 110.339 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 42.6 mt -115.32 105.13 12.51 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.173 -0.954 . . . . 0.0 110.183 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 120.18 103.84 1.99 Allowed Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 4.2 t -117.03 117.04 28.56 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.131 -1.217 . . . . 0.0 110.256 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -137.63 168.48 24.45 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 1.7 m -123.85 120.58 32.99 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.147 -1.208 . . . . 0.0 110.157 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -138.5 85.61 2.1 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.185 -0.947 . . . . 0.0 110.269 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -139.52 42.29 1.25 Allowed Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -145.29 -65.9 0.32 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.183 -1.186 . . . . 0.0 110.252 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 2.3 tptp -142.2 65.14 1.37 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.223 -0.923 . . . . 0.0 110.08 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 90.2 t -145.82 161.0 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -0.908 . . . . 0.0 109.985 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 17.8 mttp -87.73 95.82 10.22 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.335 -0.853 . . . . 0.0 109.187 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.69 162.62 6.38 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 120.211 -0.596 . . . . 0.0 109.898 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 4.4 t -89.83 137.91 31.94 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.42 150.84 4.5 Favored 'General case' 0 N--CA 1.517 2.907 0 O-C-N 120.995 -1.066 . . . . 0.0 109.337 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 47.8 t -80.62 150.59 29.41 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 120.95 -1.094 . . . . 0.0 111.442 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 46.7 mtm -48.21 -30.32 4.58 Favored 'General case' 0 N--CA 1.519 2.983 0 O-C-N 121.283 -0.886 . . . . 0.0 111.709 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . 0.524 ' HA ' HG13 ' A' ' 410' ' ' VAL . 20.6 m-85 -140.54 36.15 1.84 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.183 -0.948 . . . . 0.0 109.369 178.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -37.62 -42.64 1.03 Allowed Glycine 0 N--CA 1.507 3.374 0 O-C-N 121.196 -0.94 . . . . 0.0 113.333 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -60.04 -30.24 69.05 Favored 'General case' 0 N--CA 1.508 2.448 0 O-C-N 121.03 -1.277 . . . . 0.0 110.538 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . 0.473 ' HB2' HN62 ' A' 1002 ' ' ADN . 4.8 m-80 -134.63 26.06 3.71 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.063 -1.023 . . . . 0.0 111.075 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 35.8 t -49.11 92.2 0.01 OUTLIER 'General case' 0 N--CA 1.519 2.981 0 O-C-N 120.788 -1.195 . . . . 0.0 111.692 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -68.75 -39.04 80.52 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 121.074 -1.016 . . . . 0.0 110.176 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.86 148.43 51.8 Favored 'General case' 0 N--CA 1.508 2.466 0 O-C-N 121.21 -0.931 . . . . 0.0 109.511 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.74 90.81 1.73 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.175 -0.953 . . . . 0.0 110.935 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -100.29 168.54 9.24 Favored Pre-proline 0 N--CA 1.499 2.019 0 O-C-N 120.666 -1.271 . . . . 0.0 110.263 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -75.99 -26.34 9.49 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 O-C-N 123.538 1.283 . . . . 0.0 110.894 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 76.5 t -101.75 -19.57 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 O-C-N 121.074 -1.016 . . . . 0.0 111.779 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 41.5 t60 -63.05 -40.29 97.28 Favored 'General case' 0 N--CA 1.51 2.526 0 O-C-N 120.53 -1.356 . . . . 0.0 110.217 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -56.68 -34.26 67.22 Favored 'General case' 0 N--CA 1.51 2.568 0 O-C-N 121.134 -0.979 . . . . 0.0 109.113 178.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -72.82 -31.32 64.71 Favored 'General case' 0 N--CA 1.507 2.4 0 C-N-CA 119.109 -1.036 . . . . 0.0 111.15 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 20.9 m170 -87.38 -31.94 19.85 Favored 'General case' 0 N--CA 1.508 2.439 0 O-C-N 121.019 -1.051 . . . . 0.0 111.748 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -121.38 144.03 48.89 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.847 -1.158 . . . . 0.0 111.255 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . 0.409 ' HB2' ' HA ' ' A' ' 404' ' ' TYR . 0.0 OUTLIER -88.54 173.02 8.9 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.386 -0.821 . . . . 0.0 109.39 178.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -144.88 155.86 55.64 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.419 -0.801 . . . . 0.0 109.771 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -60.72 136.64 67.91 Favored 'Trans proline' 0 C--N 1.318 -1.07 0 N-CA-C 109.126 -1.144 . . . . 0.0 109.126 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 104.08 -2.46 44.21 Favored Glycine 0 CA--C 1.553 2.455 0 C-N-CA 119.962 -1.113 . . . . 0.0 110.715 -178.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -116.6 150.92 37.27 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 119.62 1.71 . . . . 0.0 108.884 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 2.1 p -58.16 -28.07 64.4 Favored 'General case' 0 N--CA 1.503 2.186 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.318 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -88.18 -0.71 57.42 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 120.727 -1.233 . . . . 0.0 113.349 -178.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . 0.409 ' HA ' ' HB2' ' A' ' 397' ' ' SER . 16.5 t80 -43.6 120.3 1.93 Allowed 'General case' 0 N--CA 1.522 3.156 0 CA-C-N 120.379 1.445 . . . . 0.0 111.756 -178.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -54.33 -48.17 65.47 Favored Glycine 0 N--CA 1.497 2.719 0 O-C-N 121.305 -0.872 . . . . 0.0 111.251 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 141.89 -143.71 13.33 Favored Glycine 0 N--CA 1.477 1.369 0 N-CA-C 107.571 -2.212 . . . . 0.0 107.571 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 73.5 t -111.53 92.82 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.297 -1.12 . . . . 0.0 110.614 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -108.81 84.01 1.86 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.34 -0.85 . . . . 0.0 110.062 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.51 ' O ' HG22 ' A' ' 409' ' ' ILE . 4.6 mp 51.59 67.78 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.04 -1.038 . . . . 0.0 110.549 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . 0.524 HG13 ' HA ' ' A' ' 381' ' ' TYR . 62.7 t -121.63 65.75 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 93.94 51.81 2.04 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 108.109 -1.996 . . . . 0.0 108.109 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -46.98 -60.66 2.3 Favored 'General case' 0 N--CA 1.512 2.666 0 O-C-N 121.478 -1.013 . . . . 0.0 111.333 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -144.55 42.67 1.37 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.263 -0.898 . . . . 0.0 110.424 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -124.29 39.65 3.92 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.151 -0.968 . . . . 0.0 110.261 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.58 60.72 1.68 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.261 -0.899 . . . . 0.0 109.796 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -137.05 40.14 2.51 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.167 -0.958 . . . . 0.0 110.348 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.366 179.967 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A 1002 ' ' ADN . . . . . 0.606 " O5'" ' H8 ' ' A' 1002 ' ' ADN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1003 ' ' RIB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.91 105.97 2.05 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 O-C-N 123.315 1.166 . . . . 0.0 110.35 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -136.28 48.43 2.15 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.212 -0.93 . . . . 0.0 110.229 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 118.26 -82.19 0.33 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 54.2 p -120.9 71.7 0.95 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.222 -1.164 . . . . 0.0 110.197 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -140.96 107.87 0.53 Allowed Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 66.4 m -117.31 56.48 0.82 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.291 -1.123 . . . . 0.0 110.135 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -143.13 -172.0 3.59 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.188 -0.945 . . . . 0.0 110.198 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -81.44 -98.11 0.41 Allowed Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -132.05 71.95 1.48 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.217 -1.167 . . . . 0.0 110.101 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 52.51 61.25 3.29 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 120.959 -1.088 . . . . 0.0 110.469 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 10.8 p -142.92 162.73 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.216 -0.927 . . . . 0.0 110.55 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? -89.47 99.05 12.13 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.285 -0.884 . . . . 0.0 108.646 178.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' ARG . . . . . 0.443 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 0.0 OUTLIER -68.66 168.17 13.7 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.63 -0.669 . . . . 0.0 110.22 -179.747 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 5.1 t -85.77 139.9 30.93 Favored 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 119.651 -0.819 . . . . 0.0 110.395 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . 0.432 ' HB2' ' N ' ' A' ' 406' ' ' GLY . 9.8 t -59.74 123.21 16.23 Favored 'General case' 0 N--CA 1.512 2.659 0 O-C-N 121.254 -0.904 . . . . 0.0 111.007 -178.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 16.9 t -44.12 144.04 1.04 Allowed 'General case' 0 N--CA 1.508 2.471 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -178.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 57.4 mtm -42.51 -35.86 1.18 Allowed 'General case' 0 N--CA 1.518 2.931 0 O-C-N 122.129 -0.357 . . . . 0.0 110.984 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . 0.426 ' CD1' ' N3 ' ' A' 1002 ' ' ADN . 13.9 m-85 -133.88 37.35 3.25 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 121.389 -0.82 . . . . 0.0 109.407 178.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -36.94 -47.35 1.29 Allowed Glycine 0 N--CA 1.51 3.625 0 O-C-N 120.902 -1.124 . . . . 0.0 113.346 -178.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -59.2 -24.75 63.38 Favored 'General case' 0 N--CA 1.514 2.761 0 CA-C-N 118.924 1.362 . . . . 0.0 111.159 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . 0.463 ' CB ' HN62 ' A' 1002 ' ' ADN . 7.1 m-80 -136.07 25.37 3.29 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.92 -1.113 . . . . 0.0 111.105 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 46.9 t -51.92 90.76 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.894 0 O-C-N 120.814 -1.178 . . . . 0.0 111.168 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 20.0 p90 -66.01 -36.58 83.65 Favored 'General case' 0 N--CA 1.506 2.364 0 O-C-N 121.074 -1.016 . . . . 0.0 111.052 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.428 ' HD3' ' CE1' ' A' ' 392' ' ' HIS . 14.1 ptm180 -64.92 161.96 17.38 Favored 'General case' 0 N--CA 1.511 2.583 0 O-C-N 120.918 -1.114 . . . . 0.0 110.356 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.59 84.86 1.18 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.133 -0.98 . . . . 0.0 111.505 -178.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -103.18 164.73 14.91 Favored Pre-proline 0 N--CA 1.502 2.174 0 O-C-N 120.543 -1.348 . . . . 0.0 110.356 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -76.83 -29.96 5.05 Favored 'Trans proline' 0 N--CA 1.489 1.223 0 O-C-N 123.47 1.247 . . . . 0.0 111.046 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 58.8 t -97.71 -24.63 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 O-C-N 120.985 -1.072 . . . . 0.0 111.51 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . 0.428 ' CE1' ' HD3' ' A' ' 387' ' ' ARG . 40.3 t60 -57.53 -37.51 73.17 Favored 'General case' 0 N--CA 1.509 2.51 0 O-C-N 120.794 -1.191 . . . . 0.0 110.05 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -58.73 -33.57 70.38 Favored 'General case' 0 N--CA 1.505 2.291 0 C-N-CA 119.253 -0.979 . . . . 0.0 108.84 178.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -75.08 -35.12 61.82 Favored 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 119.097 -1.041 . . . . 0.0 110.421 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' HIS . . . . . 0.423 ' HB3' ' CE1' ' A' ' 396' ' ' PHE . 8.4 m170 -74.56 -29.73 61.46 Favored 'General case' 0 N--CA 1.511 2.621 0 O-C-N 120.996 -1.065 . . . . 0.0 111.903 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' PHE . . . . . 0.423 ' CE1' ' HB3' ' A' ' 395' ' ' HIS . 70.2 m-85 -132.97 143.12 49.24 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.705 -1.247 . . . . 0.0 110.739 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . 0.443 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 74.9 m -83.14 170.78 14.39 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -144.18 157.56 56.69 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.051 -1.031 . . . . 0.0 109.468 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.58 139.37 69.65 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 N-CA-C 108.648 -1.328 . . . . 0.0 108.648 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 96.74 -1.34 61.52 Favored Glycine 0 N--CA 1.494 2.536 0 C-N-CA 119.493 -1.337 . . . . 0.0 111.176 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -115.4 173.14 6.67 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 119.577 1.689 . . . . 0.0 108.271 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 74.8 p -75.03 -31.78 61.43 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 118.869 -1.133 . . . . 0.0 110.284 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -80.37 -6.05 57.4 Favored 'General case' 0 N--CA 1.508 2.442 0 O-C-N 120.777 -1.202 . . . . 0.0 114.087 -176.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . 0.429 ' CE1' ' OG ' ' A' ' 378' ' ' SER . 5.8 t80 -40.85 119.96 1.22 Allowed 'General case' 0 N--CA 1.528 3.463 0 CA-C-N 120.679 1.581 . . . . 0.0 111.076 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -174.02 76.04 0.08 OUTLIER Glycine 0 N--CA 1.502 3.05 0 C-N-CA 119.531 -1.318 . . . . 0.0 110.823 -178.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' GLY . . . . . 0.432 ' N ' ' HB2' ' A' ' 378' ' ' SER . . . -146.2 -55.13 0.02 OUTLIER Glycine 0 N--CA 1.5 2.944 0 C-N-CA 119.882 -1.151 . . . . 0.0 111.391 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.573 ' O ' HG13 ' A' ' 407' ' ' VAL . 14.6 p -115.58 64.89 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.136 -1.214 . . . . 0.0 110.698 -179.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.428 ' NE2' ' CE2' ' A' ' 404' ' ' TYR . 14.4 mt-30 -136.08 91.86 2.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.896 . . . . 0.0 109.982 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.41 ' O ' HG22 ' A' ' 409' ' ' ILE . 51.2 mm -103.71 65.57 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.325 -0.86 . . . . 0.0 109.566 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 64.0 t -112.67 77.99 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 83.74 57.95 2.34 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 108.089 -2.004 . . . . 0.0 108.089 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -56.1 -39.69 72.56 Favored 'General case' 0 N--CA 1.509 2.488 0 O-C-N 121.316 -1.109 . . . . 0.0 110.291 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -114.62 34.74 4.59 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.171 -0.956 . . . . 0.0 110.274 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 50.75 52.09 15.62 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.888 -1.132 . . . . 0.0 110.976 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -113.55 66.38 0.66 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.216 -0.928 . . . . 0.0 110.187 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -118.24 81.16 1.63 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.364 -0.835 . . . . 0.0 110.122 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.214 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A 1002 ' ' ADN . . . . . 0.463 HN62 ' CB ' ' A' ' 384' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1003 ' ' RIB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.7 133.05 19.64 Favored 'Trans proline' 0 C--N 1.316 -1.135 0 O-C-N 123.49 1.258 . . . . 0.0 110.434 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' LEU . . . . . 0.447 ' HA ' HD13 ' A' ' 365' ' ' LEU . 1.9 mm? -116.43 -65.26 1.21 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.205 -0.935 . . . . 0.0 110.159 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -134.06 136.52 8.67 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.53 89.39 2.21 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.214 -1.168 . . . . 0.0 110.209 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -132.67 63.73 0.62 Allowed Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 58.5 m -144.84 125.65 14.31 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.237 -1.155 . . . . 0.0 110.318 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -140.74 -164.39 1.72 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.129 -0.982 . . . . 0.0 109.998 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 84.46 41.51 7.82 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -138.53 -63.83 0.54 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.221 -1.164 . . . . 0.0 110.363 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . 0.427 ' C ' HG23 ' A' ' 374' ' ' VAL . 0.0 OUTLIER -139.71 54.93 1.67 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.066 -1.021 . . . . 0.0 110.246 179.828 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . 0.427 HG23 ' C ' ' A' ' 373' ' ' LYS . 72.1 t -148.01 158.38 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.212 -0.93 . . . . 0.0 110.279 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -82.95 83.22 7.89 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.223 -0.923 . . . . 0.0 109.165 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' ARG . . . . . 0.433 ' HD3' ' HA ' ' A' ' 376' ' ' ARG . 1.3 mmt180 -62.16 151.81 34.86 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.831 -0.748 . . . . 0.0 109.977 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 1.9 m -70.48 139.31 51.65 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . 0.44 ' HB2' ' N ' ' A' ' 406' ' ' GLY . 14.6 t -55.43 168.94 0.33 Allowed 'General case' 0 N--CA 1.512 2.655 0 O-C-N 120.866 -1.146 . . . . 0.0 109.101 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 50.1 t -86.54 155.09 20.62 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 120.93 -1.106 . . . . 0.0 109.377 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -50.57 -35.61 30.74 Favored 'General case' 0 N--CA 1.515 2.81 0 O-C-N 121.126 -0.984 . . . . 0.0 111.293 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . 0.434 ' CD1' ' N3 ' ' A' 1002 ' ' ADN . 22.8 m-85 -131.38 36.59 3.77 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.34 -0.85 . . . . 0.0 109.62 178.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -37.35 -46.59 1.43 Allowed Glycine 0 N--CA 1.509 3.501 0 O-C-N 121.143 -0.973 . . . . 0.0 113.518 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -58.52 -26.74 63.82 Favored 'General case' 0 N--CA 1.512 2.667 0 CA-C-N 118.964 1.382 . . . . 0.0 110.923 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . 0.469 ' HB2' HN62 ' A' 1002 ' ' ADN . 5.5 m-80 -136.53 24.95 3.17 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.939 -1.101 . . . . 0.0 111.182 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 36.2 t -50.18 87.93 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.052 0 O-C-N 120.9 -1.125 . . . . 0.0 111.356 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' TYR . . . . . 0.46 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 21.9 p90 -60.73 -38.28 84.6 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.041 -1.037 . . . . 0.0 111.16 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.46 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 14.1 ptm180 -59.23 149.59 28.04 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 121.176 -0.953 . . . . 0.0 110.225 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.98 76.09 1.61 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.323 -0.861 . . . . 0.0 110.933 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -114.3 152.74 46.26 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.071 -1.018 . . . . 0.0 109.29 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -71.59 -76.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.316 -1.183 0 O-C-N 123.408 1.215 . . . . 0.0 110.193 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 11.2 p -38.68 -33.16 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.524 3.258 0 O-C-N 120.888 -1.133 . . . . 0.0 112.639 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . 0.416 ' CE1' ' HD3' ' A' ' 387' ' ' ARG . 37.3 t60 -65.22 -37.87 88.64 Favored 'General case' 0 N--CA 1.511 2.598 0 O-C-N 121.092 -1.005 . . . . 0.0 109.552 178.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -59.06 -34.21 71.68 Favored 'General case' 0 N--CA 1.508 2.464 0 O-C-N 121.082 -1.011 . . . . 0.0 108.887 177.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -77.43 -30.94 53.66 Favored 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.242 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 14.9 m170 -78.12 -25.63 47.56 Favored 'General case' 0 N--CA 1.511 2.598 0 O-C-N 121.075 -1.016 . . . . 0.0 111.95 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -135.89 147.07 48.01 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.686 -1.259 . . . . 0.0 110.556 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . 0.433 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 54.6 m -89.21 160.78 16.78 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.365 -0.834 . . . . 0.0 109.772 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -136.55 156.38 76.38 Favored Pre-proline 0 N--CA 1.485 1.279 0 C-N-CA 119.786 -0.766 . . . . 0.0 110.051 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -62.57 137.97 67.41 Favored 'Trans proline' 0 C--N 1.319 -1.023 0 N-CA-C 108.303 -1.46 . . . . 0.0 108.303 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 98.51 0.11 58.09 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.471 -1.347 . . . . 0.0 110.64 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -111.57 177.54 4.62 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 119.561 1.68 . . . . 0.0 108.597 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -81.06 -25.41 37.12 Favored 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 119.081 -1.047 . . . . 0.0 110.93 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -97.13 4.75 51.09 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 120.621 -1.299 . . . . 0.0 114.469 -177.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . 0.511 ' CE2' ' HB3' ' A' ' 408' ' ' GLN . 4.3 t80 -40.2 121.29 1.33 Allowed 'General case' 0 N--CA 1.53 3.57 0 CA-C-N 120.676 1.58 . . . . 0.0 110.965 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -168.61 80.15 0.1 Allowed Glycine 0 N--CA 1.495 2.602 0 C-N-CA 119.37 -1.395 . . . . 0.0 111.033 -178.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' GLY . . . . . 0.44 ' N ' ' HB2' ' A' ' 378' ' ' SER . . . -171.64 -55.22 0.04 OUTLIER Glycine 0 N--CA 1.499 2.858 0 C-N-CA 119.274 -1.441 . . . . 0.0 112.571 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.599 ' O ' HG13 ' A' ' 407' ' ' VAL . 7.1 p -138.96 92.2 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-N 118.943 1.371 . . . . 0.0 111.048 -178.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.511 ' HB3' ' CE2' ' A' ' 404' ' ' TYR . 1.0 OUTLIER -152.6 83.03 1.23 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.17 -0.957 . . . . 0.0 110.663 179.131 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.738 HG23 ' CD ' ' A' ' 412' ' ' GLN . 28.7 mt -110.26 76.32 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.427 -0.796 . . . . 0.0 109.792 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . 0.574 ' O ' HG13 ' A' ' 410' ' ' VAL . 9.8 p -115.79 69.35 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.369 -0.832 . . . . 0.0 109.197 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 93.78 56.31 1.43 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.116 -1.994 . . . . 0.0 108.116 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' GLN . . . . . 0.738 ' CD ' HG23 ' A' ' 409' ' ' ILE . 7.8 mt-30 -48.85 -66.42 0.4 Allowed 'General case' 0 N--CA 1.511 2.62 0 O-C-N 121.45 -1.029 . . . . 0.0 110.891 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -169.15 44.26 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.188 -0.945 . . . . 0.0 110.763 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -124.42 63.34 1.1 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.178 -0.951 . . . . 0.0 110.306 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . 0.428 ' O ' HG23 ' A' ' 415' ' ' THR . 6.0 t -132.64 62.16 1.66 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.143 -0.973 . . . . 0.0 110.196 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -103.48 38.83 1.7 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.164 -0.96 . . . . 0.0 109.871 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 1.4 t70 . . . . . 0 N--CA 1.494 1.774 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.356 179.974 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A 1002 ' ' ADN . . . . . 0.469 HN62 ' HB2' ' A' ' 384' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1003 ' ' RIB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.63 144.36 39.67 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 O-C-N 123.473 1.249 . . . . 0.0 110.455 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 1.6 mp -123.66 104.77 9.21 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.256 -0.902 . . . . 0.0 110.178 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -128.34 179.6 16.47 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 69.8 p -122.23 45.0 2.45 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.139 -1.212 . . . . 0.0 110.228 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -105.9 170.76 17.26 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 1.8 m -140.2 39.81 1.93 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.165 -1.197 . . . . 0.0 110.354 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -157.85 159.23 36.45 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.279 -0.888 . . . . 0.0 110.687 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -87.61 -56.48 2.11 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . 0.409 ' O ' HG23 ' A' ' 374' ' ' VAL . 7.1 m120 -145.91 65.18 1.22 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.144 -1.209 . . . . 0.0 110.411 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . 0.437 ' C ' HG23 ' A' ' 374' ' ' VAL . 4.0 mptp? 52.63 75.67 0.22 Allowed 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.954 -1.091 . . . . 0.0 110.674 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . 0.437 HG23 ' C ' ' A' ' 373' ' ' LYS . 89.1 t -148.39 158.98 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.217 -0.927 . . . . 0.0 110.229 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.67 83.1 7.76 Favored 'General case' 0 N--CA 1.504 2.238 0 C-N-CA 119.311 -0.956 . . . . 0.0 108.444 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' ARG . . . . . 0.437 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 2.3 mmt180 -60.56 154.34 21.25 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 119.949 -0.7 . . . . 0.0 110.103 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 1.8 m -71.32 140.67 50.35 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . 0.476 ' CB ' ' HA3' ' A' ' 406' ' ' GLY . 29.2 t -52.48 166.5 0.18 Allowed 'General case' 0 N--CA 1.511 2.613 0 C-N-CA 119.239 -0.984 . . . . 0.0 109.349 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 50.9 t -90.17 154.86 19.44 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 120.837 -1.164 . . . . 0.0 109.613 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 56.0 mtm -49.65 -32.07 12.3 Favored 'General case' 0 N--CA 1.519 2.995 0 O-C-N 121.279 -0.888 . . . . 0.0 111.726 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . 0.438 ' CD1' ' N3 ' ' A' 1002 ' ' ADN . 24.3 m-85 -138.5 38.31 2.25 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.229 -0.919 . . . . 0.0 109.552 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -37.65 -49.65 1.86 Allowed Glycine 0 N--CA 1.508 3.473 0 O-C-N 121.231 -0.918 . . . . 0.0 113.032 -178.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -55.24 -27.21 44.69 Favored 'General case' 0 N--CA 1.51 2.53 0 O-C-N 120.997 -1.296 . . . . 0.0 111.231 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . 0.518 ' HB2' HN62 ' A' 1002 ' ' ADN . 4.9 m-80 -138.1 29.31 2.52 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.95 -1.094 . . . . 0.0 110.936 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 37.8 t -53.54 85.89 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.988 0 O-C-N 120.98 -1.075 . . . . 0.0 111.516 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' TYR . . . . . 0.436 ' N ' ' O ' ' A' ' 384' ' ' ASN . 17.3 p90 -61.24 -31.17 70.96 Favored 'General case' 0 N--CA 1.51 2.565 0 O-C-N 121.005 -1.059 . . . . 0.0 111.64 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.447 ' HD2' " H3'" ' A' 1003 ' ' RIB . 3.6 ptm85 -79.79 160.63 26.09 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 120.977 -1.077 . . . . 0.0 110.943 -179.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.405 ' O ' ' HG3' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -156.74 112.75 2.97 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.329 -0.857 . . . . 0.0 110.909 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -121.42 169.54 8.97 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.847 -1.158 . . . . 0.0 109.785 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.9 -30.66 8.98 Favored 'Trans proline' 0 C--N 1.314 -1.27 0 O-C-N 123.473 1.249 . . . . 0.0 110.609 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 73.9 t -100.38 -22.65 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.094 -1.004 . . . . 0.0 111.772 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 41.2 t60 -61.5 -39.38 90.76 Favored 'General case' 0 N--CA 1.51 2.525 0 O-C-N 120.528 -1.358 . . . . 0.0 109.829 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -55.73 -33.15 63.98 Favored 'General case' 0 N--CA 1.507 2.416 0 C-N-CA 119.294 -0.962 . . . . 0.0 108.916 178.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.406 ' O ' ' NE ' ' A' ' 376' ' ' ARG . 1.0 OUTLIER -78.43 -32.09 48.4 Favored 'General case' 0 N--CA 1.504 2.237 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.556 179.791 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' HIS . . . . . 0.404 ' HB3' ' CE2' ' A' ' 396' ' ' PHE . 9.1 m-70 -79.93 -17.83 52.03 Favored 'General case' 0 N--CA 1.513 2.699 0 O-C-N 120.927 -1.108 . . . . 0.0 112.976 -178.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' PHE . . . . . 0.404 ' CE2' ' HB3' ' A' ' 395' ' ' HIS . 70.3 m-85 -145.09 142.61 29.83 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.442 -1.411 . . . . 0.0 110.725 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . 0.437 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 19.9 m -85.05 170.54 12.87 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.255 -0.903 . . . . 0.0 110.506 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -143.7 151.5 53.69 Favored Pre-proline 0 N--CA 1.482 1.153 0 C-N-CA 119.831 -0.748 . . . . 0.0 109.645 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -60.73 139.51 85.91 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 N-CA-C 107.767 -1.667 . . . . 0.0 107.767 178.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.18 2.43 55.83 Favored Glycine 0 CA--C 1.548 2.131 0 C-N-CA 119.331 -1.414 . . . . 0.0 110.44 -177.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.52 158.92 26.25 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 119.77 1.785 . . . . 0.0 108.681 177.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 39.8 t -62.93 -30.77 71.82 Favored 'General case' 0 N--CA 1.501 2.091 0 C-N-CA 118.995 -1.082 . . . . 0.0 110.819 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -89.42 -2.73 58.5 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 120.64 -1.287 . . . . 0.0 113.732 -177.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -48.82 138.61 10.96 Favored 'General case' 0 N--CA 1.516 2.859 0 CA-C-N 120.492 1.496 . . . . 0.0 110.491 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -167.57 58.42 0.22 Allowed Glycine 0 N--CA 1.501 2.992 0 C-N-CA 119.536 -1.316 . . . . 0.0 110.43 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' GLY . . . . . 0.476 ' HA3' ' CB ' ' A' ' 378' ' ' SER . . . -110.61 -60.12 0.49 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.528 HG12 ' O ' ' A' ' 407' ' ' VAL . 91.1 t 34.52 63.95 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 122.414 -0.463 . . . . 0.0 111.983 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 11.6 mp0 -103.05 92.75 4.68 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.361 -0.837 . . . . 0.0 110.526 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.525 HG23 ' CD ' ' A' ' 412' ' ' GLN . 84.1 mt -111.31 67.24 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.25 -0.906 . . . . 0.0 109.685 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 61.7 t -115.18 73.5 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 83.5 55.31 2.89 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.168 -1.973 . . . . 0.0 108.168 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' GLN . . . . . 0.525 ' CD ' HG23 ' A' ' 409' ' ' ILE . 4.9 mt-30 -47.83 -63.31 1.1 Allowed 'General case' 0 N--CA 1.513 2.724 0 O-C-N 121.477 -1.013 . . . . 0.0 110.932 -179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -138.37 37.59 2.28 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.307 -0.871 . . . . 0.0 110.429 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -141.93 69.84 1.33 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.177 -0.952 . . . . 0.0 110.133 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 7.5 t -133.69 49.2 2.3 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.126 -0.984 . . . . 0.0 110.189 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 3.2 t70 51.05 34.25 10.52 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.101 -0.999 . . . . 0.0 111.108 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 17.8 t0 . . . . . 0 N--CA 1.494 1.734 0 O-C-N 121.032 -1.042 . . . . 0.0 110.171 179.981 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A 1002 ' ' ADN . . . . . 0.518 HN62 ' HB2' ' A' ' 384' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1003 ' ' RIB . . . . . 0.447 " H3'" ' HD2' ' A' ' 387' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -72.97 147.81 44.21 Favored 'Trans proline' 0 C--N 1.317 -1.114 0 O-C-N 123.428 1.225 . . . . 0.0 110.456 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.62 -59.79 0.44 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.186 -0.946 . . . . 0.0 110.277 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -142.35 121.31 1.76 Allowed Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 33.5 m -143.26 87.71 1.98 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.268 -1.137 . . . . 0.0 110.241 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -79.55 81.08 1.49 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.39 56.44 1.45 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.117 -1.225 . . . . 0.0 110.183 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -159.57 178.43 9.87 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.17 -0.956 . . . . 0.0 110.946 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -76.29 -89.56 0.26 Allowed Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -136.75 67.65 1.44 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.169 -1.194 . . . . 0.0 110.111 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 52.4 65.77 1.41 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.007 -1.058 . . . . 0.0 110.61 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 11.1 p -143.38 162.3 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.319 -0.863 . . . . 0.0 110.43 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.7 84.73 6.19 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.283 -0.886 . . . . 0.0 109.411 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' ARG . . . . . 0.453 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 1.2 mmt180 -60.83 148.92 37.62 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.664 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 5.5 t -67.77 140.93 56.69 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 1.3 p -54.16 158.93 2.04 Favored 'General case' 0 N--CA 1.507 2.379 0 C-N-CA 119.311 -0.956 . . . . 0.0 109.374 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 53.6 t -84.08 154.73 23.03 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 120.996 -1.065 . . . . 0.0 110.139 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 51.5 mtm -51.74 -30.82 24.04 Favored 'General case' 0 N--CA 1.515 2.821 0 O-C-N 121.306 -0.872 . . . . 0.0 111.82 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . 0.422 ' O ' ' N ' ' A' ' 385' ' ' CYS . 22.3 m-85 -137.11 36.73 2.55 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.063 -1.023 . . . . 0.0 109.3 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -40.31 -46.84 3.53 Favored Glycine 0 N--CA 1.506 3.3 0 O-C-N 121.34 -0.85 . . . . 0.0 112.901 -178.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -59.22 -28.26 66.5 Favored 'General case' 0 N--CA 1.509 2.486 0 CA-C-N 118.789 1.295 . . . . 0.0 110.957 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -136.92 28.82 2.87 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.818 -1.176 . . . . 0.0 111.039 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . 0.422 ' N ' ' O ' ' A' ' 381' ' ' TYR . 9.9 t -47.44 140.24 5.94 Favored 'General case' 0 N--CA 1.518 2.967 0 O-C-N 120.961 -1.087 . . . . 0.0 111.722 -178.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' TYR . . . . . 0.445 ' HE2' " H2'" ' A' 1002 ' ' ADN . 4.1 p90 -113.05 -39.78 4.12 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.192 -0.942 . . . . 0.0 110.654 178.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.438 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 13.6 ptm180 -69.53 155.46 40.45 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 120.9 -1.125 . . . . 0.0 109.626 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.33 97.21 2.51 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.153 -0.967 . . . . 0.0 110.871 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -113.76 169.25 6.7 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 120.752 -1.217 . . . . 0.0 110.502 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -75.44 -25.76 10.89 Favored 'Trans proline' 0 CA--C 1.549 1.226 0 O-C-N 123.54 1.284 . . . . 0.0 110.466 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.8 t -100.87 -23.04 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 O-C-N 121.115 -0.99 . . . . 0.0 112.14 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . 0.401 ' CE1' ' HD3' ' A' ' 387' ' ' ARG . 40.9 t60 -62.85 -38.3 90.28 Favored 'General case' 0 N--CA 1.515 2.782 0 O-C-N 120.529 -1.357 . . . . 0.0 110.013 -178.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -56.31 -32.16 64.36 Favored 'General case' 0 N--CA 1.508 2.43 0 C-N-CA 119.175 -1.01 . . . . 0.0 108.927 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.42 ' O ' ' NE ' ' A' ' 376' ' ' ARG . 1.0 OUTLIER -80.73 -32.69 35.65 Favored 'General case' 0 N--CA 1.505 2.314 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.149 179.461 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' HIS . . . . . 0.427 ' HB3' ' CE2' ' A' ' 396' ' ' PHE . 16.5 m170 -72.92 -30.76 64.16 Favored 'General case' 0 N--CA 1.509 2.519 0 O-C-N 121.069 -1.019 . . . . 0.0 111.01 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' PHE . . . . . 0.427 ' CE2' ' HB3' ' A' ' 395' ' ' HIS . 47.6 m-85 -138.01 148.04 44.76 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.83 -1.169 . . . . 0.0 110.53 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . 0.453 ' OG ' ' CB ' ' A' ' 376' ' ' ARG . 3.0 m -90.05 172.24 8.98 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.481 -0.762 . . . . 0.0 110.409 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -142.46 151.03 56.66 Favored Pre-proline 0 N--CA 1.487 1.38 0 C-N-CA 119.656 -0.818 . . . . 0.0 110.816 -178.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -61.96 139.44 79.32 Favored 'Trans proline' 0 C--N 1.321 -0.902 0 N-CA-C 107.489 -1.774 . . . . 0.0 107.489 178.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 98.54 0.57 57.93 Favored Glycine 0 CA--C 1.552 2.382 0 C-N-CA 119.37 -1.395 . . . . 0.0 110.203 -177.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -114.85 165.23 13.06 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 119.529 1.664 . . . . 0.0 107.933 177.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.85 -25.35 62.78 Favored 'General case' 0 N--CA 1.506 2.361 0 C-N-CA 119.086 -1.046 . . . . 0.0 111.615 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -99.51 8.57 44.39 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 120.576 -1.328 . . . . 0.0 113.133 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . 0.413 ' HA ' ' HB3' ' A' ' 397' ' ' SER . 21.2 t80 -47.08 130.3 12.46 Favored 'General case' 0 N--CA 1.516 2.847 0 CA-C-N 120.279 1.399 . . . . 0.0 110.652 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -72.94 -34.39 58.93 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 115.18 -121.89 5.44 Favored Glycine 0 C--O 1.216 -0.997 0 N-CA-C 106.778 -2.529 . . . . 0.0 106.778 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 98.1 t -136.3 99.26 2.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 O-C-N 121.741 -0.858 . . . . 0.0 109.644 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -110.6 48.85 0.89 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.284 -0.885 . . . . 0.0 110.613 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.547 ' N ' HD12 ' A' ' 409' ' ' ILE . 5.2 mp 46.4 66.01 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.38 -0.825 . . . . 0.0 111.142 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . 0.565 ' O ' HG13 ' A' ' 410' ' ' VAL . 8.3 p -119.39 68.37 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 104.44 56.63 0.72 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.17 -1.972 . . . . 0.0 108.17 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' GLN . . . . . 0.498 ' CD ' HG23 ' A' ' 409' ' ' ILE . 8.2 mt-30 -54.26 -63.83 1.02 Allowed 'General case' 0 N--CA 1.509 2.479 0 O-C-N 121.386 -1.067 . . . . 0.0 110.313 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -160.08 40.25 0.18 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.15 -0.969 . . . . 0.0 110.629 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -114.26 62.26 0.66 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.241 -0.912 . . . . 0.0 110.066 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . 0.63 HG22 " O5'" ' A' 1002 ' ' ADN . 0.2 OUTLIER -113.09 65.21 0.64 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.217 -0.927 . . . . 0.0 110.005 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -140.57 40.44 1.87 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.246 -0.909 . . . . 0.0 110.267 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 118.099 -0.953 . . . . 0.0 110.206 -179.999 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A 1002 ' ' ADN . . . . . 0.63 " O5'" HG22 ' A' ' 415' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1003 ' ' RIB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -72.84 167.58 26.89 Favored 'Trans proline' 0 C--N 1.317 -1.09 0 O-C-N 123.427 1.224 . . . . 0.0 110.381 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' LEU . . . . . 0.446 HD22 ' HA ' ' A' ' 365' ' ' LEU . 0.2 OUTLIER 53.14 78.42 0.14 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.045 -1.034 . . . . 0.0 110.782 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 102.21 119.51 4.57 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 8.0 t 54.55 99.59 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.145 -1.209 . . . . 0.0 110.806 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 151.94 -121.54 1.21 Allowed Glycine 0 N--CA 1.497 2.709 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 5.8 t -116.2 96.53 5.59 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.227 -1.161 . . . . 0.0 110.417 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -142.48 67.36 1.32 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.241 -0.912 . . . . 0.0 109.992 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -139.48 41.66 1.31 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.14 -58.75 0.27 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.259 -1.142 . . . . 0.0 110.358 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . 0.457 ' C ' HG23 ' A' ' 374' ' ' VAL . 0.0 OUTLIER -129.68 56.08 1.74 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.167 -0.958 . . . . 0.0 110.473 -179.899 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . 0.457 HG23 ' C ' ' A' ' 373' ' ' LYS . 90.6 t -149.65 160.9 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.182 -0.949 . . . . 0.0 110.168 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 26.6 tttm -83.77 84.87 7.4 Favored 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 119.223 -0.991 . . . . 0.0 109.202 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' ARG . . . . . 0.482 ' HB3' ' OG ' ' A' ' 397' ' ' SER . 1.9 mmt180 -69.07 152.78 44.78 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.277 -0.969 . . . . 0.0 108.925 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 6.5 t -70.62 144.37 51.17 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 119.486 -0.886 . . . . 0.0 108.903 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . 0.412 ' HB2' ' N ' ' A' ' 406' ' ' GLY . 0.1 OUTLIER -56.34 158.66 4.07 Favored 'General case' 0 N--CA 1.509 2.487 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.793 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 44.1 t -78.91 157.58 28.22 Favored 'General case' 0 N--CA 1.508 2.445 0 O-C-N 120.712 -1.243 . . . . 0.0 110.384 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 55.0 mtm -48.67 -29.5 4.45 Favored 'General case' 0 N--CA 1.513 2.721 0 O-C-N 121.211 -0.93 . . . . 0.0 112.242 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -121.83 17.83 11.03 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.967 -1.083 . . . . 0.0 112.447 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 46.42 -114.41 1.44 Allowed Glycine 0 N--CA 1.499 2.834 0 O-C-N 120.782 -1.199 . . . . 0.0 112.487 177.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . 0.531 ' HB2' ' HG3' ' A' ' 399' ' ' PRO . . . -76.83 -18.31 58.46 Favored 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.488 -1.007 . . . . 0.0 112.585 -178.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . 0.583 ' CB ' HN62 ' A' 1002 ' ' ADN . 33.6 m-80 -84.9 0.69 50.24 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 120.546 -1.346 . . . . 0.0 111.871 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 49.2 t -49.67 87.5 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.935 0 O-C-N 120.775 -1.203 . . . . 0.0 111.585 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' TYR . . . . . 0.443 ' N ' ' O ' ' A' ' 384' ' ' ASN . 31.8 p90 -66.14 -36.41 83.07 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 120.848 -1.157 . . . . 0.0 110.865 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.615 ' HD2' " H3'" ' A' 1003 ' ' RIB . 10.6 ptm180 -71.19 160.99 31.85 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.193 -0.942 . . . . 0.0 110.072 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 36.4 pttt -159.5 110.97 2.04 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.336 -0.853 . . . . 0.0 110.534 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -117.73 170.83 5.67 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 120.949 -1.095 . . . . 0.0 110.355 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -74.28 -27.93 11.01 Favored 'Trans proline' 0 N--CA 1.489 1.238 0 O-C-N 123.486 1.256 . . . . 0.0 110.875 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 58.3 t -103.12 -18.86 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 120.987 -1.071 . . . . 0.0 111.933 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . . . . . . . . . 34.3 t60 -65.12 -39.42 93.06 Favored 'General case' 0 N--CA 1.508 2.471 0 O-C-N 120.559 -1.338 . . . . 0.0 109.961 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -55.15 -37.18 66.65 Favored 'General case' 0 N--CA 1.51 2.568 0 C-N-CA 119.215 -0.994 . . . . 0.0 108.467 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.42 ' O ' ' NE ' ' A' ' 376' ' ' ARG . 1.2 mp0 -74.84 -31.01 61.55 Favored 'General case' 0 N--CA 1.502 2.16 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.076 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 23.2 m170 -75.72 -27.09 58.05 Favored 'General case' 0 N--CA 1.509 2.522 0 O-C-N 120.975 -1.078 . . . . 0.0 111.61 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -140.19 150.72 44.53 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.821 -1.174 . . . . 0.0 110.612 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . 0.482 ' OG ' ' HB3' ' A' ' 376' ' ' ARG . 3.1 m -89.46 171.74 9.5 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.467 -0.771 . . . . 0.0 109.836 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -144.56 153.03 54.56 Favored Pre-proline 0 N--CA 1.487 1.415 0 O-C-N 121.437 -0.79 . . . . 0.0 108.903 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . 0.531 ' HG3' ' HB2' ' A' ' 383' ' ' ALA . 35.7 Cg_endo -60.72 137.75 75.1 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 N-CA-C 109.0 -1.192 . . . . 0.0 109.0 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 104.07 -1.2 44.23 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.619 -1.277 . . . . 0.0 111.566 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -112.87 176.2 5.11 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 119.987 1.894 . . . . 0.0 109.3 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 2.7 t -79.15 -25.57 42.86 Favored 'General case' 0 N--CA 1.506 2.332 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.864 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -98.1 1.48 47.63 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.66 -1.275 . . . . 0.0 112.498 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -46.16 137.62 5.94 Favored 'General case' 0 N--CA 1.515 2.817 0 CA-C-N 120.096 1.316 . . . . 0.0 110.738 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.412 ' O ' ' HG3' ' A' ' 408' ' ' GLN . . . -139.56 20.85 2.92 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.461 -1.352 . . . . 0.0 112.196 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' GLY . . . . . 0.412 ' N ' ' HB2' ' A' ' 378' ' ' SER . . . -56.23 -26.16 49.52 Favored Glycine 0 N--CA 1.492 2.379 0 CA-C-N 119.959 1.879 . . . . 0.0 111.185 179.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.48 ' O ' HG12 ' A' ' 407' ' ' VAL . 84.9 t -102.83 70.79 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.342 -1.093 . . . . 0.0 110.256 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.412 ' HG3' ' O ' ' A' ' 405' ' ' GLY . 4.4 mp0 -77.48 81.67 3.94 Favored 'General case' 0 N--CA 1.513 2.694 0 O-C-N 120.978 -1.076 . . . . 0.0 110.074 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.592 HG23 ' CD ' ' A' ' 412' ' ' GLN . 88.3 mt -114.12 69.61 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.994 -1.066 . . . . 0.0 110.118 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . 0.554 HG13 ' O ' ' A' ' 410' ' ' VAL . 10.6 p -118.87 63.93 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.427 -0.796 . . . . 0.0 108.863 178.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 93.78 52.27 1.99 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 107.931 -2.068 . . . . 0.0 107.931 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' GLN . . . . . 0.592 ' CD ' HG23 ' A' ' 409' ' ' ILE . 2.8 mt-30 -47.83 -68.11 0.22 Allowed 'General case' 0 N--CA 1.512 2.652 0 O-C-N 121.46 -1.024 . . . . 0.0 111.265 -178.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -172.25 46.31 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.037 -1.039 . . . . 0.0 110.917 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -116.1 49.8 1.09 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.145 -0.972 . . . . 0.0 110.443 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.35 66.38 0.71 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.291 -0.881 . . . . 0.0 109.884 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -137.92 41.39 2.31 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.258 -0.901 . . . . 0.0 110.225 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.195 179.981 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A 1002 ' ' ADN . . . . . 0.583 HN62 ' CB ' ' A' ' 384' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1003 ' ' RIB . . . . . 0.615 " H3'" ' HD2' ' A' ' 387' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -72.62 169.15 22.58 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 O-C-N 123.45 1.237 . . . . 0.0 110.429 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.13 -176.37 3.33 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.289 -0.882 . . . . 0.0 110.143 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 83.31 -176.69 52.86 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 1.3 p -116.43 -57.87 2.15 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.205 -1.174 . . . . 0.0 110.239 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -138.37 53.2 0.72 Allowed Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 3.1 t -131.02 94.23 3.55 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.134 -1.215 . . . . 0.0 110.316 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -119.06 106.35 12.32 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.174 -0.954 . . . . 0.0 109.979 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -143.04 41.37 1.17 Allowed Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -146.57 -66.12 0.28 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.202 -1.175 . . . . 0.0 110.587 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . 0.412 ' C ' HG23 ' A' ' 374' ' ' VAL . 0.0 OUTLIER -158.06 73.28 0.67 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.174 -0.954 . . . . 0.0 110.86 -179.71 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . 0.412 HG23 ' C ' ' A' ' 373' ' ' LYS . 57.7 t -146.83 159.75 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.122 -0.986 . . . . 0.0 110.158 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 375' ' ' LYS . 0.0 OUTLIER -89.05 100.11 12.96 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 122.089 0.947 . . . . 0.0 109.078 179.093 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.46 -177.22 0.06 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.484 -0.76 . . . . 0.0 111.109 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 3.3 m -108.24 130.84 55.14 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . 0.484 ' HB3' ' HA3' ' A' ' 406' ' ' GLY . 30.7 t -48.91 118.44 2.6 Favored 'General case' 0 N--CA 1.515 2.802 0 O-C-N 121.656 -0.653 . . . . 0.0 110.724 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . 0.436 ' HB2' ' CD2' ' A' ' 398' ' ' HIS . 9.3 t -38.56 151.35 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.731 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -178.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 53.9 mtm -46.27 -34.6 4.57 Favored 'General case' 0 N--CA 1.509 2.513 0 O-C-N 121.838 -0.539 . . . . 0.0 111.117 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -114.52 9.33 16.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.123 -0.985 . . . . 0.0 113.163 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 57.82 -120.44 21.55 Favored Glycine 0 N--CA 1.491 2.361 0 O-C-N 120.175 -1.578 . . . . 0.0 112.159 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -75.6 -13.38 60.34 Favored 'General case' 0 N--CA 1.51 2.531 0 O-C-N 121.485 -1.009 . . . . 0.0 112.655 -178.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . 0.591 ' CB ' HN62 ' A' 1002 ' ' ADN . 58.1 m-20 -86.01 -2.35 58.22 Favored 'General case' 0 N--CA 1.507 2.407 0 O-C-N 120.575 -1.328 . . . . 0.0 111.12 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 52.7 t -47.02 89.54 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.998 0 O-C-N 120.825 -1.172 . . . . 0.0 111.872 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' TYR . . . . . 0.402 ' N ' ' O ' ' A' ' 384' ' ' ASN . 31.3 p90 -70.34 -38.19 74.8 Favored 'General case' 0 N--CA 1.508 2.428 0 O-C-N 120.892 -1.13 . . . . 0.0 110.956 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.422 ' HD3' ' CE1' ' A' ' 392' ' ' HIS . 14.1 ptm180 -57.79 152.26 16.08 Favored 'General case' 0 N--CA 1.51 2.532 0 O-C-N 121.028 -1.045 . . . . 0.0 110.262 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -142.16 79.16 1.66 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.244 -0.91 . . . . 0.0 111.058 -179.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -97.26 160.64 28.45 Favored Pre-proline 0 N--CA 1.502 2.137 0 O-C-N 120.977 -1.077 . . . . 0.0 110.534 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -75.96 -29.2 6.98 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 O-C-N 123.547 1.288 . . . . 0.0 111.214 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 57.3 t -99.15 -22.38 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 O-C-N 121.236 -0.915 . . . . 0.0 111.594 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . 0.422 ' CE1' ' HD3' ' A' ' 387' ' ' ARG . 38.4 t60 -59.19 -37.76 78.2 Favored 'General case' 0 N--CA 1.51 2.542 0 O-C-N 120.611 -1.305 . . . . 0.0 110.152 -179.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -59.39 -33.72 71.55 Favored 'General case' 0 N--CA 1.505 2.295 0 C-N-CA 119.112 -1.035 . . . . 0.0 108.805 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -72.19 -33.34 67.59 Favored 'General case' 0 N--CA 1.503 2.19 0 C-N-CA 119.206 -0.997 . . . . 0.0 110.828 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 27.2 m170 -79.64 -34.81 40.2 Favored 'General case' 0 N--CA 1.509 2.485 0 O-C-N 120.983 -1.073 . . . . 0.0 111.224 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -121.92 158.51 28.87 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.029 -1.044 . . . . 0.0 110.304 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.45 173.77 6.16 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 178.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . 0.436 ' CD2' ' HB2' ' A' ' 379' ' ' CYS . 76.6 m80 -145.74 157.35 51.47 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 120.891 -1.131 . . . . 0.0 108.871 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -62.69 140.57 81.49 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 N-CA-C 108.892 -1.234 . . . . 0.0 108.892 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.88 -3.63 55.9 Favored Glycine 0 N--CA 1.496 2.689 0 C-N-CA 119.684 -1.246 . . . . 0.0 111.299 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -112.14 177.17 4.73 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 119.544 1.672 . . . . 0.0 108.689 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 1.4 p -79.36 -28.34 41.97 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.099 -1.04 . . . . 0.0 110.556 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -88.29 -4.45 58.69 Favored 'General case' 0 N--CA 1.509 2.501 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -176.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . 0.432 ' CE1' ' OG ' ' A' ' 378' ' ' SER . 7.9 t80 -39.06 125.07 1.52 Allowed 'General case' 0 N--CA 1.533 3.679 0 CA-C-N 120.742 1.61 . . . . 0.0 111.869 -178.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -177.05 75.83 0.07 OUTLIER Glycine 0 N--CA 1.501 2.986 0 C-N-CA 119.308 -1.425 . . . . 0.0 111.327 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' GLY . . . . . 0.484 ' HA3' ' HB3' ' A' ' 378' ' ' SER . . . -144.62 -55.66 0.02 OUTLIER Glycine 0 N--CA 1.505 3.263 0 C-N-CA 119.501 -1.333 . . . . 0.0 111.933 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.583 ' O ' HG13 ' A' ' 407' ' ' VAL . 11.5 p -105.72 61.3 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-N 118.713 1.256 . . . . 0.0 110.312 -179.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -134.0 92.89 3.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.396 -0.815 . . . . 0.0 109.601 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.531 HG23 ' CD ' ' A' ' 412' ' ' GLN . 77.8 mt -99.59 68.84 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.245 -0.909 . . . . 0.0 109.559 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 57.8 t -119.86 70.96 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 97.59 53.83 1.29 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 108.379 -1.889 . . . . 0.0 108.379 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' GLN . . . . . 0.531 ' CD ' HG23 ' A' ' 409' ' ' ILE . 6.6 mt-30 -49.27 -62.73 1.38 Allowed 'General case' 0 N--CA 1.511 2.615 0 O-C-N 121.348 -1.089 . . . . 0.0 110.711 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -141.39 36.01 1.68 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.269 -0.894 . . . . 0.0 110.343 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -113.22 43.29 1.76 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.152 -0.967 . . . . 0.0 110.142 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -116.72 66.9 0.72 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.293 -0.88 . . . . 0.0 109.902 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 53.41 41.13 32.15 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.11 -0.994 . . . . 0.0 110.643 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 27.5 t0 . . . . . 0 N--CA 1.501 2.094 0 O-C-N 121.066 -1.021 . . . . 0.0 110.761 179.979 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A 1002 ' ' ADN . . . . . 0.591 HN62 ' CB ' ' A' ' 384' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1003 ' ' RIB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.317 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -72.78 -40.45 1.94 Allowed 'Trans proline' 0 C--N 1.317 -1.12 0 O-C-N 123.4 1.21 . . . . 0.0 110.4 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' LEU . . . . . 0.413 HD22 ' HA ' ' A' ' 365' ' ' LEU . 0.1 OUTLIER -133.75 -60.23 0.83 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.143 -0.973 . . . . 0.0 110.171 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 96.72 -82.79 0.76 Allowed Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 2.4 t -116.92 -57.23 2.19 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.224 -1.162 . . . . 0.0 110.141 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 135.88 148.61 5.61 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 17.4 m -116.16 44.08 2.03 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.217 -1.167 . . . . 0.0 109.916 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -114.42 -54.68 2.56 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.332 -0.855 . . . . 0.0 110.547 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 155.59 -78.65 0.19 Allowed Glycine 0 N--CA 1.497 2.722 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -143.17 60.56 1.41 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.183 -1.186 . . . . 0.0 110.348 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 52.01 65.03 1.62 Allowed 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.057 -1.027 . . . . 0.0 110.626 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 11.1 p -143.67 160.66 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.259 -0.901 . . . . 0.0 110.595 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.23 97.62 10.03 Favored 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 119.337 -0.945 . . . . 0.0 108.533 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' ARG . . . . . 0.4 ' NE ' ' HA ' ' A' ' 376' ' ' ARG . 0.2 OUTLIER -68.64 148.14 50.88 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.641 -0.824 . . . . 0.0 109.919 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 5.8 t -69.08 142.59 54.44 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 19.0 p -55.65 156.49 4.79 Favored 'General case' 0 N--CA 1.508 2.427 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 48.5 t -80.31 154.08 28.03 Favored 'General case' 0 N--CA 1.507 2.419 0 O-C-N 120.763 -1.211 . . . . 0.0 111.039 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 60.4 mtm -49.34 -33.26 13.03 Favored 'General case' 0 N--CA 1.516 2.844 0 O-C-N 121.303 -0.873 . . . . 0.0 111.288 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . 0.431 ' CD1' ' N3 ' ' A' 1002 ' ' ADN . 16.0 m-85 -136.36 39.13 2.69 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.208 -0.932 . . . . 0.0 108.831 178.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -39.02 -43.07 1.72 Allowed Glycine 0 N--CA 1.509 3.504 0 O-C-N 121.521 -0.737 . . . . 0.0 113.064 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -62.01 -29.53 70.34 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.015 -1.285 . . . . 0.0 110.745 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . 0.474 ' HB2' HN62 ' A' 1002 ' ' ADN . 7.2 m-80 -133.66 25.14 4.05 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.955 -1.091 . . . . 0.0 111.803 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 17.1 t -47.81 90.12 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.022 0 O-C-N 120.788 -1.195 . . . . 0.0 112.269 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 24.8 p90 -62.92 -41.92 99.63 Favored 'General case' 0 N--CA 1.51 2.569 0 O-C-N 120.832 -1.168 . . . . 0.0 110.289 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.451 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 0.2 OUTLIER -63.98 157.07 26.02 Favored 'General case' 0 N--CA 1.509 2.499 0 O-C-N 121.134 -0.979 . . . . 0.0 110.231 -179.531 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.38 92.23 1.58 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.314 -0.866 . . . . 0.0 110.805 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -106.84 162.68 18.9 Favored Pre-proline 0 N--CA 1.5 2.059 0 O-C-N 121.138 -0.976 . . . . 0.0 110.44 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -74.17 -26.53 12.6 Favored 'Trans proline' 0 CA--C 1.545 1.072 0 O-C-N 123.56 1.295 . . . . 0.0 111.264 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 60.8 t -99.86 -24.8 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 O-C-N 121.141 -0.974 . . . . 0.0 111.492 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . 0.433 ' CE1' ' NH1' ' A' ' 387' ' ' ARG . 44.8 t60 -61.36 -36.93 81.56 Favored 'General case' 0 N--CA 1.511 2.588 0 O-C-N 120.633 -1.292 . . . . 0.0 110.19 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -56.49 -34.27 66.8 Favored 'General case' 0 N--CA 1.507 2.4 0 C-N-CA 119.117 -1.033 . . . . 0.0 108.492 177.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.72 -32.85 58.1 Favored 'General case' 0 N--CA 1.506 2.36 0 C-N-CA 119.454 -0.899 . . . . 0.0 111.087 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -75.74 -34.41 60.29 Favored 'General case' 0 N--CA 1.509 2.524 0 O-C-N 121.133 -0.979 . . . . 0.0 110.938 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -128.56 151.27 49.65 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.985 -1.072 . . . . 0.0 110.528 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.33 168.83 11.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.577 -0.702 . . . . 0.0 109.322 178.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -140.94 152.93 66.7 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.357 -0.839 . . . . 0.0 109.728 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . 0.442 ' HA ' ' CD2' ' A' ' 404' ' ' TYR . 36.3 Cg_endo -59.43 136.87 74.55 Favored 'Trans proline' 0 C--N 1.316 -1.153 0 N-CA-C 108.839 -1.254 . . . . 0.0 108.839 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 102.41 0.04 50.16 Favored Glycine 0 CA--C 1.55 2.244 0 C-N-CA 119.635 -1.269 . . . . 0.0 111.419 -179.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -111.28 171.91 7.2 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 119.954 1.877 . . . . 0.0 109.451 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 50.5 m -75.5 -24.48 56.88 Favored 'General case' 0 N--CA 1.505 2.323 0 C-N-CA 119.246 -0.982 . . . . 0.0 111.103 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -102.14 5.89 40.57 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 120.644 -1.285 . . . . 0.0 112.728 -178.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . 0.442 ' CD2' ' HA ' ' A' ' 399' ' ' PRO . 14.0 t80 -44.65 133.46 5.91 Favored 'General case' 0 N--CA 1.515 2.815 0 O-C-N 120.688 -1.258 . . . . 0.0 112.483 -179.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -72.26 -34.13 61.28 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.209 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 109.13 94.6 2.33 Favored Glycine 0 N--CA 1.496 2.643 0 CA-C-N 119.236 1.518 . . . . 0.0 110.902 179.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.616 ' O ' HG13 ' A' ' 407' ' ' VAL . 14.9 p -23.36 102.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.433 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -144.57 72.04 1.33 Allowed 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 176.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.483 HG23 ' CD ' ' A' ' 412' ' ' GLN . 70.2 mt -81.26 67.66 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 O-C-N 121.325 -0.859 . . . . 0.0 110.564 -178.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . 0.433 ' O ' HG12 ' A' ' 410' ' ' VAL . 81.5 t -125.49 63.02 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 96.41 52.38 1.59 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 107.868 -2.093 . . . . 0.0 107.868 -177.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' GLN . . . . . 0.483 ' CD ' HG23 ' A' ' 409' ' ' ILE . 2.6 mt-30 -49.51 -62.71 1.4 Allowed 'General case' 0 N--CA 1.512 2.67 0 O-C-N 121.385 -1.067 . . . . 0.0 110.733 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -129.41 41.16 3.5 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.21 -0.931 . . . . 0.0 109.758 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 53.0 39.39 29.36 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.133 -0.979 . . . . 0.0 110.615 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.44 64.86 0.94 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.288 -0.882 . . . . 0.0 110.044 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -119.49 43.07 2.72 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.256 -0.903 . . . . 0.0 110.172 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.142 -179.934 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A 1002 ' ' ADN . . . . . 0.474 HN62 ' HB2' ' A' ' 384' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1003 ' ' RIB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.347 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.74 109.29 2.75 Favored 'Trans proline' 0 C--N 1.318 -1.036 0 O-C-N 123.482 1.253 . . . . 0.0 110.442 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 4.0 tp -128.93 129.33 45.33 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.215 -0.928 . . . . 0.0 110.174 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 84.7 -109.47 3.26 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 1.9 t -134.23 78.94 1.78 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.21 -1.171 . . . . 0.0 110.168 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -132.72 84.58 0.29 Allowed Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 6.2 t -142.48 129.47 20.72 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.174 -1.191 . . . . 0.0 110.195 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -142.68 88.14 2.04 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.191 -0.943 . . . . 0.0 110.174 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -144.32 41.03 1.13 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -137.27 -65.0 0.55 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.23 -1.159 . . . . 0.0 110.029 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.49 62.34 1.42 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.194 -0.941 . . . . 0.0 110.227 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 60.0 t -144.61 160.51 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.202 -0.936 . . . . 0.0 109.917 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 31.6 mtpt -88.71 94.32 9.87 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 119.618 -0.833 . . . . 0.0 109.732 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' ARG . . . . . 0.434 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 42.1 mtm-85 -55.81 146.01 22.83 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.706 -0.621 . . . . 0.0 110.573 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 2.3 m -69.28 137.48 53.08 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 87.4 p -52.84 157.3 1.7 Allowed 'General case' 0 N--CA 1.512 2.656 0 O-C-N 121.054 -1.029 . . . . 0.0 109.749 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . . . . . . . . . 12.7 t -80.74 158.52 25.49 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 120.854 -1.154 . . . . 0.0 109.107 179.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -55.59 -39.12 70.3 Favored 'General case' 0 N--CA 1.513 2.688 0 O-C-N 121.149 -0.97 . . . . 0.0 109.946 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . 0.42 ' HB2' ' N1 ' ' A' 1002 ' ' ADN . 8.5 m-85 -128.29 38.29 4.01 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -38.04 -44.87 1.58 Allowed Glycine 0 N--CA 1.507 3.373 0 O-C-N 121.321 -0.862 . . . . 0.0 113.13 -177.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -59.35 -27.86 66.32 Favored 'General case' 0 N--CA 1.507 2.422 0 CA-C-N 118.653 1.226 . . . . 0.0 110.703 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . 0.432 ' HB2' HN62 ' A' 1002 ' ' ADN . 7.4 m-80 -133.14 19.82 4.06 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.843 -1.161 . . . . 0.0 112.109 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 33.7 t -43.75 88.78 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.367 0 CA-C-N 119.787 1.176 . . . . 0.0 112.775 -178.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 387' ' ' ARG . 20.4 p90 -63.17 -40.59 97.96 Favored 'General case' 0 N--CA 1.509 2.504 0 O-C-N 120.95 -1.094 . . . . 0.0 111.537 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.455 ' N ' ' CD1' ' A' ' 386' ' ' TYR . 15.1 ptm180 -56.02 151.15 12.41 Favored 'General case' 0 N--CA 1.513 2.708 0 O-C-N 120.821 -1.175 . . . . 0.0 110.376 -179.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -133.34 72.68 1.49 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.142 -0.974 . . . . 0.0 110.725 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -106.71 149.27 38.22 Favored Pre-proline 0 N--CA 1.498 1.972 0 O-C-N 121.094 -1.004 . . . . 0.0 109.547 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -69.73 -83.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.316 -1.173 0 O-C-N 123.498 1.262 . . . . 0.0 108.94 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 88.2 t -38.64 -26.48 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.526 3.358 0 O-C-N 120.833 -1.167 . . . . 0.0 113.288 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . 0.426 ' CE1' ' HD3' ' A' ' 387' ' ' ARG . 25.9 t60 -64.15 -39.36 93.84 Favored 'General case' 0 N--CA 1.512 2.626 0 O-C-N 120.312 -1.493 . . . . 0.0 108.504 177.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -59.87 -37.42 79.26 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.291 -0.881 . . . . 0.0 109.228 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -70.01 -26.55 64.12 Favored 'General case' 0 N--CA 1.507 2.393 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.215 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 19.2 m170 -90.99 -34.6 15.08 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.757 -1.214 . . . . 0.0 110.605 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -117.33 144.45 44.88 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.048 -1.033 . . . . 0.0 110.355 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . 0.434 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 0.1 OUTLIER -98.0 167.03 11.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 110.528 179.611 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -140.07 153.57 69.43 Favored Pre-proline 0 N--CA 1.488 1.431 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.894 -178.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -62.28 137.9 68.53 Favored 'Trans proline' 0 N--CA 1.484 0.954 0 N-CA-C 108.038 -1.562 . . . . 0.0 108.038 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.37 -2.35 56.22 Favored Glycine 0 CA--C 1.551 2.343 0 C-N-CA 119.695 -1.24 . . . . 0.0 110.384 -177.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -115.47 140.07 49.48 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 119.649 1.725 . . . . 0.0 108.499 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 5.8 m -49.43 -25.61 2.69 Favored 'General case' 0 N--CA 1.509 2.512 0 O-C-N 121.11 -0.994 . . . . 0.0 113.201 -178.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -99.32 11.1 40.04 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 120.28 -1.513 . . . . 0.0 113.551 -177.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . 0.476 ' CE2' ' O ' ' A' ' 406' ' ' GLY . 6.1 t80 -51.91 142.73 14.88 Favored 'General case' 0 N--CA 1.515 2.816 0 O-C-N 120.365 -1.46 . . . . 0.0 109.487 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -135.26 29.2 2.94 Favored Glycine 0 N--CA 1.499 2.895 0 C-N-CA 119.267 -1.444 . . . . 0.0 112.157 -178.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' GLY . . . . . 0.476 ' O ' ' CE2' ' A' ' 404' ' ' TYR . . . -141.71 142.54 12.03 Favored Glycine 0 C--O 1.209 -1.464 0 N-CA-C 107.544 -2.222 . . . . 0.0 107.544 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 95.4 t -129.02 72.82 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 O-C-N 121.264 -1.139 . . . . 0.0 108.558 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -79.87 88.92 5.26 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.928 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 61.8 mt -103.08 78.08 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.105 -0.997 . . . . 0.0 109.912 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . 0.467 ' O ' HG12 ' A' ' 410' ' ' VAL . 59.1 t -113.53 63.67 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.234 -0.916 . . . . 0.0 109.612 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 118.42 -46.34 1.15 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 65.85 -66.08 0.17 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.713 -0.875 . . . . 0.0 110.93 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -159.69 39.55 0.19 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.111 -0.993 . . . . 0.0 110.961 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 51.52 41.88 28.96 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.953 -1.092 . . . . 0.0 110.888 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . 0.455 ' O ' HG23 ' A' ' 415' ' ' THR . 6.1 t -131.94 62.65 1.63 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.272 -0.893 . . . . 0.0 110.116 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -102.87 39.25 1.57 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.223 -0.923 . . . . 0.0 109.944 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 . . . . . 0 N--CA 1.495 1.824 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.342 179.933 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A 1002 ' ' ADN . . . . . 0.432 HN62 ' HB2' ' A' ' 384' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1003 ' ' RIB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_